Page last updated: 2024-11-08

carbon tetrachloride and Disease Models, Animal

carbon tetrachloride has been researched along with Disease Models, Animal in 878 studies

Carbon Tetrachloride: A solvent for oils, fats, lacquers, varnishes, rubber waxes, and resins, and a starting material in the manufacturing of organic compounds. Poisoning by inhalation, ingestion or skin absorption is possible and may be fatal. (Merck Index, 11th ed)
tetrachloromethane : A chlorocarbon that is methane in which all the hydrogens have been replaced by chloro groups.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" The objective of the present study was to evaluate the antioxidant, cytotoxic, thrombolytic, and antidiarrheal activities of carbon tetrachloride (CCl4) fraction of leaves of A."7.96Evaluation of carbon tetrachloride fraction of Actinodaphne angustifolia Nees (Lauraceae) leaf extract for antioxidant, cytotoxic, thrombolytic and antidiarrheal properties. ( Alam, T; Azam, S; Islam, MA; Jakaria, M; Kamal, AM; Khan, TA; Uddin, MN; Zaman, RU, 2020)
" This study aimed to use a mouse model of carbon tetrachloride (CCL₄)-induced liver fibrosis to investigate the effects of BM-MSCs during liver hypoxia and the involvement of the transforming growth factor beta 1 (TGF-ß1) and SMADs pathway."7.91Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis. ( Chen, T; Li, J; Xiao, P; Xie, X; Yan, X; Zhang, L; Zhou, D; Zhu, J, 2019)
"Modulation of chemokine CXCL12 and its receptor CXCR4 has been implicated in attenuation of bleomycin (BLM)-induced pulmonary fibrosis and carbon tetrachloride (CCl4)-induced hepatic injury."7.83Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice. ( Barta, I; Chow, LN; Crawford, J; Gusti, V; Hughes, MR; Lecour, S; Lo, B; Manisali, I; McNagny, KM; Ng, BY; Schreiner, P; Scott, RW; Simonson, E; Underhill, TM; Webb, M, 2016)
"Launaea procumbens methanol extract (LPME) was evaluated against carbon tetrachloride (CCl4)-induced pancreatic oxidative damage and hyperglycemia in rats."7.81Carbon tetrachloride-induced lipid peroxidation and hyperglycemia in rat: a novel study. ( Ahmed, M; Khan, MR; Khan, RA; Sahreen, S; Shah, NA, 2015)
" Then, we examined possible in vivo hepatoprotective effects of EP extract on mouse models of carbon tetrachloride (CCl4)-induced chronic and acute liver failure."7.80Protective effects of Ephedra pachyclada extract on mouse models of carbon tetrachloride- induced chronic and acute liver failure. ( Azarnia, M; Ghasemi, M; Jamali, M; Mirabolghasemi, G; Naghizadeh, MM; Nazarian, S; Rajabi, M; Tahamtani, Y, 2014)
" In this study, we investigated whether 3-genes iPSC transplantation is capable of rescuing carbon tetrachloride (CCl(4))-induced fulminant hepatic failure and hepatic encephalopathy in mice."7.78Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc. ( Chang, HM; Chang, YL; Chen, HL; Chen, LK; Chen, SY; Chen, YJ; Chiang, CH; Chien, Y; Hsieh, JH; Huo, TI; Jeng, SY; Lai, YH; Li, HY; Liao, YW; Peng, CH, 2012)
" Forty Sprague-Dawley rats with carbon tetrachloride-induced liver cirrhosis and 20 control rats were intraperitoneally administered a single dose of DEG, and randomly killed 1, 2, 5 or 8 days following exposure."7.77Pre-existing liver cirrhosis reduced the toxic effect of diethylene glycol in a rat model due to the impaired hepatic alcohol dehydrogenase. ( , 2011)
"The aim of this study was to investigate the pharmacokinetic changes of verapamil and its major metabolite, norverapamil, after oral administration of verapamil (10 mg/kg) in rabbits with slight, moderate and severe hepatic failure induced by carbon tetrachloride."7.73Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride. ( Burm, JP; Choi, JS, 2005)
"The aim of the present work was to assess the capacity of Spirulina maxima to prevent fatty liver development induced in rats by an intraperitoneal single dose (1 ml/kg) of carbon tetrachloride."7.70Spirulina maxima prevents induction of fatty liver by carbon tetrachloride in the rat. ( Díaz-Zagoya, JC; Juárez-Oropeza, MA; Mascher, D; Miranda-Zamora, R; Paredes-Carbajal, MC; Torres-Durán, PV, 1998)
"To predict the potential utility of calcitriol in human osteoporosis with hepatic dysfunction, we examined the effects of calcitriol and alfacalcidol in ovariectomized (OVX) aged-rats with CCl4-induced hepatic failure."7.70[Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure]. ( Ishibashi, Y; Kojima, E; Kuriyama, K; Kusajima, H; Momo, K; Tachiiri, T; Yamanishi, A, 1999)
"Metformin is a hypoglycaemic agent used to treat type 2 diabetes mellitus (DM2) patients, with a broad safety profile."5.51Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma. ( Callegari, E; Gramantieri, L; Guerriero, P; Negrini, M; Pinton, P; Rimessi, A; Sabbioni, S; Shankaraiah, RC; Silini, EM, 2019)
"Several hallmarks of liver fibrosis are influenced by S1P, and the interference of S1P signaling by treatment with FTY720 results in beneficial effects in various animal models of fibrosis."5.40FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells. ( Kong, Y; Tang, N; Wang, H; Wang, S, 2014)
"Chronic inflammation was induced by i."5.40Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice. ( Barbosa, KP; de França, ME; Luna, RL; Nunes, AK; Oliveira, AG; Oliveira, WH; Pastor, AF; Peixoto, CA; Rocha, SW; Rodrigues, GB, 2014)
"In rats with acute hepatic failure, the hepatic P-glycoprotein concentration increased 1."5.31Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure. ( Huang, ZH; Murakami, T; Nagai, J; Okochi, A; Takano, M; Yumoyo, R, 2001)
"The relationships between the pharmacokinetic behaviour of glycyrrhizin and its restorative effect for hepatic function were investigated in patients with chronic hepatitis and in rats chronically treated with carbon tetrachloride (CCl4-treated rats)."5.08The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride-intoxicated rats. ( Aikawa, T; Iga, T; Kotaki, H; Sawada, Y; Tanaka, N; Yamamura, Y, 1997)
" In carbon tetrachloride-induced micronodular cirrhosis, portal sinusoidal flow, which reaches liver parenchyma, is high, and this is more pronounced in the presence of ascites."4.81Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow. ( Reichen, J; Sägesser, H; Van de Casteele, M; Zimmermann, H, 2001)
"Here, we examine the impact of housing temperature on steatosis, hepatocellular damage, hepatic inflammation, and fibrosis in NASH diet, methionine and choline deficient diet, and western diet + carbon tetrachloride experimental models of NAFLD in C57BL/6 mice."4.31Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease. ( Alarcon, PC; Damen, MSMA; Divanovic, S; Giles, DA; Moreno-Fernandez, ME; Oates, JR; Sawada, K; Stankiewicz, TE; Szabo, S, 2023)
"The effects of the miR-125a/VDR axis on hepatic fibrosis and its underlying mechanisms were investigated in a carbon tetrachloride (CCl4)-induced mouse model and patients with liver cirrhosis by immunohistochemistry, real-time PCR, Western blotting, and luciferase reporter assay."4.02MicroRNA-125a/VDR axis impaired autophagic flux and contributed to fibrosis in a CCL4-induced mouse model and patients with liver cirrhosis. ( Fan, Z; He, W; Liu, L; Ni, W; Wang, X; Zhao, L, 2021)
" The objective of the present study was to evaluate the antioxidant, cytotoxic, thrombolytic, and antidiarrheal activities of carbon tetrachloride (CCl4) fraction of leaves of A."3.96Evaluation of carbon tetrachloride fraction of Actinodaphne angustifolia Nees (Lauraceae) leaf extract for antioxidant, cytotoxic, thrombolytic and antidiarrheal properties. ( Alam, T; Azam, S; Islam, MA; Jakaria, M; Kamal, AM; Khan, TA; Uddin, MN; Zaman, RU, 2020)
" This study aimed to use a mouse model of carbon tetrachloride (CCL₄)-induced liver fibrosis to investigate the effects of BM-MSCs during liver hypoxia and the involvement of the transforming growth factor beta 1 (TGF-ß1) and SMADs pathway."3.91Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis. ( Chen, T; Li, J; Xiao, P; Xie, X; Yan, X; Zhang, L; Zhou, D; Zhu, J, 2019)
"Canine BM cells were harvested and cultured, and the resultant BMSCs were returned to carbon tetrachloride (CCl4)-induced liver cirrhosis model canines via either a peripheral vein (Vein group) or hepatic artery (Artery group)."3.91Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model. ( Aibe, Y; Fujisawa, K; Matsuda, T; Matsumoto, T; Nishimura, T; Sakaida, I; Sasaki, R; Takami, T; Tani, K; Taura, Y; Yamamoto, N, 2019)
"The aim of the study was to examine whether a rat model of liver cirrhosis induced by carbon tetrachloride (CCl4) is a suitable model of muscle wasting and alterations in amino acid metabolism in cirrhotic humans."3.88Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis. ( Holeček, M; Vodeničarovová, M, 2018)
"Liver fibrosis/cirrhosis was induced in wild type and TGFβ overproducing transgenic mice by carbon tetrachloride and thioacetamide administration."3.85Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models. ( Bugyik, E; Dezső, K; Mózes, M; Nagy, P; Paku, S; Rókusz, A; Szücs, A; Veres, D, 2017)
"The effect of systemic treatment with adipose tissue-derived MSCs, pre-differentiated into hepatocytic cells, was investigated in a rat model of liver cirrhosis induced by chronic inhalation of carbon tetrachloride."3.85Improvement of portal venous pressure in cirrhotic rat livers by systemic treatment with adipose tissue-derived mesenchymal stromal cells. ( Brückner, S; Christ, B; Hempel, M; Roderfeld, M; Roeb, E; Schwill, F; Thonig, A; Zipprich, A, 2017)
"Modulation of chemokine CXCL12 and its receptor CXCR4 has been implicated in attenuation of bleomycin (BLM)-induced pulmonary fibrosis and carbon tetrachloride (CCl4)-induced hepatic injury."3.83Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice. ( Barta, I; Chow, LN; Crawford, J; Gusti, V; Hughes, MR; Lecour, S; Lo, B; Manisali, I; McNagny, KM; Ng, BY; Schreiner, P; Scott, RW; Simonson, E; Underhill, TM; Webb, M, 2016)
"Curcumin significantly attenuated inflammation and fibrosis, as revealed by histological and biochemical analysis."3.83Curcumin protects against liver fibrosis by attenuating infiltration of Gr1hi monocytes through inhibition of monocyte chemoattractant protein-1. ( Chen, J; Huang, R; Liu, Y; Pan, Z; Sun, Z; Wang, G; Wang, J; Wu, C; Wu, H; Xia, J; Xiong, Y; Yan, X; Zhang, Z, 2016)
"Launaea procumbens methanol extract (LPME) was evaluated against carbon tetrachloride (CCl4)-induced pancreatic oxidative damage and hyperglycemia in rats."3.81Carbon tetrachloride-induced lipid peroxidation and hyperglycemia in rat: a novel study. ( Ahmed, M; Khan, MR; Khan, RA; Sahreen, S; Shah, NA, 2015)
" U-MSCs and DHLCs were injected 48 h after induced fulminant hepatitis (intraperitoneal injection of carbon tetrachloride) in SCID/BALB-c mice."3.81Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis. ( Boin, I; da Silva Santos Duarte, A; Escanhoela, C; Kharmandayan, P; Latuf-Filho, P; Malheiros Luzo, ÂC; Manzini, BM; Olalla Saad, ST; Ramos, AL; Sankaramanivel, S, 2015)
"Sorafenib--a broad kinase inhibitor--is a standard therapy for advanced hepatocellular carcinoma (HCC) and has been shown to exert antifibrotic effects in liver cirrhosis, a precursor of HCC."3.80Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice. ( Chen, Y; Duda, DG; Duyverman, AM; Hiddingh, L; Huang, P; Huang, Y; Jain, RK; Koppel, C; Lauwers, GY; Reiberger, T; Roberge, S; Samuel, R; Zhu, AX, 2014)
" Then, we examined possible in vivo hepatoprotective effects of EP extract on mouse models of carbon tetrachloride (CCl4)-induced chronic and acute liver failure."3.80Protective effects of Ephedra pachyclada extract on mouse models of carbon tetrachloride- induced chronic and acute liver failure. ( Azarnia, M; Ghasemi, M; Jamali, M; Mirabolghasemi, G; Naghizadeh, MM; Nazarian, S; Rajabi, M; Tahamtani, Y, 2014)
"This study demonstrates that hesperidin prevents experimental necrosis and fibrosis."3.80Hesperidin prevents liver fibrosis in rats by decreasing the expression of nuclear factor-κB, transforming growth factor-β and connective tissue growth factor. ( Muriel, P; Pérez-Vargas, JE; Segovia, J; Shibayama, M; Tsutsumi, V; Zarco, N, 2014)
" C57BL/6N mice were fed a high-fat diet (HFD) to develop obesity and were either administered carbon tetrachloride (CCl4 ) eight times (0."3.79A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. ( Ishikawa, F; Kado, S; Kano, M; Kobayashi, T; Kubota, N; Masuoka, N; Miyazaki, K; Nagata, Y, 2013)
" In this study, we found that diethylnitrosamine initiation with CCl4 and ethanol promotion could induce a short-term, two-stage liver carcinogenesis model in male BALB/c mice, the process of hepatocarcinogenesis including liver damage, liver necrosis/cell death, liver inflammation, liver proliferation, liver hyperplasia, liver steatosis, and liver cirrhosis and hepatocellular nodules, which mimicked the usual sequence of events observed in human HCC."3.79Two-stage model of chemically induced hepatocellular carcinoma in mouse. ( Huang, SX; Kuang, ZP; Li, YD; Luo, M; Luo, XL; Wu, JN; Xie, YA; Yang, F, 2013)
" In the present experiments we investigated the efficiency of a primary hepatocyte mitogen 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOB) on two different liver cirrhosis/fibrosis models in mice induced by chronic administration of CCl(4) and thioacetamide respectively."3.781,4-Bis[2-(3,5-dichloropyridyloxy)]benzene induces substantial hyperplasia in fibrotic mouse liver. ( Bugyik, E; Dezso, K; Nagy, P; Paku, S; Szurián, K; Turányi, E, 2012)
" In this study, we investigated whether 3-genes iPSC transplantation is capable of rescuing carbon tetrachloride (CCl(4))-induced fulminant hepatic failure and hepatic encephalopathy in mice."3.78Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc. ( Chang, HM; Chang, YL; Chen, HL; Chen, LK; Chen, SY; Chen, YJ; Chiang, CH; Chien, Y; Hsieh, JH; Huo, TI; Jeng, SY; Lai, YH; Li, HY; Liao, YW; Peng, CH, 2012)
"Droxidopa might be an effective therapeutic agent for hemodynamic and renal alterations of liver cirrhosis and should be tested in cirrhosis patients."3.78Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats. ( Augustin, S; Brull, A; Coll, M; Esteban, R; Ezkurdia, N; Genescà, J; Guardia, J; Martell, M; Raurell, I; Rodriguez, S, 2012)
" Forty Sprague-Dawley rats with carbon tetrachloride-induced liver cirrhosis and 20 control rats were intraperitoneally administered a single dose of DEG, and randomly killed 1, 2, 5 or 8 days following exposure."3.77Pre-existing liver cirrhosis reduced the toxic effect of diethylene glycol in a rat model due to the impaired hepatic alcohol dehydrogenase. ( , 2011)
" Female rats with carbon tetrachloride (CCl₄-induced liver cirrhosis were injected CM-DiI-labeled monocytes, CD14⁻ cells (1 x 10⁷ cells/rat) or saline via the portal vein."3.76The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. ( Cao, Y; Cheng, X; Cui, L; Fan, D; Han, Y; Han, Z; Liang, J; Qiao, L; Shi, Y; Wang, J; Yan, L; Zhou, X, 2010)
"Human MSCs labeled with FDA-approved SPIO particles (Feridex) were transplanted via the mesenteric vein into rabbits (n = 16) with carbon tetrachloride-induced hepatic failure."3.76MRI of magnetically labeled mesenchymal stem cells in hepatic failure model. ( Choi, SH; Chung, SY; Kim, HC; Kim, HS; Lee, JM; Moon, WK; Son, KR, 2010)
" This study determined the role of nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase deficiency in the development of hepatocellular necrosis, inflammation, and apoptosis in relation to fibrosis produced by chronic carbon tetrachloride (CCl(4)) administration."3.75Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. ( Aram, G; Liu, X; Mezey, E; Potter, JJ; Torbenson, MS; Wang, L, 2009)
"We investigated the effect of human umbilical mesenchymal stem cells (HUMSCs) from Wharton's jelly on carbon tetrachloride (CCl4)-induced liver fibrosis in rats."3.75The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. ( Chen, TH; Chen, YM; Fu, TW; Fu, YS; Hung, SC; Ko, TL; Shih, YH; Tsai, PC, 2009)
"The liver injury in the model rat was induced by alpha-naphthylisothiocyanate (ANIT) and carbon tetrachloride (CCl(4) ) respectively, and the effects of Yinchenhao Decoction (, YCHD), a proved effective Chinese medical formula for treating the dampness-heat jaundice syndrome in clinic, on the two liver injury models were evaluated by analyzing the serum level of alanine aminotransferase (ALT), asparate aminotransferase (AST), alkaline phosphatase (ALP), malondialchehyche (MDA), total bilirubin (T-BIL), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX) as well as the ratio of liver weight to body weight."3.75Comparative study on the protective effects of Yinchenhao Decoction against liver injury induced by alpha-naphthylisothiocyanate and carbon tetrachloride. ( Cao, HX; Jiang, XG; Liu, L; Lu, HT; Sun, H; Sun, WJ; Wang, P; Wang, XJ; Wu, ZM; Zhang, GM; Zhou, J, 2009)
"Rat models of experimental hepatic fibrosis were established by injection with CCl(4); the treated rats received emodin via oral administration at a dosage of 20 mg/kg twice a week at the same time."3.75Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation. ( Dong, MX; Geng, YT; Jia, Y; Li, CC; Li, XY; Liu, JC; Niu, YC; Zhang, YB; Zhou, L, 2009)
" plantarum strains were administered in ornithine transcarbamoylase-deficient Sparse-fur mice, a model of constitutive hyperammonemia, in a carbon tetrachloride rat model of chronic liver insufficiency and in a thioacetamide-induced acute liver failure mice model."3.74Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. ( Demetter, P; Devière, J; Goffin, P; Gustot, T; Hols, P; Moreno, C; Nicaise, C; Prozzi, D; Quertinmont, E; Suain, V; Viaene, E, 2008)
" In our present study, an ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) method has been established and validated for simultaneous quantitation of 22 BAs and a metabonomic study was performed based on the chemometric analysis of the serum samples from carbon tetrachloride (CCl4)- and alpha-naphthylisothiocyanate (ANIT)-induced liver failure rats."3.74Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry. ( He, Y; Hu, Z; Li, W; Wang, C; Wang, Z; Xiong, A; Yang, L, 2008)
" Acute carbon tetrachloride (CCl(4)) toxicity was similar in wild-type (WT), PAR-1(-/-), and PAR-1(+/-) mice as judged by aminotransferase levels, area of liver necrosis, and liver peroxidation measured by Fourier-transformed infrared spectroscopy."3.74Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis. ( Bioulac-Sage, P; Costet, P; Cubel, G; Deleris, G; Dugot-Senant, N; Gillibert-Duplantier, J; Haurie, V; Petibois, C; Rosenbaum, J; Rullier, A; Taras, D, 2008)
"The aim of this study was to investigate the pharmacokinetic changes of verapamil and its major metabolite, norverapamil, after oral administration of verapamil (10 mg/kg) in rabbits with slight, moderate and severe hepatic failure induced by carbon tetrachloride."3.73Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride. ( Burm, JP; Choi, JS, 2005)
"Dual-energy CT at 120 kVp and 90 kVp was performed in 16 rabbits of experimental groups that were induced to various degrees of fatty liver by feeding carbon tetrachloride (CCl4)."3.72Quantitative diagnosis of fatty liver with dual-energy CT. An experimental study in rabbits. ( Gao, Z; Li, L; Wang, B; Zou, Q, 2003)
"In an effort to develop a reproducible model of liver cirrhosis and esophageal varices, we administered phenobarbital (PhB) and carbon tetrachloride (CCl4) in 32 rats that had previously undergone complete devascularization of the left renal vein (DLRV)."3.71A rat model of liver cirrhosis and esophageal varices. ( Alatsakis, MB; Ballas, KD; Sakadamis, AK; Tzioufa-Asimakopoulou, V, 2001)
"The aim of the present work was to assess the capacity of Spirulina maxima to prevent fatty liver development induced in rats by an intraperitoneal single dose (1 ml/kg) of carbon tetrachloride."3.70Spirulina maxima prevents induction of fatty liver by carbon tetrachloride in the rat. ( Díaz-Zagoya, JC; Juárez-Oropeza, MA; Mascher, D; Miranda-Zamora, R; Paredes-Carbajal, MC; Torres-Durán, PV, 1998)
" However, hepatic HGF levels were decreased despite an increased number of mitotic hepatocytes and increased or unchanged plasma HGF levels in rats given phenobarbital and in rats after dimethylnitrosamine intoxication, which can induce hepatic necrosis after apoptosis of hepatic stellate cells."3.70Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration. ( Fujiwara, K; Ogata, I; Tomiya, T, 1998)
"To predict the potential utility of calcitriol in human osteoporosis with hepatic dysfunction, we examined the effects of calcitriol and alfacalcidol in ovariectomized (OVX) aged-rats with CCl4-induced hepatic failure."3.70[Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure]. ( Ishibashi, Y; Kojima, E; Kuriyama, K; Kusajima, H; Momo, K; Tachiiri, T; Yamanishi, A, 1999)
" In this study, we describe a rat model of fatigue assessment using a swim tank, and we used this model to document the degree of fatigue in rat models of cholestasis caused by bile duct resection (BDR) and of hepatitis caused by carbon tetrachloride (CCl4) administration."3.69Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment. ( Maric, M; Swain, MG, 1997)
"We sought to develop a rodent model of spontaneous bacterial peritonitis and report here the preliminary results of carbon tetrachloride-induced cirrhosis in which ascites and bacterial peritonitis predictably develop."3.68A rodent model of cirrhosis, ascites, and bacterial peritonitis. ( Kanel, G; Mellencamp, MA; Runyon, BA; Sugano, S, 1991)
"In the context of basic research in liver fibrosis and cirrhosis, it is essential to keep in mind that the capacity of the organ to recover spontaneously might be a significant limitation to long-term studies that use experimental models of liver cirrhosis."2.82Liver cirrhosis: An overview of experimental models in rodents. ( Dias, ML; Dos Santos Goldenberg, RC; Faccioli, LAP; Paranhos, BA, 2022)
"And 47 medium chronic hepatitis B viral fibrosis patients were studied."2.70Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis. ( Cai, WM; Liu, RH; Weng, HL, 2001)
"Nonalcoholic fatty liver disease (NAFLD) is a continuous diseases spectrum associated with obesity, type 2 diabetes, insulin resistance, and hyperlipidemia."2.66Rodent Models of Nonalcoholic Fatty Liver Disease. ( Gao, L; Xu, J; Zhong, F; Zhou, X, 2020)
"To model liver fibrosis in mice is important as mechanisms not only of fibrogenesis, but also of fibrolysis, need to be clearly defined."2.44Mouse models of liver fibrosis. ( Herkel, J; Lohse, AW; Weiler-Normann, C, 2007)
" Rodent models of D-GalN-induced fibrosis are not recommended due to the long incubation period and weak toxic effect."1.91Dynamics of Chronic Liver Injury in Experimental Models of Hepatotoxicity. ( Bogunia, E; Czekaj, P; Grajoszek, A; Hermyt, M; Kolanko, E; Król, M; Limanówka, Ł; Michalik, M; Pająk, J; Prusek, A; Sikora, B; Skubis-Sikora, A, 2023)
"Canagliflozin (CANA) is a sodium-glucose cotransporter 2 inhibitor that was recently approved for treating diabetes."1.62Canagliflozin Improves Liver Function in Rats by Upregulating Asparagine Synthetase. ( Ding, Y; Dong, R; Meng, S; Wang, H; Wang, S; Yin, L, 2021)
" However, the pharmaceutical application of AA is limited by low oral bioavailability and poor targeting efficiency."1.62Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis. ( Pan, JC; Tu, LL; Yin, LN; Zhang, Y; Zhang, YW; Zheng, GL, 2021)
" Groups D, E, and F were intragastrically dosed with ZQRGD."1.62Effects and mechanisms of ziqi ruangan decoction on hepatic fibrosis. ( Che, JY; Chen, TT; He, J; He, Y; Shao, M; Shi, LP; Wang, J; Xie, T; Yuan, Z; Zhou, M, 2021)
"Liver fibrosis is a major medical problem with high mortality and morbidity rates where the formation of regenerative nodules and cirrhosis leads to loss of liver function and may result in the development of hepatocellular carcinoma."1.62Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis. ( Abo-Elmatty, DM; El-Demerdash, RS; Elminshawy, HH; Khalil, MR; Mehanna, ET; Mesbah, NM, 2021)
"Liver fibrosis is a multifactorial trait that develops in response to chronic liver injury."1.62The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice. ( Asaryan, A; Beaven, SW; Borawski, J; Cantor, RM; Carbone, W; Civelek, M; Clerkin, K; French, S; Fuqua, BK; Haroutunian, SG; Hui, ST; Knehr, J; Loureiro, J; Lusis, AJ; Magyar, C; Mehrabian, M; Pan, C; Parks, BW; Renaud, N; Roma, G; Tuominen, I; Ukomadu, C; Wroblewski, K, 2021)
"Liver fibrosis is a necessary stage in the development of chronic liver diseases to liver cirrhosis."1.62PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis. ( Cheng, P; Guo, C; Wu, J; Yu, Q, 2021)
"Hepatic injury progression to liver cirrhosis and cancer is a serious health issue across the world."1.62Tectona grandis leaf extract ameliorates hepatic fibrosis: Modulation of TGF- β /Smad signaling pathway and upregulating MMP3/TIMP1 ratio. ( Ijaz, B; Koloko, BL; Malik, A; Rehman, S; Shahid, AA; Tariq, S, 2021)
"Liver fibrosis is the result of an excessive accumulation of extracellular matrix that develops when inflammation and chronic injury form scar tissue in the liver."1.62Therapeutic Impact of ODN2088 to Block TLR9 Activity in Induced Liver Fibrosis Mice. ( A M Alameen, A; Alzahrani, B; Tantawy, A, 2021)
"Liver fibrosis was attenuated in mice with Tgr5 depletion."1.62Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis. ( Bian, H; Gao, X; Huang, F; Jia, W; Jiang, R; Liu, P; Liu, Z; Qiu, J; Rajani, C; Sun, B; Wang, X; Wu, Y; Xie, G; Zhang, X; Zhao, A; Zhao, S; Zheng, X, 2021)
"However, its roles in liver fibrosis remain to be determined."1.62Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis. ( Chen, J; Hu, R; Li, J; Sun, J; Xing, X; Zhou, Q; Zhu, Z, 2021)
"Liver fibrosis is a common consequence of chronic liver diseases involved with the activation of hepatic stellate cells (HSCs) and endoplasmic reticulum (ER) stress."1.62Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells. ( Li, R; Liao, X; Tian, T; Yang, Q; Yu, L; Zhan, W, 2021)
"The main etiologies of liver fibrosis include nonalcoholic fatty liver disease (NAFLD), chronic viral hepatitis, as well as alcoholic and cholestatic liver disease."1.62Mouse Models of Liver Fibrosis. ( Ravichandra, A; Schwabe, RF, 2021)
"Development of liver fibrosis results in drastic changes in the liver microenvironment, which in turn accelerates disease progression."1.62Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells. ( Cheong, LY; Hoo, RLC; Lam, KSL; Li, J; Shu, L; Song, E; Wang, C; Wu, X; Xu, A; Ye, D; Zhang, Z; Zong, J, 2021)
"Mice chronic liver fibrosis models were established and divided into the olive-induced control group, CCL4-induced control group, olive-induced TIM-4 interference group and CCL4-induced TIM-4 interference group."1.56TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway. ( Chen, G; Deng, M; Gong, J; Wang, J; Wu, H; Yuan, F, 2020)
"Liver fibrosis was induced in mice using CCl4, and the differential expressions of several fibrosis-related long noncoding RNAs were detected in liver tissues."1.56Downregulated long non-coding RNA LINC01093 in liver fibrosis promotes hepatocyte apoptosis via increasing ubiquitination of SIRT1. ( Chen, S; Luo, H; Ma, N; Tang, Y; Yu, F, 2020)
"Agn prevents liver fibrosis through its attenuation of HSC activation and division through the suppression of NF-κB in in vitro and animal models."1.56Alginate Suppresses Liver Fibrosis Through the Inhibition of Nuclear Factor-κB Signaling. ( Ding, L; Jin, W; Sheng, X; Wu, J; Xia, Z; Xu, Y; Zheng, J, 2020)
"HGTLF could significantly improve liver fibrosis in mice."1.56Huagan tongluo Fang improves liver fibrosis via down-regulating miR-184 and up-regulating FOXO1 to inhibit Th17 cell differentiation. ( Cheng, Z; Geng, J; Hu, D; Huang, A; Qiu, Y; Tian, Y; Xuan, J, 2020)
"Liver fibrosis is a common part of the pathological development of many chronic liver diseases."1.56Camellia oil (Camellia oleifera Abel.) attenuates CCl ( Cao, Z; Du, H; Fang, Y; Fu, J; Kuang, T; Lei, X; Li, C; Liu, G; Liu, Q; Liu, Z; Qian, K; Xiao, Z; Xu, X; Zhang, J, 2020)
"Ursolic acid (UA) is a traditional Chinese medicine with anti-fibrotic effects, but the molecular mechanism underlying these effects is still unclear."1.56Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways. ( Huang, C; Liu, C; Luo, F; Luo, Q; Wan, S; Zhu, X, 2020)
"The current research on the treatment of liver fibrosis mainly focuses on the activation of hepatic stellate cell, in addition to protecting liver cells."1.56Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice. ( Bai, J; Bi, Z; Li, H; Li, X; Ma, B; Ma, X; Ning, W; Shao, S; Wei, Y; Xie, C; Yang, C; Zhang, L; Zhang, R; Zhang, S; Zhou, H, 2020)
"Liver fibrosis will develop into liver cirrhosis unless the damaging factors are removed."1.56Therapeutic Potential of Bama Pig Adipose-Derived Mesenchymal Stem Cells for the Treatment of Carbon Tetrachloride-Induced Liver Fibrosis. ( Guan, W; Lai, J; Lu, H; Sun, Y; Wu, X; Zhang, S, 2020)
"Metformin is a hypoglycaemic agent used to treat type 2 diabetes mellitus (DM2) patients, with a broad safety profile."1.51Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma. ( Callegari, E; Gramantieri, L; Guerriero, P; Negrini, M; Pinton, P; Rimessi, A; Sabbioni, S; Shankaraiah, RC; Silini, EM, 2019)
"Praziquantel is a schistosomicide, which has been used for more than 30 years due to its efficiency, safety, and mild side effects."1.51Praziquantel ameliorates CCl ( Kong, D; Liu, J; Liu, X; Lu, Z; Qiu, J; Wang, Y; Xie, Y; Zhang, R; Zhou, C, 2019)
"Non-alcoholic steatohepatitis (NASH) is a major cause of chronic liver disease."1.51New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease. ( Bosch, J; Boyer-Diaz, Z; Gracia-Sancho, J; Lozano, JJ; Maeso-Díaz, R; Ortega-Ribera, M; Peralta, C, 2019)
"Furthermore, AZGP1 alleviated NAFLD by blocking TNF-α-mediated inflammation and intracellular lipid deposition, promoting proliferation, and inhibiting apoptosis in LO2 cells."1.51Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α. ( Li, ZH; Liu, T; Luo, SZ; Luo, X; Wu, JC; Xu, MY, 2019)
"However, the role of ferroptosis in liver fibrosis remains poorly understood."1.51P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. ( Chen, A; Jia, Y; Li, M; Shao, J; Wang, F; Wang, L; Zhang, F; Zhang, Z; Zheng, S, 2019)
"Liver cirrhosis is the end stage of chronic liver disease, and the only radical treatment for decompensated liver cirrhosis is still liver transplantation."1.51Canine Liver Fibrosis Model to Assess the Functions of Infused Autologous Bone Marrow-Derived Cells. ( Sakaida, I; Takami, T; Tani, K; Taura, Y, 2019)
"To prepare and characterize an optimized phospholipid complex of Ursolic acid (UA) to overcome the poor pharmacokinetic properties and to investigate the impact of the complex on hepatoprotective activity and bioavailability in animal model."1.51Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex. ( Bannerjee, S; Bhattacharjee, P; Biswas, S; Harwansh, RK; Mukherjee, PK, 2019)
"Results indicate that the treatment of BM-MSCs in combination with silymarin had a better hepatoprotective and antimutagenic effect and represents a novel strategy for the treatment of hepatotoxicity."1.51Human bone marrow-derived mesenchymal stromal cells in combination with silymarin regulate hepatocyte growth factor expression and genotoxicity in carbon tetrachloride induced hepatotoxicity in Wistar rats. ( Aithal, AP; Bairy, LK; Rao, MK; Seetharam, RN, 2019)
"In the BDL model, liver fibrosis and Kuppfer cell numbers were increased in IL-1Ra KO mice compared to wild type mice and wild type mice treated with IL-1Ra."1.51Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner. ( Balaphas, A; Buhler, LH; Clément, S; Lacotte, S; Meier, RPH; Meyer, J; Montanari, E; Morel, P; Muller, YD; Negro, F; Toso, C, 2019)
"MATERIAL AND METHODS A liver fibrosis mouse model induced by carbon tetrachloride (CCl4) intervention was employed in this study."1.51Gexia-Zhuyu Decoction Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice Partly via Liver Angiogenesis Mediated by Myeloid Cells. ( Cao, S; Deng, Z; Ge, S; Kong, F; Pan, Z; Zhang, S, 2019)
"In the animal model of liver fibrosis, all doses of volatile oil of CG significantly reduced the serum levels of AST, ALT, MDA, Hyp, γ-GT, LDH, ALP, and Alb."1.51Gas Chromatography-Mass Spectrometry (GC-MS) Analysis of the Volatile Oil of Cichorium Glandulosum Boiss et Huet and its Effects on Carbon Tetrachloride-Induced Liver Fibrosis in Rats. ( Han, C; Qin, DM; Wang, XB; Xu, J; Zou, N, 2019)
"In the present study we assessed whether liver fibrosis and cirrhosis can be reversed by treatment with MSCs or fibroblasts concomitant to partial hepatectomy (pHx)-induced liver regeneration."1.51Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers. ( Barnhoorn, MC; Coenraad, MJ; de Jonge-Muller, ESM; Hawinkels, LJAC; Molendijk, I; van der Helm, D; van Hoek, B; Verspaget, HW, 2019)
"Ketoconazole is a first orally available anti-fungal drug which has been reported as a potent inhibitor of human cytochrome P-450."1.51Hepatoprotective effect of ketoconazole in chronic liver injury model. ( Ahmed, M; Akhtar, U; Ali, G; Shehzad, U; Tayyeb, A, 2019)
"Here we established murine model of liver fibrosis and found that oroxylin A (40 mg/kg) could ameliorate angiogenesis in liver fibrosis may related to hypoxia inducible factor 1α (HIF-1α)."1.48Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1α signaling. ( Bian, M; Chen, A; Chen, X; Guo, Q; Jin, H; Shao, J; Yang, X; Zhang, C; Zhang, F; Zhao, S; Zheng, S, 2018)
"Liver fibrosis is a pathological process of chronic liver diseases."1.48Recombinant truncated TGF‑β receptor II attenuates carbon tetrachloride‑induced epithelial‑mesenchymal transition and liver fibrosis in rats. ( Cao, Y; Chu, Y; Li, H; Li, L; Liu, J; Shi, Y; Yuan, X; Zhang, Z; Zheng, J, 2018)
"Liver fibrosis is overly exuberant wound healing that leads to portal hypertension or liver cirrhosis."1.48Targeting secreted cytokine BMP9 gates the attenuation of hepatic fibrosis. ( Fan, X; Ge, S; He, J; Jia, R; Li, B; Li, P; Li, Y; Ma, X; Pan, H; Shang, Q; Wang, H; Wang, L; Yang, Z; Zhang, H; Zhu, L, 2018)
"Celecoxib has been explored as a possible treatment of liver fibrosis with contradictory results, depending on the model."1.48Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury. ( Hammock, BD; Harris, TR; Hwang, SH; Imai, DM; Kodani, S; Rand, AA; Yang, J, 2018)
"Oxaloacetic acid is an important intermediary in the tricarboxylic acid cycle (TCA cycle) and participates in metabolism and energy production."1.48Oxaloacetate Ameliorates Chemical Liver Injury via Oxidative Stress Reduction and Enhancement of Bioenergetic Fluxes. ( Han, X; Kuang, Y; Wang, Y; Xu, M; Yang, Q; Zhao, Y, 2018)
"Acute liver failure is a critical condition characterized by global hepatocyte death and often time needs a liver transplantation."1.48Mesenchymal Stem Cell/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure. ( Allen, T; Cheng, K; Cores, J; Dinh, PU; Freytes, DO; Hensley, MT; Hu, S; Huang, K; Li, Z; Liang, H; Qiao, L; Shao, C; Shen, D; Su, T; Vandergriff, AC; Wrona, EA; Xing, J; Yu, Z; Zeng, Q; Zhang, H, 2018)
"Liver fibrosis is the final common pathway for almost all causes of chronic liver injury."1.48Genetic ablation of pannexin1 counteracts liver fibrosis in a chemical, but not in a surgical mouse model. ( Alves de Castro, I; Barbisan, LF; Cogliati, B; Crespo Yanguas, S; da Silva, TC; Gijbels, E; Goes, BM; Maes, M; Pereira, IVA; Romualdo, GR; Sayuri Nogueira, M; Shestopalov, VI; Vinken, M; Willebrords, J, 2018)
"Adding PSTPIP2 expression alleviates liver fibrosis and hepatic inflammation in mice by regulating macrophage polarization."1.48PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis. ( Huang, C; Huang, HM; Li, HD; Li, J; Li, WX; Li, XF; Lv, XW; Meng, XM; Pan, XY; Wang, H; Wu, XQ; Yang, Y; Zhang, L, 2018)
"A rat model of liver fibrosis was generated by administering CCl4 via subcutaneous injection twice a week for 12 weeks."1.48Emodin alleviates CCl4‑induced liver fibrosis by suppressing epithelial‑mesenchymal transition and transforming growth factor‑β1 in rats. ( Liu, F; Ma, Z; Qian, J; Wu, G; Zhang, J, 2018)
"Inhibition of ALR expression aggravates liver fibrosis, probably via promoting HSC migration and mitochondrial fusion."1.48Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell. ( Ai, WL; An, W; Dong, LY; Gao, J; Li, ZW; Wang, J; Wang, X; Wu, Y, 2018)
" Our findings support the further development of telmisartan prodrugs that enable infrequent dosing in the treatment of liver fibrosis."1.48Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs. ( Ackley, JC; Andersen, JN; Baddour, J; Blume-Jensen, P; Brady, SW; Chickering, DE; Economides, KD; Ehrlich, DC; Golder, MR; Held, EJ; Huh, SJ; Johnson, JA; Kopesky, PW; Liu, J; Neenan, AM; Nguyen, HV; Paramasivan, S; Reiter, LA; Saucier-Sawyer, JK; Shipitsin, MV; Vangamudi, B; Vohidov, F, 2018)
"The knowledge of pharmacokinetic and pharmacodynamic properties of antiepileptic drugs is helpful in optimizing drug therapy for epilepsy."1.46Evaluation of Brain Pharmacokinetic and Neuropharmacodynamic Attributes of an Antiepileptic Drug, Lacosamide, in Hepatic and Renal Impairment: Preclinical Evidence. ( Kumar, B; Medhi, B; Modi, M; Saikia, B, 2017)
"This study was designed to explore the pharmacokinetic and pharmacodynamic properties of rhubarb anthraquinones extract in diabetic nephropathy and acute liver injury rats."1.46Pharmacokinetics and pharmacodynamics of rhubarb anthraquinones extract in normal and disease rats. ( Hao, H; Hao, K; Jiang, W; Li, P; Lu, Q; Pei, X; Sun, Y, 2017)
"SC-43 significantly ameliorates liver fibrosis through SHP-1 upregulation."1.46Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis. ( Chen, DS; Chen, KF; Chen, LJ; Chen, PJ; Hu, TC; Huang, KW; Huang, YJ; Jao, P; Kao, JH; Liu, CH; Liu, CJ; Shiau, CW; Su, TH; Tai, WT; Tseng, TC; Wu, YM; Yang, HC; Yang, NJ, 2017)
"Progressive liver fibrosis leads to cirrhosis and end-stage liver disease."1.46Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation. ( Berardis, S; El Taghdouini, A; El-Kehdy, H; Evraerts, J; Henriet, P; Lombard, C; Najimi, M; Rosseels, V; Sokal, EM; van Grunsven, L, 2017)
"M2 macrophages were not effective on liver fibrosis."1.46Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice. ( Bai, J; Dou, KF; Gao, CC; Han, H; Liang, SQ; Ma, PF; Qin, HY; Ye, YC; Yi, J; Zhao, JL; Zhao, Y; Zheng, QJ, 2017)
"Detection of liver fibrosis during its earlier stages is a matter of great importance which may allow prevention of development of cirrhosis in patients with chronic liver disease."1.46Evaluation of liver fibrosis using Raman spectroscopy and infrared thermography: A pilot study. ( Escobedo, G; González, FJ; Guzmán, C; Kershenobich, D; Kolosovas-Machuca, ES; Ramírez-Elías, MG, 2017)
"Nevertheless, its pattern of liver fibrosis is frequently misinterpreted as portal type."1.46A frequent misinterpretation in current research on liver fibrosis: the vessel in the center of CCl ( Braeuning, A; Dooley, S; Hammad, S; Hengstler, JG; Meyer, C; Mohamed, FEZA, 2017)
"Elk-3 contributes to the progression of liver fibrosis by modulating the EMT via the regulation of Egr-1 under MAPK signaling."1.46Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition. ( Choi, JE; Hong, SW; Hur, W; Kim, JH; Kim, SM; Lee, EB; Lee, JH; Li, TZ; Yoon, SK, 2017)
"However, the role of myricetin on liver fibrosis remains to be elucidated."1.46The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice. ( Geng, Y; Li, W; Lu, ZM; Shi, JS; Sun, Q; Xu, HY; Xu, ZH, 2017)
" The LD50 value at 24 h was approximately 5950 mg/kg."1.43Hepatoprotective effect of cold-pressed Syzygium aromaticum oil against carbon tetrachloride (CCl4)-induced hepatotoxicity in rats. ( El-Hadary, AE; Ramadan Hassanien, MF, 2016)
"To induce liver fibrosis, male Wistar rats received CCl4 (2 ml/kg/2 times/week; i."1.43Protective Effect of Zingiber Officinale against CCl4-Induced Liver Fibrosis Is Mediated through Downregulating the TGF-β1/Smad3 and NF-ĸB/IĸB Pathways. ( Abd el Aziz, GM; El-Desouky, MA; Hasan, IH; Hozayen, WG, 2016)
"Hepatocarcinogenesis was significantly accelerated in the fibrotic livers compared to those of the control, significantly decreasing the life span of the mice."1.43Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background. ( Ahn, SH; Cho, KJ; Chung, SI; Han, KH; Ju, HL; Kim, DY; Moon, H; Ro, SW, 2016)
"Liver cirrhosis is the common pathological histology manifest among a number of chronic liver diseases and liver cancer."1.43Hepatic IGF-1R overexpression combined with the activation of GSK-3β and FOXO3a in the development of liver cirrhosis. ( Cai, Y; Chen, Y; E, C; Li, J; Li, W; Liu, W; Pan, Y; Wu, Q; Zhang, X; Zheng, X, 2016)
"Melatonin was administered orally at 2."1.43Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis. ( Hong, JM; Kang, JW; Lee, SM, 2016)
"The progression of liver fibrosis, an intrinsic response to chronic liver injury, is associated with hepatic hypoxia, angiogenesis, abnormal inflammation, and significant matrix deposition, leading to the development of cirrhosis and hepatocellular carcinoma (HCC)."1.43Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis. ( Chan, KM; Chen, Y; Chern, GG; Chiang, T; Hsu, FF; Liu, CH; Liu, JY; Liu, YC; Wu, YH, 2016)
"Liver fibrosis was induced by intraperitoneal administration with CCl4."1.43Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance. ( Deng, WS; Gu, L; Sun, XF; Xu, Q; Zhou, H, 2016)
"The present in vivo study revealed that the long term usage of ZES was safe for organs in laboratory animals."1.43Pharmacological safety evaluation of a traditional herbal medicine "Zereshk-e-Saghir" and assessment of its hepatoprotective effects on carbon tetrachloride induced hepatic damage in rats. ( Mandegary, A; Nematollahi, MH; Pardakhty, A; Sarhadynejad, Z; Sattaie-Mokhtari, S; Sharififar, F, 2016)
"Liver fibrosis is a global health problem and previous studies have demonstrated that reactive oxygen species (ROS) play important roles in fibrogenesis."1.43Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation. ( Gao, Y; Gu, J; Kong, X; Sun, X; Wen, Y; Xia, Q; Yu, C; Yu, Y, 2016)
"Next, to elucidate the roles of Sfrp5 in liver fibrosis, we investigated a carbon-tetrachloride (CCl4 )-induced liver fibrosis model using Sfrp5 knockout (KO) and wild type (WT) mice in vivo."1.42Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. ( Chatani, N; Egawa, M; Ezaki, H; Furuta, K; Hamano, M; Kamada, Y; Kiso, S; Kizu, T; Ogura, S; Ouchi, N; Shimono, A; Takehara, T; Yoshida, Y, 2015)
"Histamine levels were evaluated in serum."1.42Histamine restores biliary mass following carbon tetrachloride-induced damage in a cholestatic rat model. ( Francis, H; Francis, T; Graf, A; Hargrove, L; Harris, R; Hodges, K; Johnson, C; Kennedy, L; Ueno, Y, 2015)
"Neuropathic pain was induced by CCI of the sciatic nerve."1.42Hyperbaric oxygen treatment at various stages following chronic constriction injury produces different antinociceptive effects via regulation of P2X4R expression and apoptosis. ( Ding, YY; Hu, PY; Meng, LX; She, YJ; Song, XR; Tan, YH; Zhao, BS, 2015)
"Liver cancer is a major health-care concern and its oncogenic mechanisms are still largely unclear."1.42Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation. ( Eguchi, A; Feldstein, AE; Font-Burgada, J; Johnson, CD; Karin, M; Povero, D; Wree, A, 2015)
"CCl4-induced liver fibrosis protects mice against lethal dose of APAP, Possibly by a mechanism involving inhibition of the cytoplasmic translocation of HMGB1."1.42[Protective effects and possible mechanisms of hepatic fibrosis against APAP-induced lethal injury]. ( Bai, L; Chen, Y; Duan, Z; Ren, F; Zhang, X; Zheng, S; Zu, K, 2015)
"Liver fibrosis was induced by intraperitoneal injections of carbon tetrachloride (CCl4) or bile duct ligation (BDL) for two weeks."1.42Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice. ( Choi, HS; Eun, HS; Jeong, WI; Jung, JY; Lee, YS; Park, KG; Park, SH; Suh, JM; Yi, HS, 2015)
"Liver fibrosis was induced by repeated intraperitoneal injection of carbon tetrachloride."1.42Macrophage autophagy protects against liver fibrosis in mice. ( Chobert, MN; Denaës, T; El-Benna, J; Lodder, J; Lotersztajn, S; Pawlotsky, JM; Teixeira-Clerc, F; Wan, J, 2015)
" The toxic rat group received CCl4, while the treatment group received CCl4+P."1.42Effects of Pistacia Atlantica Extract on Erythrocyte Membrane Rigidity, Oxidative Stress, and Hepatotoxicity Induced by CCl4 in Rats. ( Mirzaei, A; Tolooei, M, 2015)
"The CCl4‑induced rats exhibited liver fibrosis, increased hydroxyproline content, impaired liver function, upregulated expression levels of the α‑SMA and TGF‑β1 pro‑fibrogenic proteins, and increased expression of HSP70, compared with the control group."1.42Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70. ( Chen, B; Chen, J; He, W; Qi, L; Shao, D; Wang, L; Wang, M; Zhuang, Y, 2015)
"Sesamin was administered in two different dose (5 and 10 ml/kg bw) to evaluate the hepatoprotective activity."1.42Sesamin ameliorates oxidative liver injury induced by carbon tetrachloride in rat. ( Liu, L; Lv, D; Zhu, CQ, 2015)
"In the treatment group, liver fibrosis significantly decreased compared to the model group (P < 0."1.42Effect of flavonoid compounds extracted from Iris species in prevention of carbon tetrachloride-induced liver fibrosis in rats. ( Lv, HY; Wang, YL; Zhang, Q, 2015)
"Liver fibrosis is a feature in the majority of chronic liver diseases and oxidative stress is considered to be its main pathogenic mechanism."1.42Protective effects of extracts from Pomegranate peels and seeds on liver fibrosis induced by carbon tetrachloride in rats. ( Bi, XY; Fang, RT; Luo, AL; Ren, GX; Wei, XL; Yang, YH; Zang, WJ; Zhao, M, 2015)
"Prednisolone treatment prevents T/NKT cell hepatitis but exacerbates hepatotoxin-induced liver injury by inhibiting macrophage- and neutrophil-mediated phagocytic and hepatic regenerative functions."1.40Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice. ( Feng, D; Gao, B; Kwon, HJ; Park, O; Won, YS, 2014)
"A mouse model of fibrosis-associated liver cancer that was designed to emulate cirrhotic liver, a prevailing disease state observed in most humans with HCC, was used."1.40Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. ( Beland, FA; Chappell, G; Hoenerhoff, M; Hong, HH; Kutanzi, K; Pogribny, IP; Rusyn, I; Tryndyak, V; Uehara, T, 2014)
"In the present study, liver fibrosis was induced in wild-type (WT), TLR7-deficient, and IFN-α/β receptor-1 (IFNAR1)-deficient mice and TLR7-mediated signaling was assessed in liver cells isolated from these mice."1.40Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis. ( Kim, B; Kim, JW; Lim, CW; Park, S; Roh, YS; Seki, E, 2014)
"Several hallmarks of liver fibrosis are influenced by S1P, and the interference of S1P signaling by treatment with FTY720 results in beneficial effects in various animal models of fibrosis."1.40FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells. ( Kong, Y; Tang, N; Wang, H; Wang, S, 2014)
"Decursin treatment significantly reduced the ratio of liver/body weight, α-SMA activation, and type I collagen overexpression in CCl4 treated mice liver."1.40Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro. ( Choi, YJ; Chung, CH; Jeong, SI; Kim, DH; Kim, J; Kim, SJ; Kim, SY; Yu, KY, 2014)
"In 2 groups of SD rats, liver fibrosis was induced in experimental animals by repetitive carbon tetrachloride injections, while the control group received saline injections."1.40The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study. ( Geng, X; Hao, L; Liu, A; Ma, C; Song, Q; Sun, B; Wang, H; Wang, Y; Zhao, G, 2014)
"Non-alcoholic fatty liver disease (NAFLD) is defined as a spectrum of conditions ranging from hepatocellular steatosis to steatohepatitis and fibrosis, progressing to cirrhosis, which occur in the absence of excessive alcohol use."1.40Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model. ( Chanderasekharan, H; Chheda, TK; Madanahalli, JR; Marikunte, VV; Moolemath, Y; Oommen, AM; Sadasivan, SK; Shivakumar, P, 2014)
" Both conditions failed to cause a significant effect on Cmax or Tmax."1.40Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats. ( Matar, KM; Tayem, YI, 2014)
"Advanced liver fibrosis results in cirrhosis and liver failure, and liver transplantation is often the only option for effective therapy; however, the shortage of available donor livers limits this treatment."1.40Therapeutic potential of amniotic-fluid-derived stem cells on liver fibrosis model in mice. ( Chen, YH; Cheng, PJ; Cheng, WT; Chou, CJ; Kao, YJ; Ko, IC; Peng, SY; Shaw, SW; Wu, SC, 2014)
"The model of liver fibrosis was induced by intraperitoneal injection with CCl4 three times per week lasting for 12 weeks in CCl4 group and the BMP-7+CCl4 group."1.40BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor. ( Cao, ST; Chen, YP; Dong, JZ; Lin, Z; Shi, KQ; Wang, LP; Xiong, LJ; Zhang, SN; Zou, ZL, 2014)
"Human hepatocellular carcinoma (HCC) develops most often as a complication of fibrosis or cirrhosis."1.40The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma. ( Pogribny, IP; Rusyn, I; Uehara, T, 2014)
" The LD50 of MSE was more than 5000 mg/kg."1.40Hepatoprotective and antioxidant activity of Melaleuca styphelioides on carbon tetrachloride-induced hepatotoxicity in mice. ( Al-Sayed, E; El-Lakkany, NM; Hammam, OA; Sabra, AN; Seif El-Din, SH, 2014)
"Chronic kidney disease, end-stage renal failure, and liver diseases are increasing worldwide and constitute a huge burden on health care costs, with attendant high morbidity and debility."1.40Hepato- and nephroprotective activities of a Nigerian local king tuber oyster mushroom, Pleurotus tuberregium (higher Basidiomycetes), in chemically induced organ toxicities in rats. ( Akah, PA; Ihim, SA; Laiyemo, KA; Nworu, CS; Ugwu, LE, 2014)
"Chronic inflammation was induced by i."1.40Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice. ( Barbosa, KP; de França, ME; Luna, RL; Nunes, AK; Oliveira, AG; Oliveira, WH; Pastor, AF; Peixoto, CA; Rocha, SW; Rodrigues, GB, 2014)
"Treatment with paeonol significantly protected the liver from injury by reducing the activities of serum aspartate aminotransferase, alanine aminotransferase, improving the histological architecture of the liver, and by inhibiting activation of hepatic stellate cells (HSCs) in vivo."1.39Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: in vivo and in vitro studies. ( Chen, L; Kong, D; Lu, Y; Wei, D; Zhang, F; Zhang, X; Zheng, S; Zhu, X, 2013)
"Two models of rat liver fibrosis, the carbon tetrachloride and bile duct ligation models, were treated with rAAV/siRNA-TIMP-1."1.39Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis. ( Bai, Y; Chen, J; Cong, M; Cong, R; Fan, X; Jia, J; Li, H; Liu, T; Peng, Z; Tang, S; Tong, X; Wang, B; Wang, P; Wu, P; Yang, A; You, H, 2013)
"In contrast, no change in liver fibrosis was observed in BDL-cirrhotic rats but an increase in the eNOS pathway."1.39Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats. ( Bosch, J; García-Calderó, H; García-Pagán, JC; Gracia-Sancho, J; Rodríguez-Vilarrupla, A; Rosado, E; Tripathi, D, 2013)
" At the studying of the bile formation and bile secretion functions in the conditions of the toxic tetrachlormethane lesion the hepatoprotective effect of the dosage form was confirmed, which was realized by the increasing of the speed of bile secretion and its volume."1.39[Studying of hepatoprotective properties of dry extract from apricot leaves on the model of liver lesion by tetrachloromethane]. ( Fira, LS; Likhatskiĭ, PG; Medvid', II; Pyla, VP; Shtroblia, AL; Vashkeba, EM, 2013)
"The gold standard in assessing liver fibrosis is biopsy despite limitations like invasiveness and sampling error and complications including morbidity and mortality."1.39Molecular MRI of collagen to diagnose and stage liver fibrosis. ( Caravan, P; Fuchs, BC; Lauwers, GY; Parkar, A; Polasek, M; Schühle, DT; Sinskey, AJ; Tanabe, KK; Wang, H; Wei, L; Yang, Y, 2013)
"To induce liver fibrosis in this model, rats were given a subcutaneous injection of a 40% solution of CCl4 in olive oil at a dose of 0."1.39Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway. ( Cao, Q; Fan, FG; Guo, XL; Jin, J; Jin, L; Lan, R; Liang, B; Wang, XC; Wang, XW; Yang, JH, 2013)
" The liver injury was introduced with over dosage of non steroidal anti-inflammatory drugs (NSAIDs) and carbon tetrachloride (CCl4)."1.39Efficacy of herbal coded Hepcon on drug induced hepatitis in experimental animals through histopathological and biochemical analysis. ( Asif, HM; Jamil, A; Jamil, MS; Mahmood, Z; Roohi, M; Saeed, A; Usmanghani, K, 2013)
"Liver fibrosis was induced in male C57BL/6N mice by injecting a 10% CCl(4) solution intraperitoneal twice a week for six weeks."1.39Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells. ( Chen, M; Cheng, Q; Huang, C; Li, N; Li, Q; Lin, Q; Qian, Z; Shi, G; Wang, X; Zheng, J, 2013)
"Using two liver cirrhosis mouse models induced by CCl4 or thioacetamide, we showed that targeting AR in the BM-MSCs improved their self-renewal and migration potentials and increased paracrine effects to exert anti-inflammatory and anti-fibrotic actions to enhance liver repair."1.39Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis. ( Chang, C; Huang, CK; Lai, KP; Lee, SO; Lin, TH; Luo, J; Ma, WL; Tsai, MY, 2013)
" Hepatic endothelial function was assessed in isolated and perfused rat livers by dose-response curves to acetylcholine (ACh) and methoxamine (Mtx)."1.39Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats. ( Abrante, B; Abreu, P; de Ganzo, ZA; Felipe, V; González-Méndez, Y; Hernández-Guerra, M; Moreno, M; Quintero, E; Salido, E, 2013)
" Liver function tests and histopathological evaluation were carried out at the end of dosing using standards kits."1.39Hepatoprotective effect of herbal drug on CCl(4) induced liver damage. ( Feroz, Z; Khan, RA, 2013)
" Moreover, we evaluated endothelial function by dose-relaxation curves to acetylcholine, hepatic NO bioavailability and TXA2 production."1.39Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats. ( Bosch, J; Di Pascoli, M; Diví, M; García-Pagán, JC; Gracia-Sancho, J; Rodríguez-Vilarrupla, A; Rosado, E; Vilaseca, M, 2013)
"FHL2(-/-) mice displayed aggravated liver fibrosis compared to wt mice."1.39Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice. ( Adam, AC; Büttner, R; Goltz, D; Huss, S; Khlistunova, I; Kirfel, J; Stellmacher, C; Trebicka, J; Weiskirchen, R, 2013)
"Azelnidipine is a calcium blocker that has been shown to have antioxidant effects in endothelial cells and cardiomyocytes."1.38Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence. ( Horiguchi, N; Ichikawa, T; Izumi, T; Kakizaki, S; Kishimoto, K; Mori, M; Ohyama, T; Sato, K; Takagi, H; Yamazaki, Y, 2012)
"Dietary cholesterol aggravates liver fibrosis because free cholesterol accumulates in HSCs, leading to increased TLR4 signaling, down-regulation of bone morphogenetic protein and activin membrane-bound inhibitor, and sensitization of HSC to TGFβ."1.38A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells. ( Ebinuma, H; Hibi, T; Hiroi, S; Hokari, R; Irie, R; Kanai, T; Kurihara, C; Miura, S; Okada, Y; Oshikawa, T; Saito, H; Shimamura, K; Sugiyama, K; Suzuki, T; Teratani, T; Tominaga, S; Tomita, K; Yokoyama, H, 2012)
" However, DDB therapeutic effectiveness is restricted by its low oral bioavailability that arises from its poor solubility and dissolution."1.38Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. ( Abdelbary, GA; Aburahma, MH, 2012)
"Liver cirrhosis is associated with bacterial translocation (BT) and endotoxemia."1.38Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense. ( Beisner, J; Bevins, CL; Hofmann, C; Nuding, S; Schoelmerich, J; Stange, EF; Teltschik, Z; Wehkamp, J; Wiest, R, 2012)
"Carbon tetrachloride was used to induce acute liver injury in mice; cells or secreted proteins were administered by intrasplenic or intraperitoneal injection, respectively."1.38Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice. ( Ahn, EK; Chenoweth, JG; Choi, TH; Heo, J; Hoeppner, DJ; Hong, SH; Kang, GY; Kim, JH; Kim, SE; Kim, SK; Kim, Y; Kwon, H; Lee, JH; Lim, HJ; McKay, RD; Park, HS; Song, KW; Tesar, PJ; Woo, DH; You, HJ, 2012)
"Carbon tetrachloride (CCl(4)) was used to induce liver injury in TP knockout (TP(-/-)) mice and wild-type (WT) mice."1.38Thromboxane A(2) receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment. ( Ae, T; Hosono, K; Ito, Y; Koizumi, W; Majima, M; Minamino, T; Narumiya, S; Ohkubo, H; Sakagami, H; Sato, T; Shibuya, A; Suzuki, T, 2012)
"Oleuropein is a non-toxic secoiridoid found in the leaves and fruits of olive (Olea europaea L."1.38Preventive and therapeutic effects of oleuropein against carbon tetrachloride-induced liver damage in mice. ( Domitrović, R; Jakovac, H; Marchesi, VV; Rahelić, D; Romić, Ž; Šain, I, 2012)
" The plant proved to be safe for human use because it did not induce any signs of toxicity or mortality in mice when administered orally at doses up to 5000 mg kg(-1)."1.38Hepatoprotective activity of Cyperus alternifolius on carbon tetrachloride-induced hepatotoxicity in rats. ( Alqasoumi, SI; Awaad, AS; El-Gindi, OD; El-Sayed, DF; Soliman, GA, 2012)
" Nitric oxide (NO) bioavailability and eNOS activation were measured in hepatic endothelial cells (HEC) isolated from cirrhotic rat livers."1.38PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats. ( Bosch, J; García-Calderó, H; García-Pagán, JC; Laviña, B; Rodríguez-Vilarrupla, A; Roglans, N; Rosado, E; Russo, L, 2012)
"Xanthohumol was applied orally at a dose of 1 mg/g body weight 2 days prior as well as during and after exposure to CCl(4)."1.38Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. ( Dorn, C; Heilmann, J; Hellerbrand, C, 2012)
"Phenacetin metabolism was impaired more severely in 6 rats that died than in 21 living rats (P < 0."1.38Phenacetin O-deethylation is a useful tool for evaluation of hepatic functional reserve in rats with CCl(4)-induced chronic liver injury. ( Cai, M; He, P; Li, X; Liu, Z; Qu, Z; Wang, X; Xiao, J; Zhou, M, 2012)
"Molecular MRI of liver fibrosis with a collagen-specific probe identifies fibrotic tissue in two rodent models of disease."1.38Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. ( Alford, JK; Caravan, P; Fuchs, BC; Guimaraes, AR; Lauwers, GY; Loving, GS; Polasek, M; Schühle, DT; Tanabe, KK; Uppal, R; Wei, L; Yamada, S, 2012)
" However, due to its impermeability across the gastrointestinal mucosa, oral bioavailability of the drug was relatively low."1.38Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles. ( Fu, S; Han, J; Jin, S; Lu, Y; Lv, Q; Qi, J; Wu, W; Yuan, H, 2012)
"In the experimental group, liver fibrosis was induced by intraperitoneal injection of carbon tetrachloride."1.38Evaluation of liver fibrosis by investigation of hepatic parenchymal perfusion using contrast-enhanced ultrasound: an animal study. ( Huang, YP; Lau, TY; Lee, ES; Leung, G; Tipoe, GL; Ying, M; Yuen, QW; Zheng, YP, 2012)
"Metabolomics has been frequently used in pharmacodynamic studies, especially those on traditional Chinese medicine (TCM)."1.38Radix Paeoniae Rubra and Radix Paeoniae Alba Attenuate CCl4-induced acute liver injury: an ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic approach for the pharmacodynamic study of Traditional Chinese Medicines (TCMs) ( Shi, YH; Teng, ZQ; Wang, R; Xiong, AZ; Yang, L; Yang, QW, 2012)
" In conclusion, the nanoemulsification method may be applied for poor water-soluble ethanolic herbal extracts to reduce the dosage and time."1.38Nanoemulsified ethanolic extract of Pyllanthus amarus Schum & Thonn ameliorates CCl4 induced hepatotoxicity in Wistar rats. ( Deepa, V; Goparaju, A; Murthy, PB; Reddy, PN; Sridhar, R, 2012)
"Curcumin was significantly returned the expression levels of mir-199 and -200 with their associated target gene nearly to their normal levels."1.38Curcumin reorganizes miRNA expression in a mouse model of liver fibrosis. ( Al-Olayan, EM; Hassan, ZK, 2012)
"Carbon tetrachloride (CCl(4)) is a common hepatotoxin used in experimental models to elicit liver injury."1.37Identification of liver proteins and their roles associated with carbon tetrachloride-induced hepatotoxicity. ( Fan, ST; Jiang, PP; Jor, IW; Lee, CY; Ling, WL; Man, K; Sit, WH; Tam, KT; Wan, JM; Wong, LL, 2011)
" Advanced liver fibrosis was induced in female mice by chronic administration of carbon tetrachloride."1.37Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. ( Forbes, SJ; Gordon-Walker, TT; Hartland, S; Hume, DA; Iredale, JP; Pope, C; Ramachandran, P; Robson, AJ; Thomas, JA; Van Deemter, M; Wojtacha, D, 2011)
"Oxidative stress is related to the liver fibrosis, anticipating the hepatic stellate cells' (HSC) activation."1.37Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis. ( Catoi, C; Clichici, S; Daicoviciu, D; Decea, N; Filip, A; Gherman, C; Login, C; Mocan, T; Moldovan, R; Muresan, A; Nagy, A, 2011)
"Using a mouse liver fibrosis model, we show that carbon tetrachloride treatment induces ADAMTS1 expression in parallel to that of type I collagen."1.37Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta. ( Baffet, G; Bonnier, D; Bourd-Boittin, K; Ezan, F; Leyme, A; Mari, B; Samson, M; Theret, N; Tuffery, P, 2011)
"Our results showed that the induced NAFLD and insulin resistance (IR) were accompanied with hyperglycemia and hyperlipidemia and lowered brain glucose level with elevated ATPase activity, prooxidant status (TBARS level, xanthine oxidase and cytochrome 2E1 activities), and inflammatory markers."1.37Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction. ( Ghareeb, DA; Hafez, HS; Hussien, HM; Kabapy, NF, 2011)
"The methanol extract was purified by repeated column chromatography, resulting in the identification of five metabolites whose hepatoprotective effects were evaluated by measuring aspartate transaminase, alanine transaminase, alkaline phosphatase, glutamate, total bilirubin level, lactate dehydrogenase, total serum protein, and lipid peroxidation (thiobarbituric acid reactive substances assay) in CCl(4)-induced hepatic injury in mice."1.37Effect of flavonoids from Prosthechea michuacana on carbon tetrachloride induced acute hepatotoxicity in mice. ( Anaya Sosa, I; Hoyo Vadillo, C; Perez Gutierrez, RM; Victoria, TC, 2011)
"Experimental liver fibrosis was induced by subcutaneous injection of CCl4."1.37[Dynamic expression of TGF-beta1/Smad protein in CCl4-induced liver fibrosis and its significance in rats]. ( Bao, JF; Shi, JP; Xu, S, 2011)
"Liver fibrosis is regulated by an epigenetic relay pathway that includes MeCP2, EZH2, and miR132."1.36MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. ( Chu, DC; Mann, DA; Mann, J; Maxwell, A; Oakley, F; Tsukamoto, H; Zhu, NL, 2010)
"Since liver fibrosis frequently occurs before hepatoma development, this study investigated the expression profile of HDGF and its relationship with transforming growth factor-beta (TGF-beta) signaling in experimental models of hepatofibrogenesis."1.36Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis. ( Chan, HH; Chao, D; Chen, CL; Cheng, KH; Cheng, YF; Chung, YH; Goto, S; Hu, TH; Jawan, B; Kao, YH; Kuo, SM; Lin, YC; Sun, CK; Tai, MH; Wu, DC, 2010)
"Treatment with cystamine and garlic extract reduced the liver fibrosis and collagen deposition, particularly in the garlic extract group (p<0."1.36Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase. ( Amoruso, DC; Caporaso, N; D'Argenio, G; D'Armiento, MR; Fogliano, V; Mazzone, G; Mezza, E; Morisco, F; Ribecco, MT; Romano, A; Vitaglione, P, 2010)
"Hepatocellular carcinoma is the third leading cause of cancer mortality worldwide; current chemotherapeutic interventions for this disease are largely ineffective."1.36Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. ( Graña, X; Knudsen, ES; Mayhew, CN; Reed, CA; Rivadeneira, DB; Sotillo, E; Thangavel, C, 2010)
"MSCs caused a decrease in liver fibrosis histopathologically, 4 weeks after transplantation."1.36Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. ( Azhdari, Z; Baharvand, H; Gharavi, M; Piryaei, A; Rabani, V; Shahsavani, M, 2010)
" Using a bivascular liver perfusion dose-response curves to adenosine of the HA were performed in the presence and the absence of pan-adenosine blocker (8-SPT), A1 blocker (caffeine) or nitric oxide synthase-blocker (l-NMMA) after preconstriction with an alpha1-agonist (methoxamine)."1.36A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver. ( Groszmann, RJ; Mehal, WZ; Ripoll, C; Zipprich, A, 2010)
"Glycogen was decreased by CCl(4), while celecoxib partially prevented and reversed this effect."1.36Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat. ( Castro-Sánchez, L; Chávez, E; Moreno, MG; Muriel, P; Salazar, EP; Segovia, J; Shibayama, M; Tsutsumi, V; Vergara, P, 2010)
"All mice developed liver fibrosis."1.36Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. ( Brenner, DA; Gu, G; Iwaisako, K; Kisseleva, T; Osterreicher, CH; Scholten, A; Scholten, D, 2010)
"Carbon tetrachloride (CCl(4))-treated mouse model in vivo and in hepatic stellate cells (HSC) in vitro were used."1.36Leukamenin F suppresses liver fibrogenesis by inhibiting both hepatic stellate cell proliferation and extracellular matrix production. ( Hu, LH; Li, CJ; Liu, Q; Shen, X; Wang, X; Zhang, Y, 2010)
"Although pharmacokinetic alternations by hepatic injury have been extensively studied, little is known about the potential influence of hepatoprotective agent's treatment."1.36Integral pharmacokinetics of multiple lignan components in normal, CCl4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers. ( Dai, C; Hao, H; Kang, A; Li, J; Liang, Y; Sun, S; Wang, G; Xie, L; Xie, T; Xie, Y; Zheng, X, 2010)
"Hydroxyproline, which is an indicator of fibrosis in liver tissue, was high in the ethanol-treated control group."1.36Carotenoid lutein protects rats from paracetamol-, carbon tetrachloride- and ethanol-induced hepatic damage. ( Firdous, AP; Kuttan, R; Preethi, KC; Sindhu, ER, 2010)
"Fulminant hepatitis or acute liver failure (ALF), initiated by viral infection or hepatic toxin, is a devastating medical complication without effective therapeutic treatment."1.35Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure. ( Han, YP; Yan, C; Zhou, L, 2008)
"To induce liver fibrosis, C57BL6 female mice were injected i."1.35Platelets contribute to the reduction of liver fibrosis in mice. ( Aoyagi, Y; Fukunaga, K; Hashimoto, I; Ikeda, O; Matsuo, R; Murata, S; Nakano, Y; Ohkohchi, N; Watanabe, M; Yasue, H, 2009)
"After transplantation into mice with acute liver failure, ASC-derived hepatocytes can restore such liver functions as ammonia and purine metabolism."1.35Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. ( Banas, A; Kato, T; Ochiya, T; Okochi, H; Osaki, M; Takeshita, F; Teratani, T; Tokuhara, M; Yamamoto, Y, 2009)
"To this end, liver fibrosis was induced in AR+/+ and AR-/- mice by chronic CCl(4) administration."1.35The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. ( Avila, MA; Berasain, C; Cartagena-Lirola, H; Castillo, J; Goñi, S; Latasa, MU; Lotersztajn, S; Nicou, A; Perugorria, MJ; Prieto, J; Vespasiani-Gentilucci, U; Zagami, MG, 2008)
" Chronic administration of CCl(4) for 12 weeks led to an increase of collagen type I and a decrease of type III in the wall of aorta."1.35Red wine polyphenols affect the collagen composition in the aorta after oxidative damage induced by chronic administration of CCl(4). ( Andriantsitohaina, R; Babal, P; Cerna, A; Hlavackova, L; Janega, P; Pechanova, O, 2009)
"Taurine treatment reduced fibrosis scores significantly as compared to placebo."1.35Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury. ( Comert, B; Mas, MR; Mas, N; Tasci, I; Tuncer, M, 2008)
" The circulating levels of apelin, the messenger RNA (mRNA) and protein expression of apelin and apelin receptor, the immunohistological detection of apelin and apelin receptor, and the effects induced by the chronic administration of an apelin receptor antagonist on fibrosis and vessel density were evaluated in rats with cirrhosis and ascites and in control rats."1.35The hepatic apelin system: a new therapeutic target for liver disease. ( Arroyo, V; Bernardi, M; del Arbol, LR; Fernández-Varo, G; Jiménez, W; Melgar-Lesmes, P; Morales-Ruiz, M; Principe, A; Ros, J, 2008)
"Several in vitro studies have demonstrated the ability of pure trans-resveratrol (t-Res) to act as an anti-oxidant, but the scientific literature is lacking in in vivo studies dealing with dietary t-Res bioavailability in oxidative stress models."1.35Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation. ( Caporaso, N; Fogliano, V; Milani, S; Morisco, F; Ottanelli, B; Vitaglione, P, 2009)
"A novel naringenin-loaded nanoparticles system (NARN) was developed to resolve the restricted bioavailability of naringenin (NAR) and to enhance its hepatoprotective effects in vivo on oral administration."1.35Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. ( Cham, TM; Lin, CC; Lin, LT; Wu, TH; Yen, FL, 2009)
"CXCR3(-/-) mice had increased liver fibrosis; progression was associated with decreased numbers of intrahepatic interferon gamma-positive T cells and reduced interferon gamma messenger RNA, indicating that CXCL9-CXCR3 regulates Th1-associated immune pathways."1.35Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. ( Berg, T; Berres, ML; Dahl, E; Friedman, SL; Gassler, N; Hellerbrand, C; Hillebrandt, S; Keppeler, H; Lammert, F; Schmitz, P; Scholten, D; Streetz, KL; Tacke, F; Trautwein, C; Wasmuth, HE; Weiskirchen, R; Zaldivar, MM; Zimmermann, H, 2009)
"Liver index and the degree of liver fibrosis were also determined."1.35Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis. ( Chen, LJ; Dai, LL; He, CM; Huang, CQ; Peng, XD; Yang, B, 2009)
"The progression of toxic hepatitis is accompanied by the activation of oxidative processes in the liver associated with an enhancement of the mitochondrial respiratory chain activity and superoxide anion production (O(2)(*-))."1.35Superoxide anion production by the mitochondrial respiratory chain of hepatocytes of rats with experimental toxic hepatitis. ( Arkadyeva, A; Emelyanova, L; Morozov, V; Sakuta, G; Shiryaeva, A, 2009)
"The glycogen content was 50% higher in experimental group compared to the control."1.35[Comparative morphofunctional analysis of rat hepatocyte cultures isolated from the normal and pathologically changed liver due to experimental toxic hepatitis]. ( Baĭdiuk, EV; Bezborodkina, NN; Sakuta, GA; Shiriaeva, AP, 2009)
"Deficiency of tPA aggravated liver fibrosis through promoting hepatic stellate cells (HSCs) activation and inhibiting ECM degradation by decreasing MMP-2, MMP-9 activities and disrupting the balance between MMP-13 and TIMP-1."1.35Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis. ( Hsiao, Y; Hu, H; Ling, CC; Song, HY; Tao, XM; Zou, T, 2008)
"Adenosine is a potent endogenous regulator of tissue repair that is released from injured cells and tissues."1.35Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis. ( Chan, ES; Chiriboga, L; Cronstein, BN; Fernandez, P; Peng, Z; Wilder, T; Yee, H, 2008)
" In addition, in CH livers, PP dose-response curves to the NO donor, S-nitroso-N-acetyl-D,L-penicillamine (SNAP), were performed after pre-incubation with Ibtx or its vehicle."1.35Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis. ( Abraldes, JG; Bataller, R; Bosch, J; García-Pagán, JC; Graupera, M; Matei, V; Rodríguez-Vilarrupla, A, 2008)
"Lethal fulminant hepatic failure in nonobese diabetic severe combined immunodeficient mice was induced by carbon tetrachloride gavage."1.35Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. ( Chen, CT; Chuang, CH; Fang, SC; Hung, SP; Kuo, TK; Lee, OK; Shih, YR; Yang, VW, 2008)
"We treated carbon tetrachloride (CCl(4)) into rats for eight weeks to induce liver fibrosis and arranged these rats for cholinergic denervation, hepatic branch vagotomy or atropine administration."1.35Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats. ( Cheng, JT; Cheng, KC; Hsu, CT; Lam, HB; Yeh, CH, 2008)
"Bakuchiol treatment stimulated the activation of extracellular signal-regulated kinase 1/2 (ERK), c-Jun NH2-terminal protein kinase (JNK), and p38 mitogen-activated protein kinases (MAPK) in vitro."1.34Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. ( Kim, YC; Park, EJ; Sohn, DH; Zhao, YZ, 2007)
"We compared the dose-response relationships and the neuromuscular blocking effects of mivacurium in 66 rabbits randomly treated with 0."1.34The pharmacodynamics of mivacurium in the rabbit with carbon tetrachloride-induced liver disease. ( Cheong, MA; Kim, KS; Lee, GS, 2007)
"Hydroxyproline was 504."1.34Contribution of mononuclear bone marrow cells to carbon tetrachloride-induced liver fibrosis in rats. ( Cao, BQ; Chen, R; Huang, SB; Lin, JZ; Lin, N; Tang, ZF; Xiang, P; Xu, RY; Zhong, YS, 2007)
"Advanced liver cirrhosis is associated with hyperdynamic circulation consisting of systemic hypotension, decreased peripheral resistance, and cardiac dysfunction, termed cirrhotic cardiomyopathy."1.34Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. ( Bátkai, S; Harvey-White, J; Kechrid, R; Kunos, G; Mukhopadhyay, P; Pacher, P, 2007)
"The extent and kinetic of the disease progression were followed by the measurement of ultrasound backscatter intensity."1.34Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice. ( Champy, MF; D'Sa, A; Garo, E; Guimond, A; Monassier, L; Selloum, M; Teletin, M; Vonesch, JL, 2007)
"Liver necrosis was induced by administering a single intraperitoneal (i."1.34Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in wistar rats. ( Antić-Stanković, J; Kotur-Stevuljević, J; Milenković, M; Stefanović, A; Topić, A; Uskoković-Marković, S, 2007)
"The model for inducing liver cirrhosis in rats was established according to a previously published protocol."1.34Heme oxygenase-1 induction by hemin protects liver cells from ischemia/reperfusion injury in cirrhotic rats. ( Guo, H; Hao, ZM; Li, YC; Xue, H, 2007)
" Treatment of the toxic hepatitis with heptral increased the level of cytochrome P450, cytochrome b5, glutation activity of glutationetranspherase glutathione and reduced content of homocysteine."1.34[Efficacy and safety of heptral, vitamin B6 and folic acid during toxic hepatitis induced by CCL4]. ( Antelava, NA; Gogoluari, LI; Gogoluari, MI; Okudzhava, MV; Pirtskhalaĭshvili, NN, 2007)
"Gabexate mesilate treatment significantly decreased the elevation of serum transaminase levels and improved liver histology 24 h after the administration of CCl4 (0."1.33Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats. ( Goto, T; Kataoka, E; Lin, JG; Mikami, K; Miura, K; Ohshima, S; Segawa, D; Shibuya, T; Watanabe, D; Watanabe, S; Yoneyama, K, 2005)
"Bicyclol is a novel synthetic drug for the treatment of chronic viral hepatitis in China."1.33Mechanism of protective action of bicyclol against CCl-induced liver injury in mice. ( Li, Y; Liu, GT; Wei, HL; Xu, JY; Yu, LH; Zhang, H, 2005)
" However, the increase in CCl(4) dosage significantly worsened survival."1.33Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. ( Chang, ML; Chang, PY; Chen, JC; Yeh, CT, 2005)
" With repetitive dosing CCl(4) can be used to induce bridging hepatic fibrosis (4 wk of twice-weekly dosing), cirrhosis (8 wk of twice-weekly dosing) and advanced micronodular cirrhosis (12 wk of twice-weekly dosing)."1.33Modeling liver fibrosis in rodents. ( Constandinou, C; Henderson, N; Iredale, JP, 2005)
"Liver cirrhosis was induced by intraperitoneal administration of CCl4 at a dose of 0."1.33Cryopreserved fetal liver cell transplants support the chronic failing liver in rats with CCl4-induced cirrhosis. ( Fuller, BJ; Mazur, SP; Ochenashko, OV; Petrenko, AY; Somov, AY; Volkova, NA, 2006)
"Immune-induced and CCL4-induced liver fibrosis models were established by dexamethasone (0."1.33Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models. ( Li, J; Luo, XD; Nie, QH; Shao, B; Xie, YM; Zhang, YF; Zhou, YX, 2006)
"The only novel protein with regard to liver fibrosis depicting a unidirectional expression pattern in both animal models was Sbp2."1.33Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. ( Berres, ML; Graf, J; Henkel, C; Hillebrandt, S; Lammert, F; Meyer, HE; Roderfeld, M; Roeb, E; Stühler, K; Weiskirchen, R, 2006)
"Rat liver fibrosis was induced by subcutaneous injection of tetrachloride (CCl4)."1.33Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats. ( Chen, H; Cong, X; Fei, R; Gao, Y; Liu, F; Wang, Y; Wei, L; Zhan, Y, 2006)
"Hepatic encephalopathy is a neurologic syndrome secondary to liver failure that causes cognitive and motor abnormalities."1.33Functional abnormalities of the motor tract in the rat after portocaval anastomosis and after carbon tetrachloride induction of cirrhosis. ( Bartolí, R; Chatauret, N; Córdoba, J; Odena, G; Oria, M; Planas, R; Raguer, N, 2006)
"Aniline was ring hydroxylated in liver microsomes but not in nuclei from either control or EtOH-treated animals."1.33Liver nuclear and microsomal CYP2E1-mediated metabolism of xenobiotics in rats chronically drinking an alcohol-containing liquid diet. ( Castro, GD; Castro, JA; Delgado de Layño, AM; Diaz Gómez, MI; Fanelli, SL, 2006)
"Retrorsine pretreatment did not affect sensitivity for carbon tetrachloride."1.32Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute? ( Aselmann, H; Bahlmann, FH; Dahlke, MH; Jäger, MD; Klempnauer, J; Neipp, M; Piso, P; Popp, FC; Schlitt, HJ, 2003)
"Liver cirrhosis was inflicted in rats by percutaneous injection of 40% CCl4 on the back."1.32Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis. ( Liu, QG; Ma, QY; Pan, CE; Yang, W; Yao, YM; Zhang, M, 2003)
"We have developed a type 2 diabetes rat model that closely resembles the diabetic patients and takes only 24 days to develop robust diabetes."1.32Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats. ( Dnyanmote, AV; Latendresse, JR; Limaye, PB; Mehendale, HM; Sawant, SP; Shankar, K, 2004)
"Candesartan cilexetil treatment significantly reduced the fibrosis development."1.32Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis. ( Bayram, I; Ozbek, H; Tuncer, I; Ugras, S, 2003)
"Hepatic cirrhosis was induced in male Sprague-Dawley rats by intraperitoneal injection of carbon tetrachloride, and the cirrhotic rats were divided into three groups:Liposome-pcDNA(3)/iNOS (n = 10), Tris buffer (n = 10) and nude plasmid (n = 10), which were injected into the portal vein of experiment cirrhotic rats respectively."1.32[Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats]. ( Luo, HF; Qiu, JF; Wu, ZY; Zhang, ZQ, 2004)
"CCl4-induced liver fibrosis enhanced lipid peroxidation and TIMPs activation, increased ALT and AST, depleted antioxidants SOD and GPx, and caused collagen deposition in liver tissue."1.32The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis. ( Avenoso, A; Calatroni, A; Campo, GM; Campo, S; D'Ascola, A; Ferlazzo, AM, 2004)
"Our data suggest that liver cirrhosis induced by CCl4 or TAA is associated with alterations in cell cycle-related proteins, and that the expression of these proteins is responsible for hepatocyte regeneration in the damaged liver and may be involved in liver carcinogenesis."1.31Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide. ( Jang, JJ; Jeong, DH; Lee, JH; Lee, MJ; Lee, SJ; Lee, YS; Lim, IK, 2001)
"Liver cirrhosis was induced by CCl(4) inhalation and phenobarbital in Wistar rats."1.31Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. ( Castilla-Cortázar, I; García, M; Muguerza, B; Prieto, J; Quiroga, J; Santidrián, S, 2001)
"In rats with acute hepatic failure, the hepatic P-glycoprotein concentration increased 1."1.31Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure. ( Huang, ZH; Murakami, T; Nagai, J; Okochi, A; Takano, M; Yumoyo, R, 2001)
"Gliotoxin treatment significantly reduced the number of activated stellate cells and mean thickness of bridging fibrotic septae in livers from rats treated with carbon tetrachloride."1.31Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. ( Arthur, MJ; Iredale, JP; Issa, R; Mann, DA; Murray, GI; Primrose, JN; Smart, DE; Trim, N; Wright, MC, 2001)
" This simple and sensitive assay method was feasibly applied to the pharmacokinetic study of propranolol after intravenous administration of 2 mg/kg of propranolol to normal and carbon tetrachloride-induced liver cirrhotic rats."1.31Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection. ( Hong, JH; Kang, JS; Kim, HK; Lee, MH; Park, MS, 2001)
" We studied the effects of TRZ on the hepatotoxicity of carbon tetrachloride (CCl(4)) and acetaminophen (APAP) in rats, both of which exert their toxic effects through bioactivation associated with cytochrome P450 3A (CYP3A) and 2E1 (CYP2E1)."1.31Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats. ( Kaneko, T; Li, J; Qin, LQ; Sato, A; Wang, PY; Wang, Y, 2002)
"Carbon tetrachloride (CCl4) was fed by gavage to rats, and 2, 7, 14, and 28 days later, small and large cholangiocytes were isolated."1.30Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. ( Alpini, G; Baiocchi, L; Benedetti, A; Caligiuri, A; Francis, H; Glaser, S; Lasater, J; LeSage, GD; Marucci, L; Phinizy, JL; Rodgers, R; Tretjak, Z; Ugili, L, 1999)
" Animals pretreated with this hepatotoxic agent showed a significant prolongation in the half-life of diazepam in plasma that is due more to an increase in volume of distribution rather than to a decrease in clearance."1.28Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury. ( Díaz-García, JM; Fos-Galve, D; Oliver-Botana, J, 1992)
"Medroxyprogesterone acetate (MPA) has an inducing effect on the hepatic drug-metabolizing enzyme system in the rat."1.27Medroxyprogesterone acetate improvement of the hepatic drug-metabolizing enzyme system in rats after chemical liver injury. ( Kärki, NT; Saarni, HU; Sotaniemi, EA; Stengård, J, 1983)
"This results in deep hepatic coma over a narrowly predictable time span and death within 12-52 h."1.27A predictable pathophysiological model of porcine hepatic failure. ( Alp, MH; Hickman, R, 1986)

Research

Studies (878)

TimeframeStudies, this research(%)All Research%
pre-199024 (2.73)18.7374
1990's55 (6.26)18.2507
2000's208 (23.69)29.6817
2010's473 (53.87)24.3611
2020's118 (13.44)2.80

Authors

AuthorsStudies
Xu, S3
Kong, F2
Sun, Z3
Xi, Y1
Qi, F1
Sun, J5
Chen, J17
Martin-Mateos, R1
Li, J26
Yin, Z1
Lu, X3
Glaser, KJ1
Mounajjed, T1
Yashiro, H1
Siegelman, J1
Winkelmann, CT1
Wang, J14
Ehman, RL1
Shah, VH4
Yin, M2
Ogbonna Okoro, C1
Aloke, C1
Ibiam, UA1
Obasi, NA1
Orji, OU1
Ogbonnia, EC1
Ogbu, PN1
Emelike, CU1
Ufebe, GO1
Nwamaka Ezeani, N1
Xu, G2
Lv, X1
Feng, Y1
Li, H16
Chen, C2
Lin, H2
Wang, C8
Wang, S8
Ding, Y6
Dong, R1
Wang, H18
Yin, L3
Meng, S1
Sun, BR1
Li, HY2
Wang, GP1
Jia, QA1
Zhang, C10
Almundarij, TI1
Alharbi, YM1
Abdel-Rahman, HA1
Barakat, H2
Le, TV1
Dinh, NBT1
Dang, MT1
Phan, NCL1
Dang, LTT1
Grassi, G1
Holterman, AXL1
Le, HM1
Truong, NH1
Li, X15
Zhang, S10
Zhang, R3
Wei, Y3
Yang, C5
Zhang, F9
Zhou, H6
Chu, S1
Bi, H2
Cui, L2
He, W3
Tian, Y2
Liu, F4
Gao, G1
Wang, Z10
Chen, N1
Márquez-Quiroga, LV1
Arellanes-Robledo, J1
Vásquez-Garzón, VR1
Villa-Treviño, S1
Muriel, P4
Ge, S3
Yang, W3
Chen, H5
Yuan, Q2
Liu, S4
Zhao, Y10
Zhang, J14
Zhang, YW1
Tu, LL1
Zhang, Y17
Pan, JC1
Zheng, GL1
Yin, LN1
Hu, D3
Huang, S3
Zhao, X3
Zhang, W6
Kostallari, E1
Wei, B1
Sicard, D1
Cooper, SA1
Gao, J5
Dehankar, M1
Li, Y13
Cao, S3
Tschumperlin, DJ1
Ren, Z2
Huo, Y1
Zhang, Q5
Chen, S4
Lv, H1
Peng, L1
Wei, H3
Wan, C2
Shaban, NZ1
El-Kot, SM1
Awad, OM1
Hafez, AM1
Fouad, GM1
Yuan, Z1
He, J6
Xie, T2
Zhou, M3
Chen, TT1
Shi, LP1
He, Y5
Shao, M1
Che, JY1
Xu, H6
Yuan, Y3
Huang, H3
Wu, X4
Fu, J3
Xiong, Y2
Wen, S1
Fang, B1
Li, C8
Huang, Q3
Lin, X1
Faccioli, LAP1
Dias, ML1
Paranhos, BA1
Dos Santos Goldenberg, RC1
Engelmann, C1
Habtesion, A1
Hassan, M1
Kerbert, AJ1
Hammerich, L2
Novelli, S1
Fidaleo, M1
Philips, A1
Davies, N1
Ferreira-Gonzalez, S1
Forbes, SJ3
Berg, T2
Andreola, F1
Jalan, R1
Zhao, T2
Han, Z3
Qiao, H2
Gao, N1
Oates, JR1
Sawada, K1
Giles, DA1
Alarcon, PC1
Damen, MSMA1
Szabo, S1
Stankiewicz, TE1
Moreno-Fernandez, ME1
Divanovic, S1
Nevzorova, YA2
Weiskirchen, R8
Liedtke, C3
Czekaj, P1
Król, M1
Kolanko, E1
Limanówka, Ł1
Prusek, A1
Skubis-Sikora, A1
Bogunia, E1
Sikora, B1
Hermyt, M1
Michalik, M1
Grajoszek, A1
Pająk, J1
Guillard, J1
Untereiner, V1
Garnotel, R1
Boulagnon-Rombi, C1
Gobinet, C1
Proult, I1
Sockalingum, GD1
Thiéfin, G1
Qiuling, L1
Qilin, Y1
Cheng, Y4
Minping, Z1
Kangning, W1
Enhua, X1
Mohammadalipour, A1
Hashemnia, M1
Goudarzi, F1
Ravan, AP1
Pickich, MB1
Hargrove, MW1
Phillips, CN1
Healy, JC1
Moore, AN1
Roberts, MD1
Martin, JS1
Shankaraiah, RC1
Callegari, E1
Guerriero, P1
Rimessi, A1
Pinton, P1
Gramantieri, L1
Silini, EM1
Sabbioni, S1
Negrini, M1
Liu, J17
Kong, D2
Qiu, J3
Xie, Y2
Lu, Z2
Zhou, C3
Liu, X10
Wang, Y27
Rong, X1
Yang, Y11
Zhang, G2
Zhang, H10
Maeso-Díaz, R1
Boyer-Diaz, Z1
Lozano, JJ2
Ortega-Ribera, M1
Peralta, C1
Bosch, J7
Gracia-Sancho, J4
Xu, P3
Yao, J3
Ji, J2
Shi, H6
Jiao, Y1
Hao, S1
Chen, D3
Zhang, L11
Zhou, D3
Yan, X2
Zhu, J5
Xiao, P1
Chen, T4
Xie, X1
Liu, T3
Luo, X2
Li, ZH1
Wu, JC1
Luo, SZ1
Xu, MY1
Zhong, F2
Zhou, X8
Xu, J5
Gao, L4
Ye, L1
Yu, Y2
Fishman, P1
Cohen, S1
Itzhak, I1
Amer, J2
Salhab, A1
Barer, F1
Safadi, R2
Kurahashi, T1
Yoshida, Y3
Ogura, S2
Egawa, M2
Furuta, K2
Hikita, H1
Kodama, T1
Sakamori, R1
Kiso, S3
Kamada, Y3
Wang, IC1
Eguchi, H1
Morii, E1
Doki, Y1
Mori, M3
Kalinichenko, VV1
Tatsumi, T1
Takehara, T2
Yun, H1
Duan, X1
Xiong, W1
Kang, J1
Pu, X1
Chen, Z2
Zhao, L4
Liang, J2
Rao, W1
Cui, M1
Ren, S2
Xu, D3
Han, Q1
Zang, YJ1
Zhang, B1
Wu, BM1
Liu, JD1
Li, YH1
Wu, H5
Chen, G2
Deng, M1
Yuan, F2
Gong, J1
Zhao, J4
Han, M3
Zhou, L7
Liang, P2
Feng, S1
Lu, H3
Yuan, X2
Han, K1
Chen, X7
Cheng, J1
Xiang, X1
Feng, D4
Hwang, S2
Ren, T2
Wang, X16
Trojnar, E1
Matyas, C1
Mo, R1
Shang, D1
Seo, W2
Pacher, P2
Xie, Q1
Gao, B5
Chi, G1
Pei, JH1
Ma, QY2
Ru, YX1
Feng, ZH1
Cao, D1
Min, L1
Wang, G5
Liu, HL1
Lv, J1
Zhao, ZM1
Xiong, AM1
Tan, Y3
Glenn, JS1
Tao, YY2
Weng, HL2
Liu, CH5
Chale-Dzul, J1
Pérez-Cabeza de Vaca, R1
Quintal-Novelo, C1
Olivera-Castillo, L1
Moo-Puc, R1
Deng, Y1
Hou, L1
Fan, X4
Lin, L2
Zhao, W2
Jiang, K1
Sun, C3
Xie, S1
Qi, H2
Li, Q5
Zhang, K1
Shen, W2
Fan, G1
Ya, Y1
Ni, X1
Hou, J3
Yu, R1
Tang, Y1
Ma, N1
Luo, H1
Yu, F2
Zhou, Z4
Qi, J2
Kim, JW2
You, MJ1
Lim, CW2
Kim, B2
Terkelsen, MK1
Bendixen, SM1
Hansen, D1
Scott, EAH1
Moeller, AF1
Nielsen, R1
Mandrup, S1
Schlosser, A1
Andersen, TL1
Sorensen, GL1
Krag, A2
Natarajan, KN1
Detlefsen, S1
Dimke, H1
Ravnskjaer, K1
Ma, R1
Martínez-Ramírez, AS1
Borders, TL1
Gao, F1
Sosa-Pineda, B1
Kopilakkal, R1
Musuvathi, BM1
Liu, D1
Qin, H1
Yang, B2
Du, B1
Yun, X1
Mao, Y3
Wu, J4
Feng, J1
Wu, L4
Yu, Q2
Zhou, Y2
Chen, K4
Wang, F5
Dai, W1
Guo, C3
Xu, JB1
Gao, GC1
Yuan, MJ1
Huang, X1
Zhou, HY1
Zheng, YX1
Wu, Z2
Feng, JM1
Wu, JM2
Xia, Z1
Ding, L1
Zheng, J4
Xu, Y5
Jin, W1
Sheng, X1
Karpińska, G1
Dobrowolski, JC1
Yinda, CK1
Rector, A1
Zeller, M1
Conceição-Neto, N1
Heylen, E1
Maes, P1
Ghogomu, SM1
Van Ranst, M1
Matthijnssens, J1
Arthanari, SK1
Vanitha, J1
Ganesh, M1
Venkateshwaran, K1
de Lama Caro-Patón, G1
García-Salido, A1
Iglesias-Bouzas, MI1
Guillén, M1
Cañedo-Villaroya, E1
Martínez-Romera, I1
Serrano-González, A1
Casado-Flores, J1
Gale, P2
Lucero-Prisno, DE1
Abdullah, AS1
Huang, J4
Laurence, C1
Liang, X3
Ma, Z2
Mao, Z1
Ren, R2
Wu, S4
Wang, N2
Wang, P7
Wang, T5
Yan, H1
Zou, Y1
Olsen, KM1
Gabler, NK1
Rademacher, CJ1
Schwartz, KJ1
Schweer, WP1
Gourley, GG1
Patience, JF1
Rauch, JC1
Stokes, RS1
Shike, DW1
Luebbe, KM1
Stalker, LA1
Klopfenstein, TJ1
Funston, RN1
Unger, PA1
Lighaam, LC1
Vermeulen, E1
Kruithof, S1
Makuch, M1
Culver, EL1
van Bruggen, R1
Remmerswaal, EBM1
Ten Berge, IJM1
Emmens, RW1
Niessen, HWM1
Barnes, E1
Wolbink, GJ1
van Ham, SM1
Rispens, T1
Liang, JX1
Lin, J2
Zhang, T2
Wu, Y8
Venier, M1
Salamova, A1
Gonçales, VR1
Lian, J2
Gautam, S1
Tilley, RD1
Gooding, JJ1
Kandel, YR1
Bradley, CA1
Chilvers, MI1
Mathew, FM1
Tenuta, AU1
Smith, DL1
Wise, KA1
Mueller, DS1
Lu, N1
Lu, M2
Liu, P3
Qiu, X1
Hu, S3
Bai, S1
Xue, S1
Dai, X1
Dharmage, SC1
Abramson, MJ1
Erbas, B1
Bennett, CM1
Svanes, C1
Hui, J1
Axelrad, C1
Lowe, AJ1
Lodge, CJ1
Hoshi, M1
Osawa, Y1
Nakamoto, K1
Morita, N1
Yamamoto, Y2
Ando, T1
Tashita, C1
Nabeshima, T1
Saito, K2
Gianesello, L1
Del Prete, D1
Ceol, M1
Priante, G1
Calò, LA1
Anglani, F1
Vekaria, HJ1
Hubbard, WB1
Scholpa, NE1
Spry, ML1
Gooch, JL1
Prince, SJ1
Schnellmann, RG1
Sullivan, PG1
Hu, R2
Gu, Z1
Zhang, M8
Zhang, Z10
Peng, Y2
Feng, L1
Zhao, C1
Sarfaraz, K1
Leng, J1
Yang, P2
Gao, X2
Emam, HE1
Saad, NM1
Abdallah, AEM1
Ahmed, HB1
Palombo, M1
Ianus, A1
Guerreri, M1
Nunes, D1
Alexander, DC1
Shemesh, N1
Xiong, Q1
Liu, YS1
Hu, LX1
Shi, ZQ1
Ying, GG1
Chen, R2
Hong, X1
Yan, S1
Zha, J1
Gu, H2
Zhong, Q1
Zeng, Y2
Bu, Y1
Farghali, M1
Mayumi, M1
Syo, K1
Satoshi, A1
Seiichi, Y1
Takashima, S1
Ono, H1
Ap, Y1
Yamashiro, T1
Ahmed, MM1
Kotb, S1
Iwasaki, M1
Ihara, I1
Umetsu, K1
Hu, B2
Quan, J1
Huang, K2
Gu, X3
Yan, Y3
Wu, P2
Yang, L11
Koók, L1
Nemestóthy, N1
Bélafi-Bakó, K1
Bakonyi, P1
Xia, Q2
Li, Z9
Ye, W1
Li, S11
Ge, C1
Zakkula, A1
Pulipati, S1
Dittakavi, S1
Bestha, RM1
Zainuddin, M1
Trivedi, RK1
Mullangi, R1
Lo, GH1
Lin, CW1
Tai, CM1
Perng, DS1
Chen, IL1
Yeh, JH1
Lin, HC1
Rocha, GS1
Silva, MKL1
Cesarino, I1
Hazzaa, SM1
Abdelaziz, SAM1
Abd Eldaim, MA1
Abdel-Daim, MM1
Elgarawany, GE1
Larsson, P1
Ljuslinder, I1
Öhlund, D1
Myte, R1
Löfgren-Burström, A1
Zingmark, C1
Ling, A1
Edin, S1
Palmqvist, R1
Murthi, P2
Rajaraman, G1
Erwich, JJHM1
Dimitriadis, E1
Yoon, HG1
Oh, D1
Ahn, YC1
Noh, JM1
Pyo, H1
Cho, WK1
Song, YM1
Park, M1
Hwang, NY1
Sun, JM1
Kim, HK2
Zo, JI1
Shim, YM1
Persano, A1
Quaranta, F1
Taurino, A1
Siciliano, PA1
Iannacci, J1
Malekbala, MR1
Soltani, S1
Abdul Rashid, S1
Abdullah, LC1
Rashid, U1
Nehdi, IA1
Choong, TSY1
Teo, SH1
Yan, F1
Sun, S2
Ying, L1
Quinzi, V1
Caruso, S1
Mummolo, S1
Nota, A1
Angelone, AM1
Mattei, A1
Gatto, R1
Marzo, G1
Xin, W1
Severino, J1
Venkert, A1
Yu, H3
Knorr, D1
Yang, JM1
Carlson, L1
Hicks, R1
De Rosa, I1
Beckmann, NA1
Bitsch, RG1
Schonhoff, M1
Siebenrock, KA1
Schwarze, M1
Jaeger, S1
Jia, M1
Peng, Z3
Yang, K1
Su, C2
Yan, C2
Trivikram, TM1
Niu, ML1
Wcisło, P1
Ubachs, W1
Salumbides, EJ1
Sharp, BR1
Bowman, DMJS1
Palese, A1
Bressan, V1
Hayter, M1
Watson, R1
Bozorov, TA1
Li, DX1
Zhou, P1
Wen, XJ1
Zhang, DY1
Yoshida, H1
Koike, M1
Tada, Y1
Nakata, K1
Hino, A1
Fuji, S1
Masaie, H1
Oka, C1
Higeno, A1
Idota, A1
Yamasaki, T1
Ishikawa, J1
Nekoohesh, L2
Ghahremani, MH1
Rostami, S1
Nikbakht, M1
Naemi, R1
Mohammadi, S1
Ghadyani Nejad, L1
Mousavi, SA1
Vaezi, M1
Alimoghaddam, K1
Chahardouli, B1
El-Neanaey, WA1
Swelem, RS1
Ghallab, OM1
Mohamed Abu-Shelou, S1
Javadzadeh Shahshahani, H1
Hayati, A1
Abbasnezhad, A1
Habibi, M1
Abdolkarimi, B1
Zare, S1
Fazeli Moghadam, E1
Choghakhori, R1
Asmaa, MJS1
Al-Jamal, HA1
Hussein, AR1
Yahaya, BH1
Hassan, R2
Hussain, FA1
Shamsuddin, S1
Johan, MF1
Chen, Y21
Zhu, H2
Xi, J2
He, P3
Cuenca, J1
Liang, Z1
Sun, H3
Gutierrez, B1
Xi, X1
Arro, J1
Fan, P1
Londo, J1
Cousins, P1
Fei, Z1
Zhong, GY1
Bell, K1
Rosignol, I1
Sierra-Filardi, E1
Rodriguez-Muela, N1
Schmelter, C1
Cecconi, F1
Grus, F1
Boya, P1
Hahn, MA1
Von Elert, E1
Jiang, Y2
Wang, B5
Yang, J5
Kang, Y1
Zhang, WS1
Xiong, JH1
Kim, HJ2
Baek, SK1
Maeng, CH1
Kim, SY3
Park, TS1
Han, JJ1
Tao, W1
Yu, J4
Zhou, Q5
Mu, H1
Shen, Y1
Liu, L4
Yang, R1
Yan, B1
Min, S1
Zhang, P3
Xu, B1
Luo, G1
Liu, C5
Kim, JK2
Lee, HJ2
Hwang, SI1
Choe, G1
Hong, SK1
Vaverka, J1
Moudr, J1
Lokaj, P1
Burša, J1
Pásek, M1
Pham, DC1
Nguyen, HC1
Nguyen, TL1
Ho, HL1
Trinh, TK1
Riyaphan, J1
Weng, CF1
Wollin, L1
Togbe, D1
Ryffel, B1
Cao, H1
Wu, W6
Liu, H9
Xia, B1
Long, C2
Kuang, X1
Ning, J1
Ma, X3
Wang, R6
Tang, H1
Du, H2
Yan, J1
Zhang, X14
Shen, H2
Almanaitytė, M1
Jurevičius, J1
Mačianskienė, R1
Lu, Y7
Chen, L5
Li, L10
Cao, Y5
Han, D1
Yu, S2
An, C1
Zhong, H1
Jiang, L3
Wu, LL1
Pan, XM1
Chen, HH2
Fu, XY2
Jiang, J2
Ding, MX1
Ramadan, MZ1
Ghaleb, AM1
Ragab, AE1
Putra, A2
Rosdiana, I1
Darlan, DM1
Alif, I1
Hayuningtyas, F1
Wijaya, I1
Aryanti, R1
Makarim, FR1
Antari, AD1
You, S1
Cui, AM1
Hashmi, SF1
Nadolny, C1
Chen, Q1
Bush, X1
Hurd, Z1
Ali, W1
Qin, G1
Deng, R1
Xuan, J2
Huang, A1
Geng, J1
Cheng, Z1
Qiu, Y1
Jung, YS2
Stratton, SA1
Lee, SH2
Kim, MJ1
Jun, S1
Zheng, B1
Cervantes, CL1
Cha, JH1
Barton, MC1
Park, JI1
Zhou, F1
Guo, J3
Shi, Y4
Lu, J3
Pei, G1
Khalil, MR1
El-Demerdash, RS1
Elminshawy, HH1
Mehanna, ET1
Mesbah, NM1
Abo-Elmatty, DM1
Lei, X3
Liu, Q7
Cao, Z3
Kuang, T1
Fang, Y1
Liu, G2
Qian, K1
Liu, Z7
Xiao, Z1
Xu, X3
Ma, JQ2
Sun, YZ1
Ming, QL1
Tian, ZK2
Zhang, YJ2
Liu, CM2
Barkauskas, DS1
Medley, G1
Mohammed, YH1
Thorling, CA1
Roberts, MS2
Wan, S1
Luo, F1
Huang, C8
Luo, Q1
Zhu, X2
Mazhari, S1
Gitiara, A1
Baghaei, K1
Hatami, B1
Rad, RE1
Asadirad, A1
Joharchi, K1
Tokhanbigli, S1
Hashemi, SM1
Łos, MJ1
Aghdaei, HA1
Zali, MR1
Ghavami, S1
Zhou, J6
Shi, J3
Wu, Q2
Zhou, S1
Uddin, MN1
Alam, T1
Islam, MA1
Khan, TA1
Zaman, RU1
Azam, S1
Kamal, AM1
Jakaria, M1
Song, F2
Li, F2
Tan, H1
Huang, M1
Shu, J2
Shao, S1
Bi, Z1
Bai, J2
Ma, B1
Xie, C1
Ning, W1
Ni, M1
Wang, L8
Gao, Y6
Abbas, N1
Getachew, A1
You, K1
Shah, Z1
Tao, J1
Hussain, M1
Yang, F3
Zhuang, Y3
Li, YX1
Zhao, Z1
Cheng, B1
Cheng, G1
Cai, S1
Hu, X2
Hou, C1
Sungkar, T1
Lindarto, D1
Sembiring, RJ1
Gong, H1
Fan, Z2
Yi, D1
Guo, R1
Fang, W1
Tuominen, I1
Fuqua, BK1
Pan, C1
Renaud, N1
Wroblewski, K1
Civelek, M1
Clerkin, K1
Asaryan, A1
Haroutunian, SG1
Loureiro, J1
Borawski, J1
Roma, G1
Knehr, J1
Carbone, W1
French, S1
Parks, BW1
Hui, ST1
Mehrabian, M1
Magyar, C1
Cantor, RM1
Ukomadu, C1
Lusis, AJ1
Beaven, SW1
Li, R7
Yin, Y2
Tao, K1
Argemi, J1
Odena, G3
Xu, MJ1
Cai, Y4
Massey, V1
Parrish, A1
Vadigepalli, R1
Altamirano, J1
Cabezas, J1
Gines, P3
Caballeria, J2
Snider, N1
Sancho-Bru, P4
Akira, S1
Rusyn, I3
Bataller, R4
Al-Qabba, MM1
El-Mowafy, MA1
Althwab, SA1
Alfheeaid, HA1
Aljutaily, T1
Okamura, M1
Shizu, R1
Abe, T1
Kodama, S1
Hosaka, T1
Sasaki, T2
Yoshinari, K1
Huang, Y4
Wu, T1
Tang, Q1
Mo, L1
Yang, N2
Lin, Q2
Ji, X1
Li, N3
Xu, W2
Liu, Y10
Jin, S5
Verboven, E1
Moya, IM1
Sansores-Garcia, L1
Xie, J7
Hillen, H1
Kowalczyk, W1
Vella, G1
Verhulst, S2
Castaldo, SA1
Algueró-Nadal, A1
Romanelli, L1
Mercader-Celma, C1
Souza, NA1
Soheily, S1
Van Huffel, L1
Van Brussel, T1
Lambrechts, D1
Roskams, T1
Lemaigre, FP1
Bergers, G1
van Grunsven, LA4
Halder, G1
Ni, W1
Liu, HH1
Li, AJ1
Tang, G1
Seume, N1
Häger, C1
Kumstel, S1
Abshagen, K1
Bleich, A1
Vollmar, B1
Talbot, SR1
Zechner, D1
Zhao, Q3
Song, N2
Yan, Z2
Lin, R1
Hong, S2
Jiang, X5
Lai, J1
Sun, Y3
Guan, W1
Cavallaro, PM1
Kim, BM1
Kühn, F1
Adiliaghdam, F1
Liu, E1
Vasan, R1
Samarbafzadeh, E1
Farber, MZ1
Xu, M2
Mohad, V1
Choi, M1
Hodin, RA1
Xiang, C1
Ding, C1
Jin, L2
He, F1
Wang, BJ1
Wang, JZ1
Xie, XM1
Tong, QX1
Cheng, P1
Tariq, S1
Koloko, BL1
Malik, A2
Rehman, S1
Ijaz, B1
Shahid, AA1
Alzahrani, B1
A M Alameen, A1
Tantawy, A1
Zhu, Y6
Hu, Y2
Cheng, X2
Niu, Q1
Xie, G3
Jiang, R4
Zhao, A1
Huang, F1
Rajani, C1
Zheng, X5
Zhao, S3
Bian, H1
Sun, B2
Jia, W1
Lagnado, A1
Leslie, J2
Ruchaud-Sparagano, MH1
Victorelli, S1
Hirsova, P1
Ogrodnik, M1
Collins, AL1
Vizioli, MG1
Habiballa, L1
Saretzki, G1
Evans, SA1
Salmonowicz, H1
Hruby, A1
Geh, D1
Pavelko, KD1
Dolan, D1
Reeves, HL1
Grellscheid, S1
Wilson, CH1
Pandanaboyana, S1
Doolittle, M1
von Zglinicki, T1
Oakley, F4
Gallage, S1
Wilson, CL2
Birch, J1
Carroll, B1
Chapman, J1
Heikenwalder, M1
Neretti, N1
Khosla, S1
Masuda, CA1
Tchkonia, T1
Kirkland, JL1
Jurk, D1
Mann, DA5
Passos, JF1
Kuang, G1
Guo, X2
Wan, J4
Uchendu, IK1
Agu, CE1
Nnedu, EB1
Chukwu, IJ1
Yang, S2
Zhu, Z2
Xing, X3
Hanafy, NAN1
Yan, L3
Shao, Y2
Tong, Q1
Qin, W1
Liao, X2
Zhan, W2
Tian, T2
Yu, L2
Yang, Q4
Ravichandra, A1
Schwabe, RF3
Shuai, C1
Xia, GQ1
Lv, XW2
Shu, L1
Zong, J1
Cheong, LY1
Ye, D1
Lam, KSL1
Song, E1
Xu, A1
Hoo, RLC1
Yaqub, F1
Latief, N1
Butt, H1
Naseer, N1
Riazuddin, S1
Gárate-Rascón, M1
Recalde, M1
Jimenez, M1
Elizalde, M1
Azkona, M1
Uriarte, I1
Latasa, MU2
Urtasun, R2
Bilbao, I1
Sangro, B1
Garcia-Ruiz, C1
Fernandez-Checa, JC2
Corrales, FJ1
Esquivel, A1
Pineda-Lucena, A1
Fernández-Barrena, MG1
Ávila, MA2
Arechederra, M1
Berasain, C2
Yu, X3
Huang, L2
You, C1
Guo, Z1
Cui, H1
Yang, H2
Li, SQ1
Wang, SL1
Song, Y2
Cheng, WG1
Zhang, BB1
Wang, DM1
Wang, YL2
Lee, J1
Kim, SR1
Lee, C2
Jun, YI1
Bae, S1
Yoon, YJ1
Kim, OY1
Gho, YS1
Xie, N1
Shu, Y1
Xiang, Y1
Gu, J3
Yang, Z2
Sun, Q2
Xiu, AY1
Ding, Q1
Zhang, CQ1
Kumar, B1
Modi, M1
Saikia, B1
Medhi, B1
Giusto, M1
Barberi, L1
Di Sario, F1
Rizzuto, E1
Nicoletti, C1
Ascenzi, F1
Renzi, A1
Caporaso, N3
D'Argenio, G2
Gaudio, E3
Musarò, A1
Merli, M1
Yao, QY1
Liu, HC1
Jin, QW1
Xu, BL1
Zhang, SC1
Tu, CT1
Chang, BY1
Yoon, CS1
Oh, JS1
Hong, JH2
Kim, YC3
Turkay, R1
Aydin, AF1
Bingul, I1
Kucukgergin, C1
Dogan-Ekici, I1
Hocaoglu, E1
Inci, E1
Bakir, B1
Uysal, M1
Rókusz, A1
Veres, D1
Szücs, A1
Bugyik, E2
Mózes, M1
Paku, S2
Nagy, P2
Dezső, K2
Zhong, W2
Huang, P2
Huang, W4
Nie, L1
Lv, Z1
Li, P2
Lu, Q2
Jiang, W2
Pei, X1
Hao, H2
Hao, K1
Milosavljevic, N1
Gazdic, M1
Simovic Markovic, B1
Arsenijevic, A1
Nurkovic, J1
Dolicanin, Z1
Djonov, V1
Lukic, ML1
Volarevic, V1
Spirlandeli, AL1
Dick-de-Paula, I1
Zamarioli, A1
Jorgetti, V1
Ramalho, LNZ1
Nogueira-Barbosa, MH1
Volpon, JB1
Jordão, AA1
Cunha, FQ1
Fukada, SY1
de Paula, FJA1
Su, TH1
Shiau, CW1
Jao, P1
Yang, NJ1
Tai, WT1
Liu, CJ1
Tseng, TC1
Yang, HC1
Huang, KW1
Hu, TC1
Huang, YJ2
Wu, YM2
Chen, LJ2
Chen, PJ1
Chen, DS2
Chen, KF1
Kao, JH1
Najimi, M1
Berardis, S1
El-Kehdy, H1
Rosseels, V1
Evraerts, J1
Lombard, C1
El Taghdouini, A1
Henriet, P1
van Grunsven, L1
Sokal, EM1
Ma, PF1
Gao, CC1
Yi, J1
Zhao, JL1
Liang, SQ1
Ye, YC1
Zheng, QJ1
Dou, KF1
Han, H2
Qin, HY1
Rengasamy, M1
Singh, G1
Fakharuzi, NA1
Balasubramanian, S1
Swamynathan, P1
Thej, C1
Sasidharan, G1
Gupta, PK1
Das, AK2
Rahman, AZA1
Fakiruddin, KS1
Nian, LM1
Zakaria, Z1
Majumdar, AS1
Garg, M1
Kaur, S1
Banik, A1
Kumar, V1
Rastogi, A1
Sarin, SK1
Mukhopadhyay, A1
Trehanpati, N1
Han, X2
Yuan, G1
An, L1
Du, P2
Cao, W1
Bolkestein, M1
Verstegen, MMA1
Bijvelds, MJC1
Wang, W2
Tuysuz, N1
Ten Berge, D1
Sprengers, D1
Metselaar, HJ1
van der Laan, LJW1
Kwekkeboom, J1
Smits, R1
Peppelenbosch, MP1
Pan, Q1
Ramírez-Elías, MG1
Kolosovas-Machuca, ES1
Kershenobich, D1
Guzmán, C1
Escobedo, G1
González, FJ2
Shi, D1
Lv, L2
Fang, D1
Hu, C1
Xu, L2
Li, A1
Guo, F1
Ye, J1
Andayani, D1
de Souza, VCA1
Pereira, TA1
Teixeira, VW1
Carvalho, H1
de Castro, MCAB1
D'assunção, CG1
de Barros, AF1
Carvalho, CL1
de Lorena, VMB1
Costa, VMA1
Teixeira, ÁAC1
Figueiredo, RCBQ1
de Oliveira, SA1
Hammad, S1
Braeuning, A1
Meyer, C1
Mohamed, FEZA1
Hengstler, JG1
Dooley, S5
Hung, WL1
Yang, G2
Wang, YC1
Chiou, YS1
Tung, YC1
Yang, MJ1
Wang, BN1
Ho, CT1
Pan, MH1
Lin, Y2
Kuang, Y3
Li, K1
Ji, S1
Song, W2
Qiao, X1
Ye, M1
Klein, S3
Schierwagen, R3
Uschner, FE2
Trebicka, J5
Sahreen, S3
Khan, MR5
Khan, RA4
Bian, M1
Jin, H3
Yang, X4
Shao, J3
Chen, A3
Guo, Q2
Zheng, S6
Puengel, T1
Krenkel, O2
Kohlhepp, M1
Lefebvre, E1
Luedde, T3
Trautwein, C7
Tacke, F6
Rouède, D1
Schaub, E1
Bellanger, JJ1
Ezan, F2
Scimeca, JC1
Baffet, G2
Tiaho, F1
Ali, S2
Sajid, M1
Zhang, CH1
Zheng, L1
Gui, L1
Lin, JY1
Zhu, YM1
Deng, WS2
Luo, M2
Zhang, N3
Zheng, Y1
Chen, WG1
Song, LX1
Xu, LH1
Xu, KS2
Brückner, S1
Zipprich, A2
Hempel, M1
Thonig, A1
Schwill, F1
Roderfeld, M3
Roeb, E3
Christ, B1
Maimaitiyiming, D1
Kamilijiang, M1
Xiaerfuding, X1
Hui, SW1
Abudureyimu, M1
Hajinisha, -1
Aikemu, A1
Ahmed, AF1
Al-Yousef, HM1
Al-Qahtani, JH1
Al-Said, MS1
Athwal, VS1
Pritchett, J1
Llewellyn, J1
Martin, K1
Camacho, E1
Raza, SM1
Phythian-Adams, A1
Birchall, LJ1
Mullan, AF1
Su, K1
Pearmain, L1
Dolman, G1
Zaitoun, AM1
Friedman, SL3
MacDonald, A1
Irving, WL1
Guha, IN1
Hanley, NA1
Piper Hanley, K1
Zhao, H3
He, Q1
Chu, Y1
Shi, A1
Dong, L2
Yao, LJ1
Ding, K1
Shi, PM1
Chen, F1
Ding, J1
Xie, WF2
Zhu, L3
Shang, Q1
Pan, H1
Li, B3
Jia, R1
Zhang, GZ1
Sun, HC1
Zheng, LB1
Guo, JB1
Zhang, XL1
Peng, X3
Dai, C2
Zhang, D1
Dai, J2
Tang, L2
Ge, P1
Wang, YH3
Li, RK1
Fu, Y3
Yang, XM1
Zhang, YL2
Gu, JR1
Zhang, ZG1
Senoo, T1
Sasaki, R2
Akazawa, Y1
Ichikawa, T2
Miuma, S1
Miyaaki, H1
Taura, N1
Nakao, K1
Nasir, Z1
Qaisar, MN1
Uttra, AM1
Ahsan, H1
Khan, KU1
Khan, IU1
Saleem, M1
Asif, H1
Sharif, A1
Younis, W1
Naz, H1
Bu, FT2
Yu, HX2
Pan, XY3
Wang, Q3
Wu, YT2
Meng, XM4
Ji, DG1
Yao, SM1
Zhai, XJ1
Zhang, LR1
Zhang, YZ1
Zare, H1
Jamshidi, S1
Dehghan, MM1
Saheli, M1
Piryaei, A3
Huang, ZQ1
Chen, P1
Su, WW1
Wang, YG1
Peng, W3
Li, PB1
Harris, TR1
Kodani, S1
Rand, AA1
Imai, DM1
Hwang, SH1
Hammock, BD2
Huang, AL1
Ding, HW1
Arooj, M1
Butt, TT1
Zahid, S1
Zahid, F1
Jafar, TH1
Waquar, S1
Gan, SH1
Ahmad, S1
Mirza, MU1
Liang, H2
Su, T1
Dinh, PU1
Wrona, EA1
Shao, C1
Qiao, L2
Vandergriff, AC1
Hensley, MT1
Cores, J1
Allen, T1
Zeng, Q1
Xing, J2
Freytes, DO1
Shen, D1
Yu, Z1
Cheng, K1
Crespo Yanguas, S1
da Silva, TC1
Pereira, IVA1
Maes, M1
Willebrords, J1
Shestopalov, VI1
Goes, BM1
Sayuri Nogueira, M1
Alves de Castro, I1
Romualdo, GR1
Barbisan, LF1
Gijbels, E1
Vinken, M1
Cogliati, B1
Wu, XQ1
Li, WX1
Huang, HM1
Li, HD1
Li, XF1
Qian, J1
Wu, G1
Gwon, MG1
Kim, JY2
An, HJ1
Kim, WH1
Kim, MK1
Park, SC1
Park, KK1
Idriss, NK1
Sayyed, HG1
Osama, A1
Sabry, D1
Huang, MP1
Wang, XF1
Luo, L1
Zhu, T1
Qiu, JL1
Nwidu, LL1
Oboma, YI1
Elmorsy, E1
Carter, WG1
Kim, M1
Lee, JH6
Oh, J1
Shin, HH1
Lee, SM5
Scherer, PE1
Kwon, HM1
Choi, JH4
Park, J2
Ai, WL1
Dong, LY2
Li, ZW1
An, W2
Batool, R1
Rashid Khan, M1
Ahmed Zai, J1
Maryam, S1
Naz, I1
Bibi, S1
Peng, C1
Su, Z1
Lin, D2
Li, M4
Jia, Y4
Farouk, S1
Sabet, S1
Abu Zahra, FA1
El-Ghor, AA1
Pegoraro, CMR1
Nai, GA1
Garcia, LA1
Serra, FM1
Alves, JA1
Chagas, PHN1
Oliveira, DG1
Zocoler, MA1
Yang, CL1
Zheng, XL1
Ye, K1
Sun, YN1
Lu, YF1
Ge, H1
Tung, NT1
Tran, CS1
Nguyen, HA1
Nguyen, TD1
Chi, SC1
Pham, DV1
Bui, QD1
Ho, XH1
Fathy, M1
Khalifa, EMMA1
Fawzy, MA1
Liu, QW1
Liu, QY1
Li, JY1
Wei, L7
Ren, KK1
Zhang, XC1
Ding, T1
Xiao, L1
Zhang, WJ2
Wu, HY1
Xin, HB1
Tammam, SN1
Safy, SE1
Abdel-Halim, M1
Asimakopoulou, A1
Mansour, S1
Guan, H1
Han, R1
Han, Y2
Gui, J1
Dong, Y1
Manzhaliy, EG1
Virchenko, OV1
Falaleyeva, TM1
Beregova, TV1
Savchuk, OM1
Kondratyuk, VE1
Zhou, K1
Yin, S1
Song, G1
Dai, Z1
Tsay, HC1
Shen, X2
Ott, M1
Sharma, AD1
Takami, T2
Tani, K2
Taura, Y2
Sakaida, I5
Rong, W1
Cui, C1
Feng, Z1
Sun, X5
Ghanem, LY1
Mansour, IM1
Abulata, N1
Akl, MM1
Demerdash, ZA1
El Baz, HG1
Mahmoud, SS2
Mohamed, SH1
Mahmoud, FS1
Hassan, ASM1
Holeček, M1
Vodeničarovová, M1
Yao, Y1
Nishimura, T1
Aibe, Y1
Matsuda, T1
Fujisawa, K3
Matsumoto, T2
Yamamoto, N2
Jia, D2
Wang, YY1
Liang, DY1
Wang, D4
Cheng, C1
Guo, L1
Khan, A1
Shal, B1
Naveed, M1
Shah, FA1
Atiq, A1
Khan, NU1
Kim, YS2
Khan, S1
Jin, Y1
Donahue, K1
Tsui, M1
Fish, M1
Logan, CY1
Nusse, R1
Biswas, S1
Mukherjee, PK1
Harwansh, RK1
Bannerjee, S1
Bhattacharjee, P1
Huang, G1
He, S1
Lin, M1
Gao, Z2
Zhai, X1
Tian, X1
Aithal, AP1
Bairy, LK1
Seetharam, RN1
Rao, MK1
Meier, RPH1
Meyer, J1
Montanari, E1
Lacotte, S1
Balaphas, A1
Muller, YD1
Clément, S1
Negro, F1
Toso, C1
Morel, P1
Buhler, LH1
He, L1
Pang, Z1
Xu, C1
Hao, Q1
Li, W5
Luo, Y1
Yin, F1
Huo, X1
Niu, G1
Song, M1
Yang, JH2
Kim, KM1
Cho, SS1
Shin, SM1
Ka, SO1
Na, CS1
Park, BH1
Jegal, KH1
Ku, SK1
Park, SG1
Cho, IJ1
Ki, SH2
Golder, MR1
Andersen, JN1
Shipitsin, MV1
Vohidov, F1
Nguyen, HV1
Ehrlich, DC1
Huh, SJ1
Vangamudi, B1
Economides, KD1
Neenan, AM1
Ackley, JC1
Baddour, J1
Paramasivan, S1
Brady, SW1
Held, EJ1
Reiter, LA1
Saucier-Sawyer, JK1
Kopesky, PW1
Chickering, DE1
Blume-Jensen, P1
Johnson, JA1
Leu, JI1
Murphy, ME1
George, DL1
Deng, Z1
Pan, Z2
Zhang, HE1
Henderson, JM1
Gorrell, MD1
McGill, MR1
Jaeschke, H1
Hua, H1
Qian, Y3
Yuan, H2
Ge, W1
Zhang, A1
Jia, Z1
Ding, G1
Qin, DM1
Wang, XB1
Zou, N1
Han, C1
Akcora, BÖ1
Dathathri, E1
Ortiz-Perez, A1
Gabriël, AV1
Storm, G2
Prakash, J2
Bansal, R2
Wang, M2
Niu, J2
Ou, L1
Deng, B1
Hundertmark, J1
Ritz, TP1
Brol, MJ1
Rösch, F1
Magdaleno, F1
Manekeller, S1
Queck, A1
Schwarzkopf, K1
Odenthal, M2
Drebber, U1
Thiele, M1
Lingohr, P1
Plamper, A1
Kristiansen, G1
Lotersztajn, S4
Rheinwalt, KP1
van der Helm, D1
Barnhoorn, MC1
de Jonge-Muller, ESM1
Molendijk, I1
Hawinkels, LJAC1
Coenraad, MJ1
van Hoek, B1
Verspaget, HW1
Akhtar, U1
Ahmed, M2
Tayyeb, A1
Shehzad, U1
Ali, G1
Park, SH2
Cho, YE1
Guillot, A1
Wu, R1
Kim, SJ3
Liangpunsakul, S1
Marsh, JN1
Korenblat, KM1
Liu, TC1
McCarthy, JE1
Wickline, SA1
Hung, TM1
Lin, YC2
Chen, YH2
Lee, PH1
Chen, W3
Shi, X1
Zhu, M2
Xie, H1
Shah, NA1
Ai, G1
Hua, W1
Huang, Z1
Wei, D1
Cong, M2
Yang, A1
Bai, Y1
Tong, X1
Cong, R1
Tang, S2
Jia, J1
You, H1
Shin, DS1
Kim, KW1
Chung, HY1
Yoon, S2
Moon, JO1
Gruttadauria, S1
Grosso, G1
Pagano, D1
Biondi, A1
Echeverri, GJ1
Seria, E1
Pietrosi, G1
Liotta, R1
Basile, F1
Gridelli, B1
Hu, J1
Lin, S1
Hong, Z1
Stock, MK1
do O, NT1
Berres, ML4
Alsamman, M1
Heinrichs, D2
Nellen, A2
Wasmuth, HE3
Sahin, H2
Nissar, AU1
Farrukh, MR1
Kaiser, PJ1
Rafiq, RA1
Afnan, Q1
Bhushan, S1
Adil, HS1
Subhash, BC1
Tasduq, SA1
Jung, J1
Lee, Y1
Park, JW1
Oh, IH1
Hwang, SG1
Kim, KS2
Kim, GJ1
Kubota, N1
Kado, S1
Kano, M1
Masuoka, N1
Nagata, Y1
Kobayashi, T1
Miyazaki, K1
Ishikawa, F1
Rosado, E4
Rodríguez-Vilarrupla, A6
Tripathi, D1
García-Calderó, H2
García-Pagán, JC5
Collins, BH1
Holzknecht, ZE1
Lynn, KA1
Sempowski, GD1
Smith, CC1
Parker, W1
Rockey, DC2
Sharma, CK1
Saxena, M3
Sharma, V1
Ottu, OJ1
Atawodi, SE1
Onyike, E1
Shtroblia, AL1
Fira, LS1
Likhatskiĭ, PG1
Pyla, VP1
Vashkeba, EM1
Medvid', II1
Xu, T2
Bie, P1
Morán-Salvador, E1
Titos, E3
Rius, B1
González-Périz, A2
García-Alonso, V1
López-Vicario, C1
Miquel, R2
Barak, Y1
Arroyo, V8
Clària, J3
Fuchs, BC4
Polasek, M2
Schühle, DT2
Lauwers, GY5
Parkar, A1
Sinskey, AJ1
Tanabe, KK4
Caravan, P3
Wang, DH1
Wang, YN1
Ge, JY1
Liu, HY2
Zhang, HJ1
Qi, Y1
Liu, ZH1
Cui, XL1
Guo, XL1
Liang, B1
Wang, XW1
Fan, FG1
Jin, J1
Lan, R1
Wang, XC1
Cao, Q1
Dong, W2
Lv, B1
Wei, F1
Jiang, M1
Cong, L1
Yuan, L1
Huang, GJ1
Deng, JS1
Huang, SS1
Lee, CY2
Hou, WC1
Wang, SY1
Sung, PJ1
Kuo, YH1
Fallowfield, JA1
Hayden, AL1
Snowdon, VK1
Aucott, RL1
Stutchfield, BM1
Mole, DJ1
Pellicoro, A1
Gordon-Walker, TT2
Henke, A1
Schrader, J1
Trivedi, PJ1
Princivalle, M1
Collins, JE1
Iredale, JP5
Ghaffari, H2
Venkataramana, M1
Nayaka, SC1
Ghassam, BJ2
Angaswamy, N1
Shekar, S1
Sampath Kumara, KK1
Prakash, HS2
Lei, Y2
Zhou, AM1
Guo, T1
Jamil, MS1
Mahmood, Z1
Saeed, A1
Jamil, A1
Usmanghani, K1
Asif, HM1
Roohi, M1
Alqasoumi, SI2
Farraj, AI1
Abdel-Kader, MS1
Stewart, RK1
Dangi, A1
Murase, N1
Kimura, S1
Stolz, DB1
Wilson, GC1
Lentsch, AB1
Gandhi, CR1
Huang, SX1
Kuang, ZP1
Luo, XL1
Li, YD1
Wu, JN1
Xie, YA1
Bittnerová, L1
Jiroutová, A1
Rudolf, E1
Rezácová, M1
Kanta, J2
Kwon, HJ1
Won, YS1
Park, O1
Seo, KW1
Sohn, SY1
Bhang, DH1
Nam, MJ1
Lee, HW1
Youn, HY1
Jiang, H2
Gao, JR1
Chen, JF1
Ji, WB1
Akindele, AJ1
Adeneye, AA1
Olatoye, F1
Benebo, AS1
Chappell, G1
Kutanzi, K1
Uehara, T2
Tryndyak, V1
Hong, HH1
Hoenerhoff, M1
Beland, FA1
Pogribny, IP2
Reiberger, T1
Duyverman, AM1
Samuel, R1
Hiddingh, L1
Roberge, S1
Koppel, C1
Zhu, AX1
Jain, RK1
Duda, DG1
Ding, BS1
Lis, R1
Nolan, DJ1
Guo, P1
Simons, M1
Penfold, ME1
Shido, K1
Rabbany, SY1
Rafii, S1
Cuenca, S1
Sanchez, E4
Santiago, A1
El Khader, I1
Panda, S1
Vidal, S2
Camilo Nieto, J1
Juárez, C2
Sancho, F2
Guarner, F2
Soriano, G4
Guarner, C4
Manichanh, C1
Cetinkaya, A1
Kantarceken, B1
Bulbuloglu, E1
Kurutas, EB1
Ciralik, H1
Atli, Y1
Moles, A2
Murphy, L1
Chakraborty, JB1
Fox, C1
Park, EJ3
Mann, J3
Howarth, R1
Brain, J1
Masson, S1
Karin, M2
Seki, E4
Roh, YS1
Park, S1
Ghasemi, M1
Azarnia, M1
Jamali, M1
Mirabolghasemi, G1
Nazarian, S1
Naghizadeh, MM1
Rajabi, M1
Tahamtani, Y1
Lardizábal, MN1
Rodríguez, RE1
Nocito, AL1
Daniele, SM1
Palatnik, JF1
Veggi, LM1
Wang, YZ1
Liu, XC1
Xue, X1
Xiao, X1
Zhu, JX1
Luo, GM1
Zhu, YY1
Zeng, JX1
Wang, XY1
Wu, B1
Ye, S1
Deng, G1
Huang, XJ1
Luo, HW1
Huang, FZ1
Liu, XY1
Taslidere, E1
Esrefoglu, M1
Elbe, H1
Cetin, A1
Ates, B1
Lua, I1
James, D1
Wang, KS1
Asahina, K1
Ehling, J1
Bartneck, M1
Wei, X1
Gremse, F1
Fech, V1
Möckel, D1
Baeck, C1
Hittatiya, K1
Eulberg, D1
Kiessling, F1
Lammers, T1
Nishikawa, T1
Bellance, N1
Damm, A1
Bing, H1
Handa, K1
Yovchev, MI1
Sehgal, V1
Moss, TJ1
Oertel, M1
Ram, PT1
Pipinos, II1
Soto-Gutierrez, A1
Fox, IJ1
Nagrath, D1
Granzow, M1
Kowallick, B1
Huss, S2
Linhart, M1
Mazar, IG1
Görtzen, J1
Vogt, A1
Schildberg, FA2
Gonzalez-Carmona, MA1
Wojtalla, A1
Krämer, B1
Nattermann, J1
Siegmund, SV2
Werner, N1
Fürst, DO1
Laleman, W1
Knolle, P1
Sauerbruch, T1
Hoshida, Y1
Fujii, T2
Yamada, S3
McGinn, CM1
DePeralta, DK1
Kuroda, T1
Lanuti, M2
Schmitt, AD1
Gupta, S2
Crenshaw, A1
Onofrio, R1
Taylor, B1
Winckler, W1
Bardeesy, N1
Golub, TR1
Kong, Y1
Tang, N1
Rodrigo-Torres, D1
Affò, S1
Coll, M3
Morales-Ibanez, O1
Millán, C1
Blaya, D1
Alvarez-Guaita, A1
Rentero, C1
Maestro, MA1
Solar, M1
Enrich, C1
Chen, M2
Nie, H1
Li, G3
Sun, T1
Shu, K1
Gong, Q1
Nieto, JC1
Boullosa, A1
Sancho, FJ1
Rossi, G1
Oms, R1
Mirelis, B1
Das, M1
Boerma, M1
Goree, JR1
Lavoie, EG1
Fausther, M1
Gubrij, IB1
Pangle, AK1
Johnson, LG1
Dranoff, JA1
Korkmaz, H1
Temel, T1
Bugdaci, MS1
Tekelioglu, Y1
Ozoran, Y1
Kapicioglu, S1
Cai, XG1
Xia, JR1
Li, WD1
Lu, FL1
Zhi, H1
Tu, X1
Zang, Y2
Aksit, H1
Bildik, A1
Choi, YJ1
Kim, DH2
Kim, J1
Jeong, SI1
Chung, CH1
Yu, KY1
Ma, C1
Liu, A1
Geng, X1
Hao, L1
Song, Q1
Zhao, G2
Chheda, TK1
Shivakumar, P1
Sadasivan, SK1
Chanderasekharan, H1
Moolemath, Y1
Oommen, AM1
Madanahalli, JR1
Marikunte, VV1
Tan, CY1
Lai, RC1
Wong, W1
Dan, YY1
Lim, SK1
Ho, HK1
Atasever, A1
Yaman, D1
Abdelaziz, DH1
Ali, SA1
Matar, KM1
Tayem, YI1
Peng, SY1
Chou, CJ1
Cheng, PJ1
Ko, IC1
Kao, YJ1
Cheng, WT1
Shaw, SW1
Wu, SC1
Chen, KT1
Pernelle, K1
Tsai, YH3
Wu, YH3
Hsieh, JY1
Liao, KH1
Guguen-Guillouzo, C1
Wang, HW2
Iwaisako, K3
Jiang, C1
Moore-Morris, TJ1
Park, TJ1
Paik, YH2
Meng, F1
Asagiri, M1
Murray, LA1
Hofmann, AF1
Iida, T1
Glass, CK1
Brenner, DA4
Kisseleva, T2
Geng, F1
Fang, H2
Li, JM1
Sakai, K1
Jawaid, S1
Bou-Gharios, G1
Sakai, T1
Wang, LP1
Dong, JZ1
Xiong, LJ1
Shi, KQ1
Zou, ZL1
Zhang, SN1
Cao, ST1
Lin, Z2
Chen, YP1
Kapoor, S1
Berishvili, E1
Bandi, S1
Abdel Moneim, AE1
Pérez-Vargas, JE1
Zarco, N1
Shibayama, M3
Segovia, J2
Tsutsumi, V3
Al-Sayed, E1
El-Lakkany, NM1
Seif El-Din, SH1
Sabra, AN1
Hammam, OA1
Ai, A1
Zhou, G1
Liu, W2
Nworu, CS1
Ihim, SA1
Ugwu, LE1
Laiyemo, KA1
Akah, PA1
Kumar, P1
Smith, T1
Rahman, K1
Thorn, NE1
Anania, FA1
Syed, SN1
Rizvi, W1
Kumar, A2
Khan, AA1
Moin, S1
Ahsan, A1
Rocha, SW1
de França, ME1
Rodrigues, GB1
Barbosa, KP1
Nunes, AK1
Pastor, AF1
Oliveira, AG1
Oliveira, WH1
Luna, RL1
Peixoto, CA1
Yilmaz-Ozden, T1
Can, A1
Karatug, A1
Pala-Kara, Z1
Okyar, A1
Bolkent, S1
Hafez, MM1
Al-Shabanah, OA1
Al-Harbi, NO1
Al-Harbi, MM1
Al-Rejaie, SS1
Alsurayea, SM1
Sayed-Ahmed, MM1
Chatani, N1
Kizu, T1
Hamano, M1
Ezaki, H1
Shimono, A1
Ouchi, N1
Puviani, L1
Cavallari, G1
Bonaiuto, E1
Cannistrà, M1
Zullo, A1
Pariali, M1
Pisano, A1
Atzeni, F1
Nardo, B1
Goudarshivananavar, BC1
Vigneshwaran, V1
Dharmappa, KK1
Pramod, SN1
Pascual-Miguelañez, I1
Salinas-Gomez, J1
Fernandez-Luengas, D1
Villar-Zarra, K1
Clemente, LV1
Garcia-Arranz, M1
Olmo, DG1
Karaca, G1
Moylan, C1
Swiderska-Syn, M1
Guy, CD1
Krüger, L1
Machado, MV1
Choi, SS1
Michelotti, GA1
Burkly, LC1
Diehl, AM1
Xin, J1
Nowicki, MJ1
Johnson, C1
Hargrove, L1
Graf, A1
Kennedy, L1
Hodges, K1
Harris, R1
Francis, T1
Ueno, Y1
Francis, H2
Caviglia, JM1
AlSaid, M1
Mothana, R1
Raish, M1
Al-Sohaibani, M1
Al-Yahya, M1
Ahmad, A1
Al-Dosari, M1
Rafatullah, S1
Moratalla, A1
Gómez-Hurtado, I1
Moya-Pérez, Á1
Zapater, P2
Peiró, G1
González-Navajas, JM2
Gómez Del Pulgar, EM1
Such, J3
Sanz, Y1
Francés, R2
Bitencourt, S1
Stradiot, L1
Thoen, L1
Mannaerts, I2
Zhao, BS1
Song, XR1
Hu, PY1
Meng, LX1
Tan, YH1
She, YJ1
Ding, YY1
Scholten, D3
Nazeer, SS1
Sandhyamani, S1
Jayasree, RS1
Shebaby, WN1
Daher, CF1
El-Sibai, M1
Bodman-Smith, K1
Mansour, A1
Karam, MC1
Mroueh, M1
Lei, L1
Bao, G1
Khyrivska, D1
Hrytsevych, N1
Bula, N1
Pshyk-Titko, I1
Savytska, M1
Zayachkivska, O1
Havryluk, E1
Wree, A1
Johnson, CD1
Font-Burgada, J1
Eguchi, A1
Povero, D1
Feldstein, AE1
Bai, L1
Zu, K1
Ren, F3
Duan, Z2
Han, LH1
Sun, GY1
Thasler, W1
Abdel-Bakky, MS1
Helal, GK1
El-Sayed, EM1
Saad, AS1
Zhang, QY3
Yu, LM1
Liu, B3
Li, MY1
Zhu, RZ2
Chen, TM1
Lan, Q1
Dai, D1
Zhang, WD1
Hu, LP1
O'Brien, A1
China, L1
Massey, KA1
Nicolaou, A1
Winstanley, A1
Newson, J1
Hobbs, A1
Audzevich, T1
Gilroy, DW1
Yi, HS1
Eun, HS1
Lee, YS4
Jung, JY1
Park, KG1
Choi, HS1
Suh, JM1
Jeong, WI2
Yuan, C1
Yi, M1
Peng, F1
Xiao, F1
Mushtaq, G1
Kamal, MA1
Park, HJ1
Kim, HG1
Wang, JH2
Choi, MK2
Han, JM1
Lee, JS1
Son, CG2
Lodder, J1
Denaës, T1
Chobert, MN3
El-Benna, J1
Pawlotsky, JM1
Teixeira-Clerc, F2
Guo, H2
Shen, T1
Tang, X2
Ling, W1
Chan, KW1
Ho, WS1
Manzini, BM1
da Silva Santos Duarte, A1
Sankaramanivel, S1
Ramos, AL1
Latuf-Filho, P1
Escanhoela, C1
Kharmandayan, P1
Olalla Saad, ST1
Boin, I1
Malheiros Luzo, ÂC1
Tolooei, M1
Mirzaei, A1
Qi, L1
Chen, B3
Shao, D1
Lv, D1
Zhu, CQ1
You, Q1
Kong, LJ1
Li, FD1
Wang, HY1
Liu, DG1
Pei, FH2
Song, JT1
Cai, Z1
Lou, Q1
Li, E1
Ju, L1
Hong, F1
Si, C1
Gao, P1
Cederbaum, AI1
Xiong, H1
Lv, HY1
Qi, X1
El-Hadary, AE1
Ramadan Hassanien, MF1
Ou, Y1
Yew, TW1
Leng, B1
Su, Y1
Xue, Y1
Pan, Y2
Miao, Z1
Gong, L1
Wei, XL1
Fang, RT1
Yang, YH1
Bi, XY1
Ren, GX1
Luo, AL1
Zhao, M1
Zang, WJ1
Hasan, IH1
El-Desouky, MA1
Hozayen, WG1
Abd el Aziz, GM1
Carl, DE1
Ghosh, SS1
Gehr, TW1
Abbate, A1
Toldo, S1
Sanyal, AJ1
Xue, F2
Hu, L1
Ge, R1
Liu, K1
Wang, K1
Jing, Y1
Zong, C1
Sun, K1
Wu, D1
Cubero, FJ2
Zoubek, ME1
Hu, W1
Peng, J1
Al Masaoudi, M1
Bechmann, LP1
Boekschoten, MV1
Muller, M2
Preisinger, C1
Gassler, N2
Canbay, AE1
Davis, RJ2
Louka, ML1
Ramzy, MM1
Sachdeva, M1
Chadha, R1
Karan, M1
Singh, T1
Dhingra, S1
Tanriverdi, G1
Kaya-Dagistanli, F1
Ayla, S1
Demirci, S1
Eser, M1
Unal, ZS1
Cengiz, M1
Oktar, H1
Rengarajan, T1
Rajendran, P1
Nandakumar, N1
Lokeshkumar, B1
Balasubramanian, MP1
Xi, S1
Shi, M1
Minuk, GY2
Gong, Y2
Yue, L1
Chung, SI1
Moon, H1
Kim, DY2
Cho, KJ1
Ju, HL1
Ahn, SH1
Han, KH1
Ro, SW1
E, C1
Zakaria, S1
El-Sisi, A1
Hwang, OK1
Park, JK2
Lee, EJ1
Lee, EM2
Kim, AY1
Jeong, KS3
Kang, JW1
Hong, JM1
Amiri, F1
Molaei, S1
Bahadori, M1
Nasiri, F1
Deyhim, MR1
Jalili, MA1
Nourani, MR1
Habibi Roudkenar, M1
Schlosser, M1
De Minicis, S1
Uchinami, H1
Kuntzen, C1
Knolle, PA1
Strassburg, CP1
Lee, HY1
Marahatta, A1
Bhandary, B2
Kim, HR2
Chae, HJ2
Chow, LN1
Schreiner, P1
Ng, BY1
Lo, B1
Hughes, MR1
Scott, RW1
Gusti, V1
Lecour, S1
Simonson, E1
Manisali, I1
Barta, I1
McNagny, KM1
Crawford, J1
Webb, M1
Underhill, TM1
Wei, W2
Cai, G1
Tang, J1
Cui, Y1
Kopec, AK1
Joshi, N1
Luyendyk, JP1
Dong, P1
Alsheblak, MM1
Elsherbiny, NM1
El-Karef, A1
El-Shishtawy, MM1
Chan, KM1
Chiang, T1
Liu, JY1
Chern, GG1
Hsu, FF1
Liu, YC1
Yu, C3
Mafi, A1
Dehghani, F1
Moghadam, A1
Noorafshan, A1
Vojdani, Z1
Talaei-Khozani, T1
Tian, L2
Choudhury, ST1
Das, N1
Ghosh, S2
Ghosh, D1
Chakraborty, S1
Ali, N1
Hirata, M1
Ishigami, M1
Matsushita, Y1
Ito, T1
Hattori, H1
Hibi, H1
Goto, H1
Ueda, M1
Yamamoto, A1
Gu, L1
Sun, XF1
Xu, Q2
Twu, YC1
Lee, TS1
Lin, YL1
Hsu, SM1
Liao, CY1
Wang, CK1
Liang, YC1
Liao, YJ1
Sarhadynejad, Z1
Sharififar, F1
Pardakhty, A1
Nematollahi, MH1
Sattaie-Mokhtari, S1
Mandegary, A1
Huang, R2
Xia, J1
Wu, C2
Matsumoto, Y1
Itami, S1
Kuroda, M1
Yoshizato, K1
Kawada, N1
Murakami, Y1
Dey, P1
Dutta, S1
Biswas-Raha, A1
Sarkar, MP1
Chaudhuri, TK1
Li, TZ1
Kim, SM1
Hur, W1
Choi, JE1
Kim, JH2
Hong, SW1
Lee, EB1
Yoon, SK1
Giraudeau, C1
Leporq, B1
Doblas, S1
Lagadec, M1
Pastor, CM1
Daire, JL1
Van Beers, BE1
Wu, K1
Hou, X1
Wen, Y1
Kong, X2
Shan, L1
Dong, X1
Nai, W1
Zheng, H1
Bai, X1
Jia, C1
Dai, M1
Ci, L1
Guo, Y1
Fei, J1
Yin, R1
Guo, D1
Deng, X1
Sun, G1
Rao, HY1
Teng, X1
Ren, YY1
Lu, YQ1
Wu, N1
Liu, FF1
Morales-López, J1
Centeno-Álvarez, M1
Nieto-Camacho, A1
López, MG1
Pérez-Hernández, E1
Pérez-Hernández, N1
Fernández-Martínez, E1
Yano, S1
Hisanaga, A1
He, X1
Sakao, K1
Hou, DX1
Ruan, M1
Choi, Y1
Geng, Y1
Lu, ZM1
Xu, HY1
Shi, JS1
Xu, ZH1
Hao, M1
Yao, Z1
Lian, N1
Han, W1
Kim, YO2
Popov, Y1
Schuppan, D2
Yun, Z1
Feng, Q3
Cipriani, S2
Carino, A2
Masullo, D1
Zampella, A2
Distrutti, E1
Fiorucci, S2
Zeybel, M1
Luli, S1
Sabater, L1
Hardy, T1
Page, A1
Moran Salvador, E1
Sharkey, V1
Tsukamoto, H2
Chu, DCK1
Singh, US1
Ponzoni, M1
Perri, P1
Di Paolo, D1
Mendivil, EJ1
Yamamotoya, T1
Nakatsu, Y1
Matsunaga, Y1
Fukushima, T1
Yamazaki, H1
Kaneko, S1
Fujishiro, M1
Kikuchi, T1
Kushiyama, A1
Tokunaga, F1
Asano, T1
Sakoda, H1
Feng, W1
An, ZT1
Xu, HB1
Zhao, ZF1
Wen, W1
Ni, S1
Marchianò, S1
Biagioli, M1
Santorelli, C1
Donini, A1
Monti, MC1
Han, B1
Xie, RJ1
Ji, QH1
McCracken, JM1
Chalise, P1
Briley, SM1
Dennis, KL1
Duncan, FE1
Pritchard, MT3
Öztürk Akcora, B1
Takahara, T1
Mazzone, M1
Yata, Y1
Nonome, K1
Kanayama, M1
Kawai, K1
Pisacane, AM1
Takahara, S1
Li, XK1
Comoglio, PM1
Sugiyama, T1
Michieli, P1
Han, YP1
Hamzavi, J2
Ciuclan, L2
Godoy, P2
Ilkavets, I1
Ehnert, S2
Ueberham, E1
Gebhardt, R1
Kanzler, S1
Geier, A2
Breitkopf, K1
Weng, H3
Mertens, PR2
Etim, O1
Akpan, E1
Usoh, I1
Shan, W1
Palkar, PS2
Murray, IA1
McDevitt, EI1
Kennett, MJ1
Kang, BH1
Isom, HC1
Perdew, GH1
Peters, JM1
Watanabe, M1
Murata, S1
Hashimoto, I1
Nakano, Y1
Ikeda, O1
Aoyagi, Y1
Matsuo, R1
Fukunaga, K1
Yasue, H1
Ohkohchi, N1
Banas, A1
Teratani, T2
Tokuhara, M1
Takeshita, F1
Osaki, M1
Kato, T1
Okochi, H1
Ochiya, T1
Perugorria, MJ1
Nicou, A1
Cartagena-Lirola, H1
Castillo, J1
Goñi, S1
Vespasiani-Gentilucci, U1
Zagami, MG1
Prieto, J3
Hlavackova, L1
Janega, P1
Cerna, A1
Pechanova, O1
Andriantsitohaina, R1
Babal, P1
Nicaise, C1
Prozzi, D1
Viaene, E1
Moreno, C1
Gustot, T1
Quertinmont, E1
Demetter, P1
Suain, V1
Goffin, P1
Devière, J1
Hols, P1
Tasci, I1
Mas, N1
Mas, MR1
Tuncer, M1
Comert, B1
Hu, PF1
Zhu, YW1
Chen, YX1
Yin, C1
Yue, HY1
Shibata, H2
Yoshioka, Y1
Ohkawa, A1
Abe, Y1
Nomura, T1
Mukai, Y1
Nakagawa, S1
Taniai, M1
Ohta, T1
Mayumi, T1
Kamada, H1
Tsunoda, S1
Tsutsumi, Y1
Principe, A2
Melgar-Lesmes, P2
Fernández-Varo, G3
del Arbol, LR1
Ros, J3
Morales-Ruiz, M2
Bernardi, M4
Jiménez, W4
Vitaglione, P2
Ottanelli, B1
Milani, S1
Morisco, F2
Fogliano, V2
Das, BK1
Bepary, S1
Datta, BK1
Chowdhury, AA1
Ali, MS1
Rouf, AS1
Liu, ZR1
Zhang, JJ1
Meng, XK1
Dong, C1
Qiao, JL1
Zhang, RF1
Yue, GQ1
Zhong, HY1
Poyrazoglu, OK1
Bahcecioglu, IH1
Ataseven, H1
Metin, K1
Dagli, AF1
Yalniz, M1
Ustundag, B1
Yen, FL1
Wu, TH1
Lin, LT1
Cham, TM1
Lin, CC6
Xiong, A1
Hu, Z1
Saji, Y1
Fukushima, J1
Tamura, S1
Hayashi, N1
Moreno, M2
Ramalho, LN1
Ruiz-Ortega, M1
Ramalho, F1
Abraldes, JG2
Colmenero, J1
Dominguez, M1
Egido, J1
Regimbeau, JM1
Fuks, D1
Kohneh-Shahri, N1
Terris, B1
Soubrane, O1
Quintanilha, LF2
Mannheimer, EG1
Carvalho, AB2
Paredes, BD2
Dias, JV2
Almeida, AS1
Gutfilen, B1
Barbosa da Fonseca, LM1
Resende, CM2
Rezende, GF2
Campos de Carvalho, AC2
Goldenberg, RC2
Aram, G1
Potter, JJ1
Torbenson, MS1
Mezey, E1
Vera, M1
Nieto, N1
Ding, XC1
Ma, LN1
Chen, XX1
Mochizuki, M1
Shimizu, S1
Urasoko, Y1
Umeshita, K1
Kamata, T1
Kitazawa, T1
Nakamura, D1
Nishihata, Y1
Ohishi, T1
Edamoto, H1
Lammert, F2
Zaldivar, MM1
Hellerbrand, C5
Zimmermann, H2
Streetz, KL2
Hillebrandt, S2
Schmitz, P2
Keppeler, H1
Dahl, E1
Haiqin, L1
Qin, J1
Okumura, N1
Koh, T1
Hasebe, Y1
Seki, T2
Ariga, T2
Ichi, I1
Kamikawa, C1
Nakagawa, T1
Kobayashi, K1
Kataoka, R1
Nagata, E1
Kitamura, Y1
Nakazaki, C1
Matsura, T1
Kojo, S1
Tsai, PC1
Fu, TW1
Chen, YM1
Ko, TL1
Chen, TH1
Shih, YH1
Hung, SC1
Fu, YS1
Bennett, RG1
Heimann, DG1
Tuma, DJ1
Sathesh Kumar, S1
Ravi Kumar, B1
Krishna Mohan, G1
Kunimoto, K1
Nojima, H1
Yamazaki, Y2
Yoshikawa, T1
Okanoue, T1
Tsukita, S1
Hong, JJ1
Pan, FY1
Cheng, LC1
Zhang, HX1
Xue, B1
Li, CJ2
Hardjo, M1
Miyazaki, M1
Sakaguchi, M1
Masaka, T1
Ibrahim, S1
Kataoka, K1
Huh, NH1
ZHAO, JN1
CHEN, WJ1
MA, Y1
LENG, Z1
Gao, XL1
Qian, W1
Cao, HX1
Jiang, XG1
Lu, HT1
Zhang, GM1
Wang, XJ1
Sun, WJ1
Wu, ZM2
Tuñón, MJ1
Alvarez, M1
Culebras, JM1
González-Gallego, J1
Li, HS2
Xu, LL2
Chen, SD2
Li, XM2
Hu, YY2
Peng, XD1
Dai, LL1
Huang, CQ1
He, CM1
Shin, S1
Park, D1
Jeon, JH1
Choi, BH1
Jang, MJ1
Joo, SS1
Oh, KW1
Hong, JT1
Suh, KH1
Kim, YB1
Ismail, RS1
El-Megeid, AA1
Abdel-Moemin, AR1
Zhang, XM2
Hu, MH1
Wu, XM1
Cheng, D1
Di, L1
Shiryaeva, A1
Arkadyeva, A1
Emelyanova, L1
Sakuta, G1
Morozov, V1
Dong, MX1
Zhang, YB1
Li, CC1
Geng, YT1
Li, XY1
Liu, JC1
Niu, YC1
Chu, DC1
Maxwell, A1
Zhu, NL1
Domenicali, M3
Caraceni, P3
Giannone, F2
Baldassarre, M2
Lucchetti, G1
Quarta, C1
Patti, C1
Catani, L2
Nanni, C1
Lemoli, RM2
Jiménez-Anguiano, A1
Díaz-Medina, V1
Farfán-Labonne, BE1
Giono-Chiang, G1
Kersenobich, D1
García-Lorenzana, M1
Gutiérrez-Ruiz, MC1
Velázquez-Moctezuma, J1
Yang, JI1
Yoon, JH1
Bang, YJ1
Byun, HJ1
Myung, SJ1
Kim, W1
Lee, HS2
Kao, YH2
Chen, CL1
Jawan, B1
Chung, YH1
Sun, CK2
Kuo, SM1
Hu, TH1
Chan, HH1
Cheng, KH1
Wu, DC1
Goto, S1
Cheng, YF1
Chao, D1
Tai, MH1
Baĭdiuk, EV1
Shiriaeva, AP1
Bezborodkina, NN1
Sakuta, GA1
Peng, JH1
Amoruso, DC1
Mazzone, G1
Romano, A1
Ribecco, MT1
D'Armiento, MR1
Mezza, E1
Moon, YJ1
Yoon, HH1
Lee, MW1
Jang, IK1
Lee, DH1
Lee, SK1
Lee, KH1
Kim, YJ1
Eom, YW1
Hackl, C1
Mori, A1
Moser, C1
Lang, SA1
Dayoub, R1
Weiss, TS1
Schlitt, HJ2
Geissler, EK1
Stoeltzing, O1
Roy, CK1
Ahmadi, A1
Ebrahimzadeh, MA1
Ahmad-Ashrafi, S1
Karami, M1
Mahdavi, MR1
Saravi, SS1
Lai, TY1
Weng, YJ1
Kuo, WW1
Chen, LM1
Chung, YT1
Lin, YM1
Tsai, FJ1
Lee, CH2
Choong, YM1
Lai, EY1
Huang, CY1
Yeh, YL1
Rivadeneira, DB1
Mayhew, CN1
Thangavel, C1
Sotillo, E1
Reed, CA1
Graña, X1
Knudsen, ES1
Lessa, AS1
Takiya, CM1
Tura, BR1
Simeonova, RL1
Vitcheva, VB1
Kondeva-Burdina, MS1
Krasteva, IN1
Nikolov, SD1
Mitcheva, MK1
Jin, SZ2
Meng, XW1
Han, MZ2
Liu, BR2
Wang, XH2
Sun, LY1
Zhao, RB1
Ban, X2
Yu, HY1
Yu, HW1
Cheng, Q2
Ling, X1
Stablewski, A1
Foster, BA1
Johnson, CS1
Rustum, YM1
Porter, CW1
Hu, JJ1
Lan, L1
Chen, YW1
Li, DG1
Irie, H1
Asano-Hoshino, A1
Sekino, Y1
Nogami, M1
Kitagawa, T1
Kanda, H1
Park, CM1
Youn, HJ1
Chang, HK1
Song, YS1
Rabani, V1
Shahsavani, M2
Gharavi, M1
Azhdari, Z1
Baharvand, H3
Valojerdi, MR1
Xu, XB2
He, ZP2
Leng, XS2
Liang, ZQ1
Peng, JR1
Zhang, HY5
Xiao, M2
Liu, CL2
Zhang, XD1
Yang, FR1
Fang, BW1
Lou, JS1
Bae, MA1
Rhee, SD1
Jung, WH1
Ahn, JH1
Song, BJ1
Cheon, HG1
Allman, M1
Gaskin, L1
Rivera, CA1
Hou, W1
Piao, ZF1
Meng, QH1
Tian, Z1
Sun, R1
Feng, ZQ1
Miquel, M1
Bartolí, R2
Serafín, A1
Cabré, E1
Galan, A1
Barba, I1
Córdoba, J2
Planas, R2
Mehal, WZ1
Ripoll, C1
Groszmann, RJ1
Chávez, E1
Vergara, P1
Castro-Sánchez, L1
Salazar, EP1
Moreno, MG1
Osterreicher, CH1
Scholten, A1
Gu, G1
Yao, H1
Pan, J1
Pei, Z1
Bader, A1
Brockmeyer, NH1
Altmeyer, P1
Domitrović, R2
Jakovac, H2
Romić, Z2
Rahelić, D2
Tadić, Z1
Hu, LH1
Belot, MP1
Manin, S1
Deveaux, V1
Cadoudal, T1
Louvet, A1
Zimmer, A1
Tordjmann, T1
Mallat, A1
Kang, A1
Liang, Y1
Xie, L1
Chen, CH1
Yuen, CM1
Sheu, JJ1
Lee, FY1
Chen, YT1
Kung, CT1
Yip, HK1
Cohen, JI1
Roychowdhury, S2
Pratt, BT1
Nagy, LE2
Kulu, Y1
Goodwin, JM1
Umer, S1
Asres, K1
Veeresham, C1
Sindhu, ER1
Firdous, AP1
Preethi, KC1
Kuttan, R1
Fu, W1
Pei, L1
Ruan, J1
Hong, D1
Singab, AN1
Ayoub, NA1
Ali, EN1
Mostafa, NM1
Bhaskar, VH1
Balakrishnan, N1
Fan, D1
Horani, A1
Shoseyov, D1
Doron, S1
Mruwat, R1
Kerem, E1
Siddique, F1
Son, KR1
Chung, SY1
Kim, HC1
Kim, HS1
Choi, SH1
Lee, JM1
Moon, WK1
Wong, LL1
Fan, ST1
Man, K1
Sit, WH1
Jiang, PP1
Jor, IW1
Ling, WL1
Tam, KT1
Wan, JM1
Meng, Z1
Liu, N1
Fu, X1
Wang, YD1
Chen, WD1
Forman, BM1
Shakya, AK2
Sharma, N3
Shrivastava, S2
Shukla, S3
Hsieh, WT1
Liu, YT1
Lin, WC2
Malinak, RN1
Thomas, JA1
Pope, C1
Wojtacha, D1
Robson, AJ1
Hartland, S1
Ramachandran, P1
Van Deemter, M1
Hume, DA1
Ji, C1
Kaplowitz, N1
Lau, MY1
Kao, E1
Petrovic, LM1
Lee, AS1
Anand, KV1
Anandhi, R1
Pakkiyaraj, M1
Geraldine, P1
Tian, XP1
Yin, YY1
Clichici, S1
Catoi, C1
Mocan, T1
Filip, A1
Login, C1
Nagy, A1
Daicoviciu, D1
Decea, N1
Gherman, C1
Moldovan, R1
Muresan, A1
Lee, GH1
Kim, IK1
Ohyama, T1
Sato, K1
Kishimoto, K1
Horiguchi, N1
Kakizaki, S1
Takagi, H1
Izumi, T1
Cheng, CC1
Lin, NN1
Lee, YF1
Wu, LY1
Hsu, HP1
Lee, WJ1
Tung, KC1
Chiun, YT1
Bourd-Boittin, K1
Bonnier, D1
Leyme, A1
Mari, B1
Tuffery, P1
Samson, M1
Theret, N1
Ghareeb, DA1
Hafez, HS1
Hussien, HM1
Kabapy, NF1
Fang, F1
Wang, JB1
Zhao, YL1
Jin, C1
Kong, WJ1
Zhao, HP1
Wang, HJ1
Xiao, XH1
Cho, BO1
Ryu, HW1
Jin, CH1
Choi, DS1
Kang, SY1
Kim, DS1
Byun, MW1
Jeong, IY1
Rivera, H1
Morales-Ríos, MS1
Bautista, W1
Pérez-Álvarez, V1
Tomita, K1
Suzuki, T2
Oshikawa, T1
Yokoyama, H1
Shimamura, K1
Tominaga, S1
Hiroi, S1
Irie, R1
Okada, Y1
Kurihara, C1
Ebinuma, H2
Saito, H2
Hokari, R1
Sugiyama, K1
Kanai, T2
Miura, S1
Hibi, T2
Roy, S1
Sannigrahi, S1
Majumdar, S1
Ghosh, B1
Sarkar, B1
Perez Gutierrez, RM1
Anaya Sosa, I1
Hoyo Vadillo, C1
Victoria, TC1
Sengupta, M2
Sharma, GD1
Chakraborty, B1
Asgari, S1
Moslem, M1
Bagheri-Lankarani, K1
Pournasr, B1
Miryounesi, M1
Nakamoto, N1
Chu, PS1
Ono, Y1
Mikami, Y1
Ojiro, K1
Lipp, M1
Love, PE1
Aburahma, MH1
Abdelbary, GA1
Wu, PS2
Wu, SJ2
Lin, YH4
Chao, JC2
Teltschik, Z1
Wiest, R2
Beisner, J1
Nuding, S1
Hofmann, C1
Schoelmerich, J1
Bevins, CL1
Stange, EF1
Wehkamp, J1
Chen, YF1
Tseng, CY1
Kuo, HC1
Yang, VW2
Lee, OK2
Knight, V1
Tchongue, J2
Lourensz, D2
Tipping, P1
Sievert, W2
Tarrats, N1
Marí, M1
Woo, DH1
Kim, SK1
Lim, HJ1
Heo, J1
Park, HS1
Kang, GY1
Kim, SE1
You, HJ1
Hoeppner, DJ1
Kim, Y1
Kwon, H1
Choi, TH1
Hong, SH1
Song, KW1
Ahn, EK1
Chenoweth, JG1
Tesar, PJ1
McKay, RD1
Xiao, J2
Liong, EC1
Ching, YP1
Chang, RC1
So, KF1
Fung, ML1
Tipoe, GL2
Ross, J1
Gherardi, E1
Mallorqui-Fernandez, N1
Bocci, M1
Sobkowicz, A1
Rees, M1
Rowe, A1
Ellmerich, S1
Massie, I1
Soeda, J1
Selden, C1
Hodgson, H1
Giannone, FA1
Zaccherini, G1
Trevisani, F2
Tanahashi, N1
Shikami, J1
Yoneda, M1
Ishida, T1
Minamino, T1
Ito, Y1
Ohkubo, H1
Hosono, K1
Sato, T1
Ae, T1
Shibuya, A1
Sakagami, H1
Narumiya, S1
Koizumi, W1
Majima, M1
Marchesi, VV1
Šain, I1
Awaad, AS1
Soliman, GA1
El-Sayed, DF1
El-Gindi, OD1
Turányi, E1
Szurián, K1
Laviña, B1
Russo, L1
Roglans, N1
Hongbo, S1
Ming, K1
Honglin, S1
Ping, HY1
Ping, DZ1
Gao, FL1
Hu, ZJ1
Hong, Y1
Hu, HY1
Shin, JW1
Hwang, SY1
Dorn, C1
Heilmann, J1
Fouts, DE1
Torralba, M1
Nelson, KE1
Schnabl, B2
Bao, JF1
Shi, JP1
Qu, Z1
Cai, M1
Huang, B1
Tian, J1
Qiu, H1
Fang, L1
Cao, X1
Yabuuchi, C1
Izawa, T1
Kuwamura, M1
Takasu, N1
Torii, M1
Yamate, J1
Chang, HM1
Liao, YW1
Chiang, CH1
Chen, YJ1
Lai, YH1
Chang, YL1
Chen, HL1
Jeng, SY1
Hsieh, JH1
Peng, CH1
Chien, Y1
Chen, SY1
Chen, LK1
Huo, TI1
Abd El Latif, HA1
Asaad, GF1
El-Hussiny, M1
Kuribayashi, T1
Seita, T1
Honjo, T1
Yamazaki, S1
Momotani, E1
Yamamoto, S1
Haimerl, M1
Taura, K1
Kodama, Y1
Sirlin, C1
Yu, E1
Yu, RT1
Downes, M1
Evans, RM1
Hope, TA1
Doherty, A1
Aslam, R1
Qayyum, A1
Brasch, RC1
Proudfoot, AE1
Ma, J1
Ni, GX1
Ni, CY1
Zhang, XJ1
Wang, AY1
Zheng, SZ1
Rodriguez, S1
Raurell, I2
Ezkurdia, N1
Brull, A1
Augustin, S1
Guardia, J2
Esteban, R2
Martell, M2
Genescà, J2
Uppal, R1
Alford, JK1
Loving, GS1
Guimaraes, AR1
Schattenberg, JM1
Nagel, M1
Kohl, T1
Wörns, MA1
Zimmermann, T1
Schad, A1
Longerich, T1
He, YW1
Galle, PR1
Schuchmann, M1
Ji, L1
Ruan, Y1
Manuelpillai, U1
Vaghjiani, V1
Lacey, D1
Tee, JY1
Chan, J1
Hodge, A1
Fu, S1
Han, J1
Lv, Q1
Guerrero, JA1
Teruel, R1
Martínez, C1
Arcas, I1
Martínez-Martínez, I1
de la Morena-Barrio, ME1
Vicente, V1
Corral, J1
Kim, HY1
Piva, A1
Zampieri, F1
Di Pascoli, M2
Gatta, A1
Sacerdoti, D1
Bolognesi, M1
Reichenbach, V1
Casals, G1
Oró, D1
Ying, M1
Leung, G1
Lau, TY1
Lee, ES1
Yuen, QW1
Huang, YP1
Zheng, YP1
Saba, AB1
Onakoya, OM1
Oyagbemi, AA1
Chai, NL1
Fu, Q1
Cai, CH1
Xu, SP1
Wu, BY1
Runovich, AA1
Pivovarov, YI1
Kuril'skaya, TE1
Sergeeva, AS1
Babushkina, IV1
Bogorodskaya, SL1
Kataoka, T1
Yamato, K1
Nishiyama, Y1
Morii, Y1
Etani, R1
Takata, Y1
Hanamoto, K1
Kawabe, A1
Sakoda, A1
Ishimori, Y1
Taguchi, T1
Yamaoka, K1
Guillaume, M1
Mancini, A1
Islam, MR1
Parvin, MS1
Islam, ME1
Dietrich, P1
Moleda, L1
Kees, F1
Straub, RH1
Ichikawa, K1
Okabayashi, T1
Shima, Y1
Iiyama, T1
Takezaki, Y1
Munekage, M1
Namikawa, T1
Sugimoto, T1
Kobayashi, M1
Mimura, T1
Hanazaki, K1
Qian, Z1
Shi, G1
Zira, A1
Kostidis, S1
Theocharis, S1
Sigala, F1
Engelsen, SB1
Andreadou, I1
Mikros, E1
Huang, CK1
Lee, SO1
Lai, KP1
Ma, WL1
Lin, TH1
Tsai, MY1
Luo, J1
Chang, C1
Hernández-Guerra, M1
de Ganzo, ZA1
González-Méndez, Y1
Salido, E1
Abreu, P1
Felipe, V1
Abrante, B1
Quintero, E1
Xiong, AZ1
Teng, ZQ1
Yang, QW1
Shi, YH1
Wu, QN1
Tian, HL1
Zhang, LH1
Tian, JH1
Xiong, HR1
Liu, YL1
Yang, KH1
Huang, XT1
Li, YY1
Mi, SQ1
Wang, NS1
Marimuthu, S1
Adluri, RS1
Rajagopalan, R1
Menon, VP1
Feroz, Z1
Diví, M1
Vilaseca, M1
Deepa, V1
Sridhar, R1
Goparaju, A1
Reddy, PN1
Murthy, PB1
Acharya, SR1
Acharya, NS1
Bhangale, JO1
Shah, SK1
Pandya, SS1
Stellmacher, C1
Goltz, D1
Khlistunova, I1
Adam, AC1
Kirfel, J1
Büttner, R1
Hassan, ZK1
Al-Olayan, EM1
Chen, TW1
Chen, XL1
Li, ZL1
Zeng, NL1
Wang, LY2
Tang, HJ1
Li, CP1
Xie, XY1
Eidi, A1
Moghadam, JZ1
Mortazavi, P1
Rezazadeh, S1
Olamafar, S1
Eysackers, N1
Onyema, OO1
Van Beneden, K1
Valente, S1
Mai, A1
Bishayi, B1
Sotelo-Félix, JI1
Martinez-Fong, D1
Muriel De la Torre, P1
Hung, DY1
Chang, P1
Cheung, K1
Winterford, C1
Mukai, T1
Mera, K1
Nishida, K1
Nakashima, M1
Sasaki, H1
Sakaeda, T1
Nakamura, J1
Gioli-Pereira, L1
Coradin, K1
Nagaoka, MR1
Borges, DR1
Kouyoumdjian, M1
Janbaz, KH1
Saeed, SA1
Gilani, AH1
Greabu, M1
Olinescu, R1
Arezzini, B1
Lunghi, B1
Lungarella, G1
Gardi, C1
Zou, Q1
van der Merwe, SW1
van den Bogaerde, JB1
Goosen, C1
Maree, FF1
Milner, RJ1
Schnitzler, CM1
Biscardi, A1
Mesquita, JM1
Engelbrecht, G1
Kahn, D1
Fevery, J2
Shankar, K2
Vaidya, VS1
Apte, UM2
Manautou, JE1
Ronis, MJ1
Bucci, TJ1
Mehendale, HM3
López-Parra, M2
Planagumà, A2
Masferrer, JL1
Woerner, BM1
Koki, AT1
Rivera, F2
Rodés, J3
Leifeld, L1
Wüstefeld, T1
Graw, A1
Klein, C2
Kamino, K1
Spengler, U1
Kreipe, H1
Kubicka, S1
Müller, W1
Manns, MP1
Dahlke, MH1
Popp, FC1
Bahlmann, FH1
Aselmann, H1
Jäger, MD1
Neipp, M1
Piso, P1
Klempnauer, J1
Yao, YM1
Liu, QG1
Pan, CE1
Sawant, SP2
Dnyanmote, AV1
Limaye, PB2
Latendresse, JR2
Tuncer, I1
Ozbek, H1
Ugras, S1
Bayram, I2
Skiba, M1
Maciejewska-Paszek, I1
Pawłowska-Góral, K1
Aleksiewicz, R1
Wardas, M1
Zhang, LJ1
Yu, JP1
Li, D1
Huang, YH1
Chen, ZX1
Wang, XZ1
Siller-López, F1
Sandoval, A1
Salgado, S1
Salazar, A1
Bueno, M1
Garcia, J1
Vera, J1
Gálvez, J1
Hernández, I1
Ramos, M1
Aguilar-Cordova, E1
Armendariz-Borunda, J1
Qiu, JF1
Wu, ZY1
Zhang, ZQ1
Luo, HF1
Issa, R2
Constandinou, CM1
Fallowfield, J1
Millward-Sadler, H1
Gaca, MD1
Sands, E1
Suliman, I1
Trim, N2
Knorr, A1
Arthur, MJ2
Benyon, RC1
Campo, GM1
Avenoso, A1
Campo, S1
D'Ascola, A1
Ferlazzo, AM1
Calatroni, A1
el-Sawy, SA1
el-Shafey, AM1
el-Bahrawy, HA1
Steiling, H1
Mühlbauer, M1
Bataille, F1
Schölmerich, J1
Werner, S1
Aziz, TA1
Aziz, MA1
Fouad, HH1
Rashed, LA1
Salama, H1
Abd-Alla, S1
Wehab, MA1
Ahmed, T1
Nishitani, S1
Takehana, K1
Fujitani, S1
Sonaka, I1
Yannaki, E1
Athanasiou, E1
Xagorari, A1
Constantinou, V1
Batsis, I1
Kaloyannidis, P1
Proya, E1
Anagnostopoulos, A1
Fassas, A1
Fernández-Llama, P1
Ageloff, S1
Garra, N1
Esteva-Font, C1
Ballarin, J1
Barcelo, P1
Stokes, JB1
Knepper, MA1
Xu, DH1
Mei, XT1
Li, YM1
Lv, JY1
Xu, SB1
Mikami, K1
Goto, T1
Miura, K1
Ohshima, S1
Yoneyama, K1
Lin, JG1
Watanabe, D1
Segawa, D1
Kataoka, E1
Shibuya, T1
Watanabe, S1
Gui, SY1
Sun, WY1
Wu, CY1
Kardava, I1
Chutkerashvili, K1
Choi, JS1
Burm, JP1
Park, EY1
Ko, MS1
Kim, CW1
Lee, MH2
Kim, SG1
Gao, H1
Zhou, YW1
Liu, GT1
Wei, HL1
Xu, JY1
Yu, LH1
Chang, ML1
Yeh, CT1
Chang, PY1
Chen, JC2
Gaya, J2
Constandinou, C1
Henderson, N1
Di Vinicius, I1
Baptista, AP1
Barbosa, AA1
Andrade, ZA1
Yan, WL1
Sun, DY1
Lin, XT1
Jiang, YB1
Lorena, D1
Darby, IA1
Gadeau, AP1
Leen, LL1
Rittling, S1
Porto, LC1
Rosenbaum, J2
Desmoulière, A2
Ishikawa, T2
Terai, S2
Urata, Y2
Marumoto, Y2
Aoyama, K1
Murata, T2
Nishina, H2
Shinoda, K2
Uchimura, S1
Hamamoto, Y1
Okita, K1
Chung, H1
Hong, DP1
Jang, KS1
Shin, DM1
Ahn, JI1
Kong, G1
Immenschuh, S1
Fahimi, HD1
Baumgart-Vogt, E1
Cheng, M1
Han, FM1
Okumoto, K1
Saito, T1
Haga, H1
Hattori, E1
Ishii, R1
Karasawa, T1
Suzuki, A1
Misawa, K1
Sanjo, M1
Ito, JI1
Sugahara, K1
Togashi, H1
Kawata, S1
Topuria, D1
Kakabadze, Z1
Lobdjanidze, N1
Chavchanidze, N1
Farazi, PA1
Glickman, J1
Horner, J1
Depinho, RA1
Ochenashko, OV1
Volkova, NA1
Mazur, SP1
Somov, AY1
Fuller, BJ1
Petrenko, AY1
Noyan, T1
Kömüroğlu, U1
Sekeroğlu, MR1
Nie, QH1
Zhang, YF1
Xie, YM1
Luo, XD1
Shao, B1
Zhou, YX1
Natarajan, SK1
Thomas, S1
Ramamoorthy, P1
Basivireddy, J1
Pulimood, AB1
Ramachandran, A1
Balasubramanian, KA1
Dietrich, CG1
Siewert, E1
Jansen, B1
Gartung, C1
Lafdil, F1
Couchie, D1
Brouillet, A1
Zafrani, ES1
Mavier, P1
Laperche, Y1
Wen, T1
Zhao, JY1
Do, SH1
Yun, HS1
Jeong, DH2
Ki, MR1
Chung, JY1
Park, SJ1
Kim, SB1
Bhave, VS1
Reddy, JK1
Kuhlmann, WD1
Peschke, P1
Zhang, HQ1
Yau, YF1
Szeto, KY1
Chan, WT1
Wong, J1
Henkel, C1
Meyer, HE1
Stühler, K1
Graf, J1
Zhan, Y1
Cong, X1
Fei, R1
Oria, M2
Raguer, N1
Chatauret, N1
Arun, M1
Asha, VV1
Henderson, NC1
Pollock, KJ1
Frew, J1
Mackinnon, AC1
Flavell, RA2
Sethi, T1
Simpson, KJ1
Liao, ZX1
Nowak, U1
Gill, K1
Skamene, E1
Newkirk, MM1
Weiler-Normann, C1
Herkel, J1
Lohse, AW1
Cho, SN1
Song, KH1
Kim, MC1
Cho, SW1
Tsuchiya, S1
Tsukamoto, Y1
Taira, E1
LaMarre, J1
Shen, YP1
Xu, AL1
Chandan, BK1
Saxena, AK1
Gupta, DK1
Suri, KA1
Suri, J1
Bhadauria, M1
Singh, B1
Zhao, YZ1
Sohn, DH2
Chiva, M1
Llovet, T2
Muñoz, C2
Balanzó, J2
Pérez-Mateo, M2
Song, XY2
Hattori, S1
Dhar, DK1
Hara, N1
Tonomoto, Y1
Onoda, T1
Ono, T1
Yamanoi, A1
Tachibana, M1
Tsuchiya, M1
Nagasue, N1
Cheong, MA1
Lee, GS1
Cao, BQ1
Lin, JZ1
Zhong, YS1
Huang, SB1
Lin, N1
Tang, ZF1
Xiang, P1
Xu, RY1
Fan, J2
Burczynski, F1
Cattini, P1
Chiva, MT1
Mercè, J1
Diaz Gómez, MI1
Fanelli, SL1
Delgado de Layño, AM1
Castro, JA1
Castro, GD1
Bátkai, S1
Mukhopadhyay, P1
Harvey-White, J1
Kechrid, R1
Kunos, G1
Song, JY1
Ahn, JB1
Park, JG1
Jo, JS1
Park, DH1
Jang, HK1
Jang, JJ2
Lee, MJ2
Hidaka, I1
Hino, K1
Korenaga, M1
Gondo, T1
Nishina, S1
Ando, M1
Okuda, M1
Guimond, A1
Teletin, M1
Garo, E1
D'Sa, A1
Selloum, M1
Champy, MF1
Vonesch, JL1
Monassier, L1
Nakamura, T1
Torimura, T1
Sakamoto, M1
Hashimoto, O1
Taniguchi, E1
Inoue, K1
Sakata, R1
Kumashiro, R1
Murohara, T1
Ueno, T1
Sata, M1
Son, G1
Iimuro, Y1
Hirano, T1
Kaneda, Y1
Fujimoto, J1
Moh, A1
Iwamoto, Y1
Chai, GX1
Zhang, SS1
Kano, A1
Yang, DD1
Jacoby, JJ1
Chiu, CC1
Huang, GT1
Chou, SH1
Chien, CT1
Chiou, LL1
Chang, MH1
Fang, CH1
Liu, SJ1
Chen, XW1
Cui, B1
Huang, ZR1
Talarico, S1
Pertosa, AM1
Fogli, M1
Baccarani, M1
Fang, HL1
Lin, HY1
Chan, MC1
Lin, WL1
Uskoković-Marković, S1
Milenković, M1
Topić, A1
Kotur-Stevuljević, J1
Stefanović, A1
Antić-Stanković, J1
Salas, AL1
Montezuma, TD1
Fariña, GG1
Reyes-Esparza, J1
Rodríguez-Fragoso, L1
Xue, H1
Li, YC1
Hao, ZM1
El-Demerdash, E1
Salam, OM1
El-Batran, SA1
Abdallah, HM1
Shaffie, NM1
Hsiao, Y1
Zou, T1
Ling, CC1
Hu, H1
Tao, XM1
Song, HY1
Rullier, A1
Gillibert-Duplantier, J1
Costet, P1
Cubel, G1
Haurie, V1
Petibois, C1
Taras, D1
Dugot-Senant, N1
Deleris, G1
Bioulac-Sage, P1
Antelava, NA1
Gogoluari, MI1
Gogoluari, LI1
Pirtskhalaĭshvili, NN1
Okudzhava, MV1
Lin, HM1
Tseng, HC1
Wang, CJ1
Lin, JJ1
Lo, CW1
Chou, FP1
Mizunaga, Y1
Chang, HF1
Chu, CC1
Park, SW1
Kang, SS1
Jeon, SJ1
Son, KH1
Lu, YY1
Wang, CP1
Su, SH1
Feng, YY1
Yang, YP1
Fernandez, P1
Wilder, T1
Yee, H1
Chiriboga, L1
Chan, ES1
Cronstein, BN1
Heuchel, R1
Subramony, C1
Nowicki, M1
Graupera, M1
Matei, V1
Wang, ZB1
Huang, ZM1
Wang, JJ1
Chen, XR1
Wu, JS1
Strnad, P1
Tao, GZ1
Harada, M1
Toivola, DM1
Brunt, EM1
Omary, MB1
Semenova, EV1
Inchina, VI1
Kuo, TK1
Hung, SP1
Chuang, CH1
Chen, CT1
Shih, YR1
Fang, SC1
Mejías, M1
Otero, T1
Yuasa, T1
Yamamoto, T1
Rivas-Carrillo, JD1
Navarro-Alvarez, N1
Soto-Guiterrez, A1
Noguchi, H1
Matsumoto, S1
Tanaka, N2
Kobayashi, N1
Lam, HB1
Yeh, CH1
Cheng, KC1
Hsu, CT1
Cheng, JT1
Wu, CW1
Chu, ES1
Hui, AY1
Cheng, AS1
Go, MY1
Ching, AK1
Chui, YL1
Chan, HL1
Sung, JJ1
Zuo, CS1
Seoane, PR1
Thomsen, M1
Gillis, T1
Meloni, E1
Harnish, PP1
Renshaw, PF1
Saarni, HU1
Stengård, J1
Kärki, NT1
Sotaniemi, EA1
Di Carlo, R1
Muccioli, G1
Lando, D1
Brossa, O1
Burdino, E1
Chiappino, I1
Danni, O1
Mina, S1
Ugazio, G1
Trivedi, P1
Mowat, AP1
Proctor, E1
Chatamra, K1
Mihas, AA1
Gibson, RG1
Mihas, TA1
Hirschowitz, BI1
Arosio, B2
Santambrogio, D1
Gagliano, N2
Annoni, G3
Blondé-Cynober, F1
Plassart, F1
Rey, C1
Coudray-Lucas, C1
Moukarbel, N1
Poupon, R1
Giboudeau, J1
Cynober, L1
Sikiric, P1
Seiwerth, S1
Grabarevic, Z1
Rucman, R1
Petek, M1
Rotkvic, I1
Turkovic, B1
Jagic, V1
Mildner, B1
Duvnjak, M1
Simko, V1
Michael, S1
Klaassen, CD1
Frezza, EE1
Gerunda, GE1
Farinati, F1
DeMaria, N1
Galligioni, A1
Plebani, F1
Giacomin, A1
Van Thiel, DH1
Lin, SC2
Shyuu, SJ1
Aquilio, E1
Spagnoli, R1
Riggio, D1
Seri, S1
Huang, TL1
Villalobos, SA1
Uchida, M1
Hamura, H1
Takagi, S1
Noguchi, Y1
Honda, H1
Poli, G1
Yang, SM1
Rojkind, M1
Greenwel, P1
Takeda, A1
Okumura, H1
Okada, S1
Hsu, FL1
Tsai, YJ1
Kao, MC1
Chen, CF1
Lin, CH1
Lin, JM1
Chiu, HF2
Yang, JJ1
Lee, SG1
Day, CP1
Burt, AD1
Brown, AS1
Bennett, MK1
Farrell, DJ1
James, OF1
Yeaman, SJ1
Kelly, JD1
Dutchuk, M1
Hendricks, JD1
Williams, DE1
Schmitt-Gräff, A1
Chakroun, G1
Gabbiani, G2
Fouad, FM1
Mamer, OA1
Shahidi, F1
Muguerza, B2
Lecároz, C1
Picardi, A1
Castilla-Cortázar, I2
Quiroga, J2
Cemborain, A1
Santidrián, S2
Swain, MG1
Maric, M1
Basnet, P1
Matsushige, K1
Hase, K1
Kadota, S1
Namba, T1
Bozkurt, S1
Ersoy, E1
Tekýn, HE1
Bayram, O1
Anadol, Z1
Onuk, E1
Ercan, ZS1
Dhuley, JN1
Naik, SR1
Bulbena, O1
Culat, J1
Bravo, ML1
Yamamura, Y1
Kotaki, H1
Aikawa, T1
Sawada, Y1
Iga, T1
Lichtman, SN1
Clark, RL1
Van Roey, G1
Lijnen, P1
Verbesselt, R1
Verbruggen, A1
Torres-Durán, PV1
Miranda-Zamora, R1
Paredes-Carbajal, MC1
Mascher, D1
Díaz-Zagoya, JC1
Juárez-Oropeza, MA1
Tomiya, T1
Ogata, I1
Fujiwara, K2
LeSage, GD1
Benedetti, A1
Glaser, S1
Marucci, L1
Tretjak, Z1
Caligiuri, A1
Rodgers, R1
Phinizy, JL1
Baiocchi, L1
Lasater, J1
Ugili, L1
Alpini, G1
Yamanishi, A1
Ishibashi, Y1
Kuriyama, K1
Tachiiri, T1
Kusajima, H1
Kojima, E1
Momo, K1
Rusu, MA1
Bucur, N1
Puică, C1
Tămaş, M1
Sugimoto, M1
Machida, Y1
Ito, K1
Hashimoto, M1
Watanabe, G1
Harvey, PJ1
Gready, JE1
Hickey, HM1
Le Couteur, DG1
McLean, AJ1
Veal, N1
Oberti, F1
Moal, F1
Vuillemin, E1
Fort, J1
Kaassis, M1
Pilette, C1
Calès, P1
Wong, CK1
Ooi, VE1
Ang, PO1
Kim, KY1
Choi, I1
Kim, SS1
Nan, JX1
Kang, HC1
Lee, SJ2
Lee, BH1
Kazusaka, A1
Fujita, S1
Yeung, RY1
Lin, KF1
Li, RC1
Yang, M1
Shih, JC1
Chung, TC1
Ueng, TH1
Lin, SY1
Tsai, CC1
Chen, LD1
Wang, WC1
Ichikawa, Y1
Kitoh, J1
Yamashita, K1
Das, D1
Pemberton, PW1
Burrows, PC1
Gordon, C1
Smith, A1
McMahon, RF1
Warnes, TW1
Fusaro, LM1
Parmeggiani, L1
Tagliabue, J1
Galetti, P1
De Castri, D1
Moscheni, C1
Yabe, N1
Matsui, H1
Lim, IK1
Alcantara, RB1
Preheim, LC2
Gentry-Nielsen, MJ1
García, M1
Koniaris, LG1
Zimmers-Koniaris, T1
Hsiao, EC1
Chavin, K1
Sitzmann, JV1
Farber, JM1
Sakadamis, AK1
Ballas, KD1
Tzioufa-Asimakopoulou, V1
Alatsakis, MB1
Huang, ZH1
Murakami, T1
Okochi, A1
Yumoyo, R1
Nagai, J1
Takano, M1
Van de Casteele, M1
Sägesser, H1
Reichen, J1
Wright, MC1
Smart, DE1
Murray, GI1
Primrose, JN1
Noguchi, T1
Matsuyama, S1
Akao, M1
Hagiwara, H1
Uno, S1
Park, MS1
Kang, JS1
Xiao, W1
Cai, WM1
Liu, RH1
Wang, JY1
Zhang, QS1
Guo, JS1
Hu, MY1
Jiao, Z1
Yuan, J1
Zeng, M1
Yao, D1
Ye, T1
Zhong, L1
Hu, M1
Gole, MK1
Dasgupta, S1
Kaneko, T1
Qin, LQ1
Wang, PY1
Sato, A1
Delvoux, B1
Breuer, S1
D'Amico, T1
Gressner, AM1
Nolan, JP1
Leibowitz, AI1
Todorov, T1
Pavlov, N1
Petkov, A1
Koleva, P1
Chandra, SV1
Saxena, DK1
Díaz-García, JM1
Oliver-Botana, J1
Fos-Galve, D1
Kotzampassi, K1
Eleftheriadis, E1
Yen, MH1
Yang, CY1
Blendis, LM1
Dashti, HM1
al-Sayer, H1
Behbehani, A1
Madda, J1
Christenson, JT1
Boyles, JK1
Yoshitake, I1
Ohishi, E1
Kubo, K1
Hosokawa, Y1
Pannarale, L1
Ripani, M1
Onori, P1
Riggio, O2
Mellencamp, MA2
Runyon, BA1
Sugano, S1
Kanel, G1
Hall, PD1
Plummer, JL1
Ilsley, AH1
Cousins, MJ1
Nadkarni, GD1
Shimpi, HH1
Noronha, OP1
Angelico, M1
Alvaro, D1
Cantafora, A1
Masella, R1
Gandin, C1
Ginanni Corradini, S1
Ariosto, F1
Capocaccia, L1
Sun, MA1
Wang, BE1
Degli Esposti, S1
Biempica, L2
Zern, MA2
Oka, H1
Czaja, MJ1
Flanders, KC1
Weiner, FR1
Mullen, KD1
McCullough, AJ1
Solà, J1
Camps, J1
Bosma, A1
Brouwer, A1
Seifert, WF1
Knook, DL1
Alp, MH2
Hickman, R2
Trcka, V1
Siblíková, O1
Werin, WK1
Lahl, R1
Verstraete, M1
Vermylen, J1
Collen, D1
Nath, I1
Sood, SK1
Nayak, NC1
Ranek, L1
Bremmelgaard, A1
Dupont, B1
Jorgensen, M1
Keiding, S1
Thomsen, P1
Tyrsted, G1
Urbaszek, W1
Uhlig, K1
Kranz, D1
Schneider, G1
Strassburg, G1
Toft, J1
Szarvas, F1
Biliczki, F1
Ray, RJ1

Clinical Trials (9)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical Study on the Value of Quantitative MRI Imaging in Diffuse Liver Diseases[NCT04626492]150 participants (Anticipated)Observational [Patient Registry]2020-08-01Recruiting
Serelaxin To Lower Portal Pressure in Patients With Cirrhosis and Portal Hypertension[NCT02669875]Phase 215 participants (Actual)Interventional2017-10-18Completed
A Phase II Study of PD-0332991 in Adult Patients With Advanced Hepatocellular Carcinoma[NCT01356628]Phase 223 participants (Actual)Interventional2011-05-25Active, not recruiting
Umbilical Cord Mesenchymal Stem Cell Transfusion in Patients With Severe Liver Cirrhosis[NCT01233102]Phase 1/Phase 2200 participants (Anticipated)Interventional2009-10-31Suspended
The Effects of Leucine and Isoleucine on Glucose Metabolism[NCT02634164]12 participants (Actual)Interventional2015-12-31Completed
Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia[NCT03395028]Early Phase 16 participants (Actual)Interventional2018-01-15Completed
Mesenchymal Stem Cell Therapy for Liver Cirrhosis: A Phase I/II Study[NCT03626090]Phase 1/Phase 220 participants (Anticipated)Interventional2018-08-18Recruiting
Phase Ⅰ/Ⅱ Study of Human Umbilical Cord Derived Mesenchymal Stem Cells (UC-MSCs) for Treatment of Liver Failure[NCT01218464]Phase 1/Phase 270 participants (Anticipated)Interventional2009-03-31Recruiting
A Randomised, Controlled Trial of Losartan as an Anti-fibrotic Agent in Non-alcoholic Steatohepatitis[NCT01051219]Phase 345 participants (Actual)Interventional2011-05-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Adverse Events

The number and nature of adverse events as a measure of safety and tolerability. Safety analysis will be conducted on all patients who receive at least one dose of PD-0332991 during the study period or follow-up. An adverse event is any unfavorable and unintended sign, symptom, syndrome or illness that develops during the period of observation in the clinical study, including a new illness or condition, worsening of a concomitant illnesses or condition, effect of the study medication or combination of 2 or more factors. (NCT01356628)
Timeframe: From date of randomization through study completion, assessed up to 100 months

InterventionAdverse Events (Number)
PD-0332991504

Time to Disease Progression

Progression is defined using Response Evaluation Criteria In Solid Tumors Criteria (RECIST Version 1.1), as at least a 20% increase in the sum of diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). The appearance of one or more new lesions is also considered progression. (NCT01356628)
Timeframe: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

Interventionmonths (Mean)
PD-03329918

Reviews

15 reviews available for carbon tetrachloride and Disease Models, Animal

ArticleYear
Models of nonalcoholic steatohepatitis potentiated by chemical inducers leading to hepatocellular carcinoma.
    Biochemical pharmacology, 2022, Volume: 195

    Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Diet, High-Fat; Diethylnitrosamine; Diseas

2022
Liver cirrhosis: An overview of experimental models in rodents.
    Life sciences, 2022, Jul-15, Volume: 301

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis; Liver Cirrhosis, Expe

2022
Rodent Models of Nonalcoholic Fatty Liver Disease.
    Digestion, 2020, Volume: 101, Issue:5

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Cholesterol, Dietary; Combined Modality Therapy; Diet,

2020
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Applied physics. B, Lasers and optics, 2016, Volume: 122, Issue:12

    Topics: Action Potentials; Adolescent; Adult; Aged; Alanine Transaminase; Analgesics; Animals; Anti-Inflamma

2016
    Applied physics. B, Lasers and optics, 2016, Volume: 122, Issue:12

    Topics: Action Potentials; Adolescent; Adult; Aged; Alanine Transaminase; Analgesics; Animals; Anti-Inflamma

2016
    Applied physics. B, Lasers and optics, 2016, Volume: 122, Issue:12

    Topics: Action Potentials; Adolescent; Adult; Aged; Alanine Transaminase; Analgesics; Animals; Anti-Inflamma

2016
    Applied physics. B, Lasers and optics, 2016, Volume: 122, Issue:12

    Topics: Action Potentials; Adolescent; Adult; Aged; Alanine Transaminase; Analgesics; Animals; Anti-Inflamma

2016
Animal models of drug-induced liver injury.
    Biochimica et biophysica acta. Molecular basis of disease, 2019, 05-01, Volume: 1865, Issue:5

    Topics: Acetaminophen; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models

2019
Role of hemostatic factors in hepatic injury and disease: animal models de-liver.
    Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:7

    Topics: Animals; Bile Ducts; Blood Coagulation; Blood Coagulation Disorders; Carbon Tetrachloride; Chemical

2016
An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.
    World journal of gastroenterology, 2009, Jul-07, Volume: 15, Issue:25

    Topics: Acetaminophen; Animals; Carbon Tetrachloride; Disease Models, Animal; Galactosamine; Hepatectomy; Hu

2009
[Meta-analysis on impact of Danshen on liver regeneration in rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2012, Volume: 37, Issue:17

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs

2012
Mouse models of liver fibrosis.
    Zeitschrift fur Gastroenterologie, 2007, Volume: 45, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Liver Ci

2007
Liver damage due to free radicals.
    British medical bulletin, 1993, Volume: 49, Issue:3

    Topics: Alcoholism; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, A

1993
Animal models of liver fibrosis.
    Advances in veterinary science and comparative medicine, 1993, Volume: 37

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Liver Cirrhosis, Experimental; Liver Diseases

1993
Characterisation of portal hypertension models by microspheres in anaesthetised rats: a comparison of liver flow.
    Pharmacology & therapeutics, 2001, Volume: 90, Issue:1

    Topics: Animals; Ascites; Bile Ducts; Blood Flow Velocity; Carbon Tetrachloride; Disease Models, Animal; Hem

2001
Hepatocyte swelling and portal hypertension.
    Journal of hepatology, 1992, Volume: 15, Issue:1-2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatomegaly; Hypertension, Portal; Liver; Li

1992
Intravascular coagulation in liver disease.
    Annual review of medicine, 1974, Volume: 25

    Topics: Animals; Blood Coagulation Factors; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Di

1974

Trials

3 trials available for carbon tetrachloride and Disease Models, Animal

ArticleYear
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
    Computational & theoretical chemistry, 2013, Feb-01, Volume: 1005

    Topics: Acetaminophen; Administration, Oral; Adolescent; Adsorption; Adult; Allyl Compounds; Amylopectin; Am

2013
The pharmacokinetics of glycyrrhizin and its restorative effect on hepatic function in patients with chronic hepatitis and in chronically carbon-tetrachloride-intoxicated rats.
    Biopharmaceutics & drug disposition, 1997, Volume: 18, Issue:8

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspartate

1997
Animal experiment and clinical study of effect of gamma-interferon on hepatic fibrosis.
    World journal of gastroenterology, 2001, Volume: 7, Issue:1

    Topics: Animals; Antineoplastic Agents; Biopsy; Carbon Tetrachloride; Dimethylnitrosamine; Disease Models, A

2001

Other Studies

861 other studies available for carbon tetrachloride and Disease Models, Animal

ArticleYear
Hepatoprotective effect and metabonomics studies of radix gentianae in rats with acute liver injury.
    Pharmaceutical biology, 2021, Volume: 59, Issue:1

    Topics: Administration, Oral; Animals; Biomarkers; Carbon Tetrachloride; Disease Models, Animal; Dose-Respon

2021
Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease.
    Alcoholism, clinical and experimental research, 2021, Volume: 45, Issue:10

    Topics: Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Disease Progression; Elasticity Ima

2021
Studies on Ethanol Extracts of
    Pakistan journal of biological sciences : PJBS, 2021, Volume: 24, Issue:6

    Topics: Animals; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dis

2021
Study on the effect of active components of Schisandra chinensis on liver injury and its mechanisms in mice based on network pharmacology.
    European journal of pharmacology, 2021, Nov-05, Volume: 910

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; Disease Mod

2021
Canagliflozin Improves Liver Function in Rats by Upregulating Asparagine Synthetase.
    Pharmacology, 2021, Volume: 106, Issue:11-12

    Topics: Activating Transcription Factor 4; Adenylate Kinase; Animals; Aspartate-Ammonia Ligase; Canagliflozi

2021
C1q/tumor necrosis factor-related protein-3 acts as a target treating hepatic fibrosis.
    European review for medical and pharmacological sciences, 2021, Volume: 25, Issue:17

    Topics: Adipokines; Animals; Carbon Tetrachloride; Disease Models, Animal; Extracellular Matrix; Gene Knocko

2021
Antioxidant Activity, Phenolic Profile, and Nephroprotective Potential of
    Nutrients, 2021, Aug-26, Volume: 13, Issue:9

    Topics: Animals; Antioxidants; Brassicaceae; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Kidney;

2021
Effects of autophagy inhibition by chloroquine on hepatic stellate cell activation in CCl4-induced acute liver injury mouse model.
    Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:1

    Topics: Animals; Autophagy; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chloroquine; Disea

2022
Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
    Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:24

    Topics: Animals; Apoptosis; Biomarkers; Biopsy; Carbon Tetrachloride; Disease Models, Animal; Disease Suscep

2021
Up-regulation of Nrf2/P62/Keap1 involves in the anti-fibrotic effect of combination of monoammonium glycyrrhizinate and cysteine hydrochloride induced by CCl
    European journal of pharmacology, 2021, Dec-15, Volume: 913

    Topics: Animals; Antifibrotic Agents; Carbon Tetrachloride; Cysteine; Disease Models, Animal; Gene Knockdown

2021
MyD88 in Macrophages Enhances Liver Fibrosis by Activation of NLRP3 Inflammasome in HSCs.
    International journal of molecular sciences, 2021, Nov-17, Volume: 22, Issue:22

    Topics: Animals; Carbon Tetrachloride; Cell Line; Chemokine CXCL2; Coculture Techniques; Disease Models, Ani

2021
Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.
    Drug delivery, 2021, Volume: 28, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cell Line; Cell Proliferation; Chemistry, Pharmaceutical; Disease Mod

2021
Specnuezhenide reduces carbon tetrachloride-induced liver injury in mice through inhibition of oxidative stress and hepatocyte apoptosis.
    The Journal of pharmacy and pharmacology, 2022, Feb-01, Volume: 74, Issue:2

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug;

2022
Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis.
    American journal of physiology. Gastrointestinal and liver physiology, 2022, 02-01, Volume: 322, Issue:2

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Hepatic Stellate Cells; Huma

2022
Protective Effect of
    Nutrients, 2021, Dec-12, Volume: 13, Issue:12

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dietary Supplem

2021
The antioxidant and anti-inflammatory effects of Carica Papaya Linn. seeds extract on CCl
    BMC complementary medicine and therapies, 2021, Dec-30, Volume: 21, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Carbon Tetrachloride; Carica

2021
Effects and mechanisms of ziqi ruangan decoction on hepatic fibrosis.
    Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:6

    Topics: Actins; Animals; Anti-Inflammatory Agents; Antifibrotic Agents; Antioxidants; Carbon Tetrachloride;

2021
    Food & function, 2022, Feb-21, Volume: 13, Issue:4

    Topics: Agaricales; Animals; Animals, Outbred Strains; Antioxidants; Carbon Tetrachloride; Chemical and Drug

2022
Comprehensive analysis of transcriptomics and metabolomics to illustrate the underlying mechanism of helenalin against hepatic fibrosis.
    European journal of pharmacology, 2022, Mar-15, Volume: 919

    Topics: Animals; Antioxidants; Asteraceae; Carbon Tetrachloride; Disease Models, Animal; Drugs, Chinese Herb

2022
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF.
    Journal of hepatology, 2022, Volume: 77, Issue:5

    Topics: Acute-On-Chronic Liver Failure; Animals; Carbon Tetrachloride; Disease Models, Animal; Galactosamine

2022
Effect of ADHI on hepatic stellate cell activation and liver fibrosis in mice.
    Biochemical and biophysical research communications, 2023, 04-09, Volume: 651

    Topics: Alcohol Dehydrogenase; Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatic Stellate Cells

2023
Thermoneutral housing shapes hepatic inflammation and damage in mouse models of non-alcoholic fatty liver disease.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Choline; Disease Models, Animal; Housing; Infla

2023
Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation.
    Methods in molecular biology (Clifton, N.J.), 2023, Volume: 2669

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatic Stellate Cells; Humans; Liver; Liver

2023
Dynamics of Chronic Liver Injury in Experimental Models of Hepatotoxicity.
    Frontiers in bioscience (Landmark edition), 2023, 05-09, Volume: 28, Issue:5

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Human

2023
Longitudinal Study of Cirrhosis Development in STAM and carbon tetrachloride Mouse Models Using Fourier Transform Infrared Spectral Imaging.
    Laboratory investigation; a journal of technical methods and pathology, 2023, Volume: 103, Issue:10

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Fourier Analysis; Glycogen; Liver Cirrhosis;

2023
The application of a novel platform of multiparametric magnetic resonance imaging in a bioenvironmental toxic carbon tetrachloride-induced mouse model of liver fibrosis.
    Environmental research, 2023, 12-01, Volume: 238, Issue:Pt 1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Fibrosis; Inflammation; Liver; Liver Cirrhosi

2023
Increasing the effectiveness of tyrosine kinase inhibitor (TKI) in combination with a statin in reducing liver fibrosis.
    Clinical and experimental pharmacology & physiology, 2019, Volume: 46, Issue:12

    Topics: Animals; Atorvastatin; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Drug Evaluatio

2019
Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis.
    BMC research notes, 2019, Aug-09, Volume: 12, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemokine CCL5; Chemokine CX3CL1; Curcumin;

2019
Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
    Oncogene, 2019, Volume: 38, Issue:45

    Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Disease M

2019
Praziquantel ameliorates CCl
    British journal of pharmacology, 2019, Volume: 176, Issue:24

    Topics: Animals; Carbon Tetrachloride; Cell Line; Disease Models, Animal; Gene Expression; Hepatic Stellate

2019
Antler stem cells as a novel stem cell source for reducing liver fibrosis.
    Cell and tissue research, 2020, Volume: 379, Issue:1

    Topics: Actins; Animals; Antlers; Carbon Tetrachloride; Cell Proliferation; Coculture Techniques; Collagen;

2020
New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease.
    Cells, 2019, 09-10, Volume: 8, Issue:9

    Topics: Animals; Carbon Tetrachloride; Diet, High-Fat; Disease Models, Animal; Disease Progression; Fatty Li

2019
Deficiency of apoptosis-stimulating protein 2 of p53 protects mice from acute hepatic injury induced by CCl
    Toxicology letters, 2019, Volume: 316

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Autophagy; Carbon Tetrachlori

2019
Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Sep-24, Volume: 25

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bone Marrow; Carbon Tetrachloride; Cell

2019
Zinc-α2-glycoprotein 1 attenuates non-alcoholic fatty liver disease by negatively regulating tumour necrosis factor-α.
    World journal of gastroenterology, 2019, Sep-28, Volume: 25, Issue:36

    Topics: Adipokines; Animals; Carbon Tetrachloride; Carrier Proteins; Diet, High-Fat; Disease Models, Animal;

2019
Icariin-induced miR-875-5p attenuates epithelial-mesenchymal transition by targeting hedgehog signaling in liver fibrosis.
    Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:3

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Collagen; Disease Models, Animal; Epithelial-Mesench

2020
The A3 adenosine receptor agonist, namodenoson, ameliorates non‑alcoholic steatohepatitis in mice.
    International journal of molecular medicine, 2019, Volume: 44, Issue:6

    Topics: Actins; Adenosine A3 Receptor Agonists; Adiponectin; Animals; Carbon Tetrachloride; Disease Models,

2019
Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice.
    Cellular and molecular gastroenterology and hepatology, 2020, Volume: 9, Issue:3

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Carcinogenesis; Cells, Cultured; Chemokine CCL2; Disease M

2020
Exploration of the Hepatoprotective Effect and Mechanism of Swertia mussotii Franch in an Acute Liver Injury Rat Model.
    Combinatorial chemistry & high throughput screening, 2019, Volume: 22, Issue:9

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drugs, Chinese Herbal; High-Throughput Screen

2019
Cross-regulation by TLR4 and T cell Ig mucin-3 determines severity of liver injury in a CCl4-induced mouse model.
    Scandinavian journal of immunology, 2020, Volume: 91, Issue:4

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hepat

2020
Margatoxin mitigates CCl4‑induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling.
    International journal of molecular medicine, 2020, Volume: 45, Issue:1

    Topics: Animals; Biopsy; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Gene Expression Regulation

2020
TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway.
    Cell proliferation, 2020, Volume: 53, Issue:1

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models, Animal; Kupffer Cells

2020
TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways.
    Hepatology international, 2020, Volume: 14, Issue:1

    Topics: Adenine; Alanine; Animals; Antiviral Agents; Carbon Tetrachloride; Disease Models, Animal; DNA-Bindi

2020
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice.
    Journal of hepatology, 2020, Volume: 72, Issue:4

    Topics: Acute Disease; Acute-On-Chronic Liver Failure; Adult; Animals; Carbon Tetrachloride; Chemical and Dr

2020
Chemical induced inflammation of the liver breaks tolerance and results in autoimmune hepatitis in Balb/c mice.
    Immunology letters, 2020, Volume: 218

    Topics: Adenoviridae; Animals; Autoantigens; Autoimmunity; Biomarkers; Biopsy; Carbon Tetrachloride; CD4-Pos

2020
Mediator MED23 regulates inflammatory responses and liver fibrosis.
    PLoS biology, 2019, Volume: 17, Issue:12

    Topics: Animals; Carbon Tetrachloride; Cell Line; Chemokine CCL5; Chemokine CXCL10; Disease Models, Animal;

2019
Fuzhenghuayu Decoction ameliorates hepatic fibrosis by attenuating experimental sinusoidal capillarization and liver angiogenesis.
    Scientific reports, 2019, 12-10, Volume: 9, Issue:1

    Topics: Animals; Capillaries; Carbon Tetrachloride; Disease Models, Animal; Drugs, Chinese Herbal; Endotheli

2019
Hepatoprotective effect of a fucoidan extract from Sargassum fluitans Borgesen against CCl
    International journal of biological macromolecules, 2020, Feb-15, Volume: 145

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models, Animal; Gene Expressi

2020
Genipin Ameliorates Carbon Tetrachloride-Induced Liver Injury in Mice via the Concomitant Inhibition of Inflammation and Induction of Autophagy.
    Oxidative medicine and cellular longevity, 2019, Volume: 2019

    Topics: Animals; Autophagy; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, An

2019
Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication.
    BMC gastroenterology, 2020, Jan-15, Volume: 20, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Image Processing, Computer-Assisted; Inflamma

2020
Application Value of Magnetic Resonance Perfusion Imaging in the Early Diagnosis of Rat Hepatic Fibrosis.
    BioMed research international, 2019, Volume: 2019

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Early Diagnosis; Humans; Liver; Liver Cirrhos

2019
Downregulated long non-coding RNA LINC01093 in liver fibrosis promotes hepatocyte apoptosis via increasing ubiquitination of SIRT1.
    Journal of biochemistry, 2020, May-01, Volume: 167, Issue:5

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Down-Regulation;

2020
AK-1, a Sirt2 inhibitor, alleviates carbon tetrachloride-induced hepatotoxicity
    Toxicology mechanisms and methods, 2020, Volume: 30, Issue:5

    Topics: Animals; Antioxidants; Apoptosis; Benzamides; Carbon Tetrachloride; Cells, Cultured; Chemical and Dr

2020
Transcriptional Dynamics of Hepatic Sinusoid-Associated Cells After Liver Injury.
    Hepatology (Baltimore, Md.), 2020, Volume: 72, Issue:6

    Topics: Animals; Biopsy; Capillaries; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease

2020
Metabolic and non-metabolic liver zonation is established non-synchronously and requires sinusoidal Wnts.
    eLife, 2020, 03-10, Volume: 9

    Topics: Age Factors; Animals; Biomarkers; Capillaries; Carbon Tetrachloride; Claudin-2; Disease Models, Anim

2020
Evaluation of Hepatoprotective Activity of
    Endocrine, metabolic & immune disorders drug targets, 2020, Volume: 20, Issue:7

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Clerodendrum; C

2020
Oridonin ameliorates carbon tetrachloride-induced liver fibrosis in mice through inhibition of the NLRP3 inflammasome.
    Drug development research, 2020, Volume: 81, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cell Line; Disease Models, Animal; Diterpenes, Kaurane; Hepatic Stell

2020
TGF-β/Smad and JAK/STAT pathways are involved in the anti-fibrotic effects of propylene glycol alginate sodium sulphate on hepatic fibrosis.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:9

    Topics: Alginates; Animals; Autophagy; Bile Ducts; Carbon Tetrachloride; Disease Models, Animal; Down-Regula

2020
Lignans from Schisandra chinensis ameliorate alcohol and CCl
    Journal of ethnopharmacology, 2020, Aug-10, Volume: 258

    Topics: Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Cell Line; Chemical and Drug Induced Liver I

2020
Alginate Suppresses Liver Fibrosis Through the Inhibition of Nuclear Factor-κB Signaling.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Alginates; Animals; Carbon Tetrachloride; Cell Line; Cell Movement; Cell Proliferation; Cell Surviva

2020
A high-throughput targeted metabolomics method for the quantification of 104 non-polar metabolites in cholesterol, eicosanoid, and phospholipid metabolism: application in the study of a CCl
    The Analyst, 2020, May-18, Volume: 145, Issue:10

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cholesterol; Disease Models,

2020
Intravenous Administration is the Best Route of Mesenchymal Stem Cells Migration in Improving Liver Function Enzyme of Acute Liver Failure.
    Folia medica, 2020, 03-31, Volume: 62, Issue:1

    Topics: 5'-Nucleotidase; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbon Tetra

2020
Dysregulation of bile acids increases the risk for preterm birth in pregnant women.
    Nature communications, 2020, 04-30, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Animals; Bile Acids and Salts; Carbon Tetrachloride; Cholic Acid; Disease Models,

2020
Huagan tongluo Fang improves liver fibrosis via down-regulating miR-184 and up-regulating FOXO1 to inhibit Th17 cell differentiation.
    Experimental and molecular pathology, 2020, Volume: 115

    Topics: Animals; Base Sequence; Carbon Tetrachloride; Cell Differentiation; Disease Models, Animal; Down-Reg

2020
TMEM9-v-ATPase Activates Wnt/β-Catenin Signaling Via APC Lysosomal Degradation for Liver Regeneration and Tumorigenesis.
    Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:2

    Topics: Adenomatous Polyposis Coli Protein; Animals; beta Catenin; Carbon Tetrachloride; Carcinogenesis; Car

2021
Administration of a mixture of triterpenoids from yeyachun and phenolic acids from danshen ameliorates carbon tetrachloride-induced liver fibrosis in mice by the regulation of intestinal flora.
    Journal of pharmacological sciences, 2020, Volume: 143, Issue:3

    Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Carbon Tetrachloride; Disease Mode

2020
Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis.
    Biomedical journal, 2021, Volume: 44, Issue:5

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis; Male; Mesenchymal Ste

2021
Camellia oil (Camellia oleifera Abel.) attenuates CCl
    Food & function, 2020, May-01, Volume: 11, Issue:5

    Topics: Animals; Apoptosis; Camellia; Carbon Tetrachloride; Disease Models, Animal; Hepatocytes; Liver Cirrh

2020
Effects of gastrodin against carbon tetrachloride induced kidney inflammation and fibrosis in mice associated with the AMPK/Nrf2/HMGB1 pathway.
    Food & function, 2020, May-01, Volume: 11, Issue:5

    Topics: AMP-Activated Protein Kinase Kinases; Animals; Benzyl Alcohols; Carbon Tetrachloride; Disease Models

2020
Using in vivo multiphoton fluorescence lifetime imaging to unravel disease-specific changes in the liver redox state.
    Methods and applications in fluorescence, 2020, Jul-07, Volume: 8, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Liver Cirrhosis; Mice; Mice, Knockout; Micros

2020
Ursolic acid reverses liver fibrosis by inhibiting interactive NOX4/ROS and RhoA/ROCK1 signalling pathways.
    Aging, 2020, 06-03, Volume: 12, Issue:11

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetophenones; Animals; Carbon Tetrachloride; Disease

2020
Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis.
    European journal of pharmacology, 2020, Sep-05, Volume: 882

    Topics: Animals; Bone Marrow; Carbon Tetrachloride; Combined Modality Therapy; Disease Models, Animal; Imati

2020
Dendrobium nobile Lindl. alkaloids-mediated protection against CCl
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 129

    Topics: Alkaloids; Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver I

2020
Evaluation of carbon tetrachloride fraction of Actinodaphne angustifolia Nees (Lauraceae) leaf extract for antioxidant, cytotoxic, thrombolytic and antidiarrheal properties.
    Bioscience reports, 2020, 06-26, Volume: 40, Issue:6

    Topics: Animals; Antidiarrheals; Antioxidants; Artemia; Carbon Tetrachloride; Castor Oil; Defecation; Diarrh

2020
hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis.
    Aging, 2020, 06-25, Volume: 12, Issue:12

    Topics: Animals; Benzofurans; Biomarkers; Carbon Tetrachloride; Cell Movement; Cell Proliferation; Cells, Cu

2020
Diffusion tensor imaging quantifying the severity of chronic hepatitis in rats.
    BMC medical imaging, 2020, 07-02, Volume: 20, Issue:1

    Topics: Animals; Carbon Tetrachloride; Case-Control Studies; Diffusion Tensor Imaging; Disease Models, Anima

2020
Byakangelicin protects against carbon tetrachloride-induced liver injury and fibrosis in mice.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:15

    Topics: Animals; Apoptosis; Biopsy; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver I

2020
Gut Microbiota and Liver Fibrosis: One Potential Biomarker for Predicting Liver Fibrosis.
    BioMed research international, 2020, Volume: 2020

    Topics: Animals; Bacteria; Biomarkers; Carbon Tetrachloride; Disease Models, Animal; Feces; Gastrointestinal

2020
Kupffer cells mediate the recruitment of hepatic stellate cells into the localized liver damage.
    Biochemical and biophysical research communications, 2020, 08-20, Volume: 529, Issue:2

    Topics: Animals; Carbon Tetrachloride; Cell Movement; Chemical and Drug Induced Liver Injury; Disease Models

2020
Levistilide A reverses rat hepatic fibrosis by suppressing angiotensin II‑induced hepatic stellate cells activation.
    Molecular medicine reports, 2020, Volume: 22, Issue:3

    Topics: Actins; Angiotensin II; Animals; Carbon Tetrachloride; Cell Proliferation; Cell Survival; Cells, Cul

2020
Preventive effect of ethanol extract from Chinese sumac fruits against tetrachloromethane-induced liver fibrosis in mice.
    Food & function, 2020, Aug-01, Volume: 11, Issue:8

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, An

2020
MiR-126 Regulates Properties of SOX9
    Stem cell reports, 2020, 09-08, Volume: 15, Issue:3

    Topics: Animals; Base Sequence; Carbon Tetrachloride; Cell Differentiation; Cell Line, Tumor; Cell Prolifera

2020
Intravenous Umbilical Cord-derived Mesenchymal Stem Cells Transplantation Regulates Hyaluronic Acid and Interleukin-10 Secretion Producing Low-grade Liver Fibrosis in Experimental Rat.
    Medical archives (Sarajevo, Bosnia and Herzegovina), 2020, Volume: 74, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Fetal Blood; Hyaluronic Acid; Interleukin-10;

2020
Histidine kinase NME1 and NME2 are involved in TGF-β1-induced HSC activation and CCl
    Journal of molecular histology, 2020, Volume: 51, Issue:5

    Topics: Animals; Apoptosis; Biomarkers; Carbon Tetrachloride; Cell Line; Disease Models, Animal; Disease Sus

2020
The Genetic Architecture of Carbon Tetrachloride-Induced Liver Fibrosis in Mice.
    Cellular and molecular gastroenterology and hepatology, 2021, Volume: 11, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Gene Regulatory Networks; Genetic Predisposit

2021
Tert-butylhydroquinone mitigates Carbon Tetrachloride induced Hepatic Injury in mice.
    International journal of medical sciences, 2020, Volume: 17, Issue:14

    Topics: Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dise

2020
Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension.
    Scientific reports, 2020, 09-23, Volume: 10, Issue:1

    Topics: Animals; Carbon Tetrachloride; Collagen Type I; Collagen Type I, alpha 1 Chain; Disease Models, Anim

2020
Phenolic Profile, Antioxidant Activity, and Ameliorating Efficacy of
    Nutrients, 2020, Sep-23, Volume: 12, Issue:10

    Topics: Animals; Antioxidants; Blood Glucose; Carbon Tetrachloride; Chenopodium quinoa; Disease Models, Anim

2020
PXR Functionally Interacts with NF-κB and AP-1 to Downregulate the Inflammation-Induced Expression of Chemokine CXCL2 in Mice.
    Cells, 2020, 10-15, Volume: 9, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Che

2020
SB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-β Signaling.
    Molecular pharmaceutics, 2020, 11-02, Volume: 17, Issue:11

    Topics: Animals; Benzamides; Carbon Tetrachloride; Cell Line; Dioxoles; Disease Models, Animal; Drug Liberat

2020
Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 132

    Topics: Abietanes; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Proliferation; Disease Models,

2020
Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and Cholestasis.
    Gastroenterology, 2021, Volume: 160, Issue:3

    Topics: Adaptor Proteins, Signal Transducing; Animals; Bile Ducts; Carbon Tetrachloride; Cell Proliferation;

2021
MicroRNA-125a/VDR axis impaired autophagic flux and contributed to fibrosis in a CCL4-induced mouse model and patients with liver cirrhosis.
    Life sciences, 2021, Jan-01, Volume: 264

    Topics: Animals; Antagomirs; Autophagy; Base Sequence; Carbon Tetrachloride; Dependovirus; Disease Models, A

2021
MiR-340 suppresses CCl4-induced acute liver injury through exerting anti-inflammation targeting Sigirr.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:20

    Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Cells, Cultured; Disease

2020
Bixin attenuates carbon tetrachloride induced oxidative stress, inflammation and fibrosis in kidney by regulating the Nrf2/TLR4/MyD88 and PPAR-γ/TGF-β1/Smad3 pathway.
    International immunopharmacology, 2021, Volume: 90

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Carotenoids; Disease Models,

2021
Comparing distress of mouse models for liver damage.
    Scientific reports, 2020, 11-13, Volume: 10, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis; Liver Diseases; Mice

2020
AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis.
    Nature communications, 2020, 11-16, Volume: 11, Issue:1

    Topics: Adenylate Kinase; Alanine Transaminase; Animals; Carbon Tetrachloride; Diet, High-Fat; Disease Model

2020
Therapeutic Potential of Bama Pig Adipose-Derived Mesenchymal Stem Cells for the Treatment of Carbon Tetrachloride-Induced Liver Fibrosis.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2020, Volume: 18, Issue:7

    Topics: Adipose Tissue; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Movement; Cell Proliferati

2020
A role for intestinal alkaline phosphatase in preventing liver fibrosis.
    Theranostics, 2021, Volume: 11, Issue:1

    Topics: Adult; Alkaline Phosphatase; Animals; Carbon Tetrachloride; Common Bile Duct; Disease Models, Animal

2021
Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis.
    Theranostics, 2021, Volume: 11, Issue:1

    Topics: Adenosine; Animals; Apoptosis; Benzazepines; Bile Ducts; Carbon Tetrachloride; Cell Cycle; Cell Cycl

2021
Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis.
    Current medical science, 2020, Volume: 40, Issue:6

    Topics: Actins; Animals; Biomarkers; Carbon Tetrachloride; Chemokine CX3CL1; CX3C Chemokine Receptor 1; Dise

2020
PPARγ/NF-κB and TGF-β1/Smad pathway are involved in the anti-fibrotic effects of levo-tetrahydropalmatine on liver fibrosis.
    Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:3

    Topics: Animals; Berberine Alkaloids; Biomarkers; Carbon Tetrachloride; Disease Models, Animal; Extracellula

2021
Tectona grandis leaf extract ameliorates hepatic fibrosis: Modulation of TGF- β /Smad signaling pathway and upregulating MMP3/TIMP1 ratio.
    Journal of ethnopharmacology, 2021, May-23, Volume: 272

    Topics: Animals; Carbon Tetrachloride; Cell Survival; Chlorocebus aethiops; Collagen; Disease Models, Animal

2021
Therapeutic Impact of ODN2088 to Block TLR9 Activity in Induced Liver Fibrosis Mice.
    Pakistan journal of biological sciences : PJBS, 2021, Volume: 24, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Caspase 3; Chemical and Drug Induced Liver

2021
Elevated miR-129-5p attenuates hepatic fibrosis through the NF-κB signaling pathway via PEG3 in a carbon CCl
    Journal of molecular histology, 2021, Volume: 52, Issue:3

    Topics: Animals; Base Sequence; Carbon Tetrachloride; Disease Models, Animal; Down-Regulation; Kruppel-Like

2021
Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis.
    EBioMedicine, 2021, Volume: 66

    Topics: Animals; Bile Acids and Salts; Biomarkers; Carbon Tetrachloride; Case-Control Studies; Cell Line; Di

2021
Neutrophils induce paracrine telomere dysfunction and senescence in ROS-dependent manner.
    The EMBO journal, 2021, 05-03, Volume: 40, Issue:9

    Topics: Acute Lung Injury; Animals; Carbon Tetrachloride; Cell Line; Cellular Senescence; Coculture Techniqu

2021
Paeoniflorin modulates oxidative stress, inflammation and hepatic stellate cells activation to alleviate CCl4-induced hepatic fibrosis by upregulation of heme oxygenase-1 in mice.
    The Journal of pharmacy and pharmacology, 2021, Mar-06, Volume: 73, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Cytokines; Disease Models, A

2021
Combination of aqueous extracts of Curcuma longa (turmeric) and some calcium channel blockers synergistically improves CCl4-induced nephrotoxicity in albino rats.
    Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:5

    Topics: Acute Kidney Injury; Amlodipine; Animals; Antioxidants; Calcium Channel Blockers; Carbon Tetrachlori

2020
Antioxidant characteristics and hepatoprotective effects of a formula derived from Maydis stigma, Nelumbo nucifera and Taraxacum officinale against carbon tetrachloride-induced hepatic damage in rats.
    Pakistan journal of pharmaceutical sciences, 2020, Volume: 33, Issue:5

    Topics: Animals; Antioxidants; Biomarkers; Carbon Tetrachloride; Cell Proliferation; Chemical and Drug Induc

2020
Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis.
    International immunopharmacology, 2021, Volume: 96

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Collagen; Disease Models, Ani

2021
Starch based hydrogel NPs loaded by anthocyanins might treat glycogen storage at cardiomyopathy in animal fibrotic model.
    International journal of biological macromolecules, 2021, Jul-31, Volume: 183

    Topics: Animals; Anthocyanins; Carbon Tetrachloride; Cardiomyopathies; Cardiotoxicity; Disease Models, Anima

2021
Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis.
    Biochemical and biophysical research communications, 2021, 06-18, Volume: 558

    Topics: Animals; Caffeic Acids; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Gene Knockdow

2021
RUNX1 regulates SMAD1 by transcriptionally activating the expression of USP9X, regulating the activation of hepatic stellate cells and liver fibrosis.
    European journal of pharmacology, 2021, Jul-15, Volume: 903

    Topics: Animals; Carbon Tetrachloride; Cell Movement; Cell Proliferation; Cell Survival; Core Binding Factor

2021
Irisin ameliorates endoplasmic reticulum stress and liver fibrosis through inhibiting PERK-mediated destabilization of HNRNPA1 in hepatic stellate cells.
    Biological chemistry, 2021, 05-26, Volume: 402, Issue:6

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; eIF-2 Kinase; Endoplasmic Re

2021
Mouse Models of Liver Fibrosis.
    Methods in molecular biology (Clifton, N.J.), 2021, Volume: 2299

    Topics: Animals; Carbon Tetrachloride; Diet, High-Fat; Disease Models, Animal; Hepatic Stellate Cells; Human

2021
CD39-mediated ATP-adenosine signalling promotes hepatic stellate cell activation and alcoholic liver disease.
    European journal of pharmacology, 2021, Aug-15, Volume: 905

    Topics: 5'-Nucleotidase; Acetaldehyde; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Ca

2021
Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells.
    Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021, Volume: 8, Issue:11

    Topics: Animals; Capillaries; Carbon Tetrachloride; Disease Models, Animal; Endothelial Cells; Fatty Acid-Bi

2021
Alpha lipoic acid priming enhances the hepatoprotective effect of adipose derived stem cells in CCl4 induced hepatic injury in-vitro.
    European journal of pharmacology, 2021, Sep-05, Volume: 906

    Topics: Adipose Tissue; Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Inju

2021
Splicing Factor SLU7 Prevents Oxidative Stress-Mediated Hepatocyte Nuclear Factor 4α Degradation, Preserving Hepatic Differentiation and Protecting From Liver Damage.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:5

    Topics: Acetaminophen; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Line; Chemical and Drug Ind

2021
Hepatoprotective Effects of Polysaccharide from
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Free Radical Scavengers; Lipid

2021
Urantide prevents CCl4‑induced acute liver injury in rats by regulating the MAPK signalling pathway.
    Molecular medicine reports, 2021, Volume: 24, Issue:4

    Topics: Actins; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Anima

2021
Comparison of the Effects of Intraperitoneal Injection with Carbon Tetrachloride on Acute Liver Toxicity in Male and Female Kunming Mice.
    Medical science monitor : international medical journal of experimental and clinical research, 2021, Aug-09, Volume: 27

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injur

2021
Extracellular vesicles from in vivo liver tissue accelerate recovery of liver necrosis induced by carbon tetrachloride.
    Journal of extracellular vesicles, 2021, Volume: 10, Issue:10

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Proliferation; Disease Models, Animal; Extracellular

2021
Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis.
    Medical science monitor : international medical journal of experimental and clinical research, 2021, Aug-20, Volume: 27

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Collagen; Disease Models, Animal; Disease Susceptibility;

2021
Caveolin-1 Deficiency Protects Mice Against Carbon Tetrachloride-Induced Acute Liver Injury Through Regulating Polarization of Hepatic Macrophages.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Animals; Apoptosis; Biomarkers; Carbon Tetrachloride; Caveolin 1; Chemical and Drug Induced Liver In

2021
Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; Autophagy; Carbon Tetrachloride; Cell L

2021
Evaluation of Brain Pharmacokinetic and Neuropharmacodynamic Attributes of an Antiepileptic Drug, Lacosamide, in Hepatic and Renal Impairment: Preclinical Evidence.
    ACS chemical neuroscience, 2017, 07-19, Volume: 8, Issue:7

    Topics: Acetamides; Administration, Oral; Animals; Anticonvulsants; Area Under Curve; Brain; Carbon Tetrachl

2017
Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis.
    Physiological reports, 2017, Volume: 5, Issue:7

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Interleukin-6; Ligation; Liver Cirrhosis, Bil

2017
Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
    Journal of cellular and molecular medicine, 2017, Volume: 21, Issue:10

    Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Chronic Disease; Disease Models,

2017
Fraxin Prevents Chemically Induced Hepatotoxicity by Reducing Oxidative Stress.
    Molecules (Basel, Switzerland), 2017, Apr-06, Volume: 22, Issue:4

    Topics: Animals; Antioxidants; Biopsy; Carbon Tetrachloride; Cell Survival; Chemical and Drug Induced Liver

2017
Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
    International immunopharmacology, 2017, Volume: 47

    Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; bcl-2-Associated X Protein

2017
Can Ultrasound Imaging Predict the Success of an Experimental Steatofibrosis Model?
    Ultrasound quarterly, 2017, Volume: 33, Issue:2

    Topics: Animals; Carbon Tetrachloride; Diet, High-Fat; Disease Models, Animal; Fatty Liver; Female; Humans;

2017
Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models.
    PloS one, 2017, Volume: 12, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Disease Models, Animal; Erlotinib Hydrochloride;

2017
Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
    Oncotarget, 2017, Jun-20, Volume: 8, Issue:25

    Topics: Adult; Animals; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Down-Regulation; Female; He

2017
Pharmacokinetics and pharmacodynamics of rhubarb anthraquinones extract in normal and disease rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 91

    Topics: Administration, Oral; Animals; Anthraquinones; Carbon Tetrachloride; Chromatography, High Pressure L

2017
Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2017, Volume: 23, Issue:8

    Topics: Animals; Carbon Tetrachloride; CD8-Positive T-Lymphocytes; Cells, Cultured; Coculture Techniques; Di

2017
Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment.
    Clinics (Sao Paulo, Brazil), 2017, Volume: 72, Issue:4

    Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling

2017
Src-homology protein tyrosine phosphatase-1 agonist, SC-43, reduces liver fibrosis.
    Scientific reports, 2017, 05-11, Volume: 7, Issue:1

    Topics: Animals; Apoptosis; Bile Ducts; Carbon Tetrachloride; Cell Line; Cell Proliferation; Disease Models,

2017
Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation.
    Stem cell research & therapy, 2017, 06-05, Volume: 8, Issue:1

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Cell Proliferation; Coculture Techniques; Culture Media,

2017
Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
    Journal of hepatology, 2017, Volume: 67, Issue:4

    Topics: Animals; Antigens, Ly; Apoptosis; Carbon Tetrachloride; Cell- and Tissue-Based Therapy; Cellular Mic

2017
Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
    Stem cell research & therapy, 2017, 06-13, Volume: 8, Issue:1

    Topics: Animals; Bone Marrow Transplantation; Carbon Tetrachloride; Disease Models, Animal; Epithelial Cell

2017
Bone marrow endothelial progenitor cells activate hepatic stellate cells and aggravate carbon tetrachloride induced liver fibrosis in mice via paracrine factors.
    Cell proliferation, 2017, Volume: 50, Issue:4

    Topics: Animals; Bone Marrow Cells; Carbon Tetrachloride; Cells, Cultured; Coculture Techniques; Culture Med

2017
Screening for the protective effect target of deproteinized extract of calf blood and its mechanisms in mice with CCl4-induced acute liver injury.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Actihaemyl; Animals; Apoptosis; Blood Proteins; Blotting, Western; Carbon Tetrachloride; Disease Mod

2017
Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury.
    Gastroenterology, 2017, Volume: 153, Issue:4

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Cell Differentiation; Cell Lineage; Cell Proliferation; C

2017
Evaluation of liver fibrosis using Raman spectroscopy and infrared thermography: A pilot study.
    Photodiagnosis and photodynamic therapy, 2017, Volume: 19

    Topics: Animals; Carbon Tetrachloride; Discriminant Analysis; Disease Models, Animal; Drug Dosage Calculatio

2017
Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl
    Scientific reports, 2017, 07-31, Volume: 7, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Endotoxins; Gastrointestinal Micro

2017
Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress.
    World journal of gastroenterology, 2017, Jul-28, Volume: 23, Issue:28

    Topics: Actins; Animals; Carbon Tetrachloride; CD11b Antigen; Cell Separation; Cell- and Tissue-Based Therap

2017
A frequent misinterpretation in current research on liver fibrosis: the vessel in the center of CCl
    Archives of toxicology, 2017, Volume: 91, Issue:11

    Topics: Actins; Animals; Carbon Tetrachloride; Collagen Type IV; Disease Models, Animal; Glutamate-Ammonia L

2017
Protective effects of theasinensin A against carbon tetrachloride-induced liver injury in mice.
    Food & function, 2017, Sep-20, Volume: 8, Issue:9

    Topics: Animals; Benzopyrans; Camellia sinensis; Carbon Tetrachloride; Disease Models, Animal; Humans; Liver

2017
Nrf2 activators from Glycyrrhiza inflata and their hepatoprotective activities against CCl
    Bioorganic & medicinal chemistry, 2017, 10-15, Volume: 25, Issue:20

    Topics: Administration, Oral; Animals; Carbon Tetrachloride; Cell Survival; Chemical and Drug Induced Liver

2017
Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1627

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hemodynamics; Hypertension, Portal; Liver Cir

2017
Evaluation of Rumex hastatus leaves against hepatic fibrosis: a rat model.
    BMC complementary and alternative medicine, 2017, Aug-30, Volume: 17, Issue:1

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Disease Models, An

2017
Oroxylin A prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1α signaling.
    Journal of cellular biochemistry, 2018, Volume: 119, Issue:2

    Topics: Adaptor Proteins, Signal Transducing; Angiopoietin-2; Animals; Carbon Tetrachloride; Cell Cycle Prot

2018
Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury.
    PloS one, 2017, Volume: 12, Issue:9

    Topics: Administration, Oral; Animals; Carbon Tetrachloride; Cell Movement; Cell Polarity; Chemotaxis; Disea

2017
Determination of extracellular matrix collagen fibril architectures and pathological remodeling by polarization dependent second harmonic microscopy.
    Scientific reports, 2017, 09-22, Volume: 7, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Extracellular Matrix; Fibrillar Collagens; Im

2017
Protective potential of Parrotiopsis jacquemontiana (Decne) Rehder on carbon tetrachloride induced hepatotoxicity in experimental rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 95

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytokines; Dise

2017
Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
    Clinics and research in hepatology and gastroenterology, 2018, Volume: 42, Issue:2

    Topics: Animals; Benzoates; Carbon Tetrachloride; Disease Models, Animal; Epoxide Hydrolases; Hypertension,

2018
Changes in hydrogen sulfide in rats with hepatic cirrhosis in different stages.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2017, Volume: 37, Issue:5

    Topics: Animals; Carbon Tetrachloride; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Disease Model

2017
Improvement of portal venous pressure in cirrhotic rat livers by systemic treatment with adipose tissue-derived mesenchymal stromal cells.
    Cytotherapy, 2017, Volume: 19, Issue:12

    Topics: Adipose Tissue; Animals; Carbon Tetrachloride; Cell Differentiation; Collagen; Disease Models, Anima

2017
Protective effects of traditional Uighur medicine-seeds of Nigella glandulifera Freyn extracts against ccl4-induced acute hepatic injury in mice.
    Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:5

    Topics: Animals; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyt

2017
A hepatonephro-protective phenolic-rich extract from red onion (Allium cepa L.) peels.
    Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:5(Suppleme

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemi

2017
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
    EMBO molecular medicine, 2017, Volume: 9, Issue:12

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Disease Progress

2017
Serum metabonomics study of the hepatoprotective effect of amarogentin on CCl
    Journal of pharmaceutical and biomedical analysis, 2018, Feb-05, Volume: 149

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Discriminant Analysis; Disease Models, Animal; Drugs, Chi

2018
Recombinant truncated TGF‑β receptor II attenuates carbon tetrachloride‑induced epithelial‑mesenchymal transition and liver fibrosis in rats.
    Molecular medicine reports, 2018, Volume: 17, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Epithelial-Mesenchymal Transition; Extracellu

2018
Activation of Nrf2 pathway and inhibition of NLRP3 inflammasome activation contribute to the protective effect of chlorogenic acid on acute liver injury.
    International immunopharmacology, 2018, Volume: 54

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liv

2018
FOXA2 alleviates CCl
    Scientific reports, 2017, Nov-14, Volume: 7, Issue:1

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Disease Models, Animal; Endoplasmic Reticulum Stress; Gene

2017
Targeting secreted cytokine BMP9 gates the attenuation of hepatic fibrosis.
    Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:3

    Topics: Animals; Carbon Tetrachloride; Case-Control Studies; Cytokines; Disease Models, Animal; Gene Express

2018
    World journal of gastroenterology, 2017, Dec-14, Volume: 23, Issue:46

    Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Extrac

2017
Curcumin Attenuates on Carbon Tetrachloride-Induced Acute Liver Injury in Mice via Modulation of the Nrf2/HO-1 and TGF-β1/Smad3 Pathway.
    Molecules (Basel, Switzerland), 2018, Jan-19, Volume: 23, Issue:1

    Topics: Animals; Carbon Tetrachloride; Caspase 3; Caspase 9; Chemical and Drug Induced Liver Injury; Curcumi

2018
Potential roles of AMP-activated protein kinase in liver regeneration in mice with acute liver injury.
    Molecular medicine reports, 2018, Volume: 17, Issue:4

    Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Carbon Tetrachloride; Cell Proliferation; Chemic

2018
Exemestane Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells and Promoting the Secretion of Interleukin 10.
    Journal of immunology research, 2017, Volume: 2017

    Topics: Actins; Androstadienes; Animals; Anti-Inflammatory Agents; Aromatase Inhibitors; Bile Ducts; Carbon

2017
Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice.
    BMC gastroenterology, 2018, Feb-27, Volume: 18, Issue:1

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Count; Cell Line; Disease Models, Animal; Diterpenes;

2018
EVALUATION OF HEPATOPROTECTIVE ACTIVITY OF MELILOTUS OFFICINALIS L. AGAINST PARACETAMOL AND CARBON TETRACHLORIDE INDUCED HEPATIC INJURY IN MICE.
    Acta poloniae pharmaceutica, 2017, Volume: 74, Issue:3

    Topics: Acetaminophen; Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cy

2017
SENP2 alleviates CCl
    Toxicology letters, 2018, Jun-01, Volume: 289

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Biomarkers; Carbon Tetrachloride; Cell Lin

2018
Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 102

    Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Caveolin 1

2018
Bone marrow or adipose tissue mesenchymal stem cells: Comparison of the therapeutic potentials in mice model of acute liver failure.
    Journal of cellular biochemistry, 2018, Volume: 119, Issue:7

    Topics: Adipose Tissue; Animals; Carbon Tetrachloride; Cell- and Tissue-Based Therapy; Disease Models, Anima

2018
Antioxidant Activity and Hepatoprotective Potential of Quercetin 7-Rhamnoside In Vitro and In Vivo.
    Molecules (Basel, Switzerland), 2018, May-16, Volume: 23, Issue:5

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Cell Line; Chemical and Drug Induced Liver Injury; Dise

2018
Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury.
    Molecular pharmacology, 2018, Volume: 94, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Celecoxib; Collagen; Cycloox

2018
Design, synthesis and investigation of potential anti-inflammatory activity of O-alkyl and O-benzyl hesperetin derivatives.
    International immunopharmacology, 2018, Volume: 61

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dis

2018
Oxaloacetate Ameliorates Chemical Liver Injury via Oxidative Stress Reduction and Enhancement of Bioenergetic Fluxes.
    International journal of molecular sciences, 2018, May-31, Volume: 19, Issue:6

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Citric Acid Cyc

2018
In silico and in vivo characterization of cabralealactone, solasodin and salvadorin in a rat model: potential anti-inflammatory agents.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Coumarins; Cyclooxygenase 2; Disease Models

2018
Mesenchymal Stem Cell/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure.
    ACS nano, 2018, 07-24, Volume: 12, Issue:7

    Topics: Animals; Apoptosis; Biomimetic Materials; Carbon Tetrachloride; Cell Line; Cell Proliferation; Disea

2018
Genetic ablation of pannexin1 counteracts liver fibrosis in a chemical, but not in a surgical mouse model.
    Archives of toxicology, 2018, Volume: 92, Issue:8

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Connexins; Disease Models, Animal; Gene Expression Regula

2018
PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis.
    Oncogene, 2018, Volume: 37, Issue:47

    Topics: 5' Untranslated Regions; Adaptor Proteins, Signal Transducing; Animals; Biomarkers; Carbon Tetrachlo

2018
Emodin alleviates CCl4‑induced liver fibrosis by suppressing epithelial‑mesenchymal transition and transforming growth factor‑β1 in rats.
    Molecular medicine reports, 2018, Volume: 18, Issue:3

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Collagen; Disease Models, Animal; Emodin; Epithelial-Mese

2018
Antifibrotic Effect of Smad Decoy Oligodeoxynucleotide in a CCl₄-Induced Hepatic Fibrosis Animal Model.
    Molecules (Basel, Switzerland), 2018, Aug-10, Volume: 23, Issue:8

    Topics: Animals; Base Sequence; Carbon Tetrachloride; Disease Models, Animal; Epithelial-Mesenchymal Transit

2018
Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 48, Issue:5

    Topics: Actins; Administration, Intravenous; Animals; Bone Marrow Cells; Carbon Tetrachloride; Connective Ti

2018
Quantitative analysis of susceptibility-weighted magnetic resonance imaging in chronic hepatitis in rats.
    Magnetic resonance imaging, 2018, Volume: 54

    Topics: Animals; Carbon Tetrachloride; Diagnosis, Differential; Disease Models, Animal; Evaluation Studies a

2018
Protective Effect of Eckol against Acute Hepatic Injury Induced by Carbon Tetrachloride in Mice.
    Marine drugs, 2018, Aug-27, Volume: 16, Issue:9

    Topics: Animals; Apoptosis; Biological Products; Carbon Tetrachloride; Chemical and Drug Induced Liver Injur

2018
[Effect of Jiawei Yinchen Sini Decoction on the Production of Smad7 and CollagenⅠ,Ⅲ in Carbon Tetrachloride Induced Hepatic Fibrosis Model of Mice].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2016, Volume: 39, Issue:6

    Topics: Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Drugs, Chinese Herbal; Laminin; Liv

2016
Alleviation of carbon tetrachloride-induced hepatocellular damage and oxidative stress with a leaf extract of Glyphae brevis (Tiliaceae).
    Journal of basic and clinical physiology and pharmacology, 2018, Nov-27, Volume: 29, Issue:6

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Carb

2018
COL6A3-derived endotrophin links reciprocal interactions among hepatic cells in the pathology of chronic liver disease.
    The Journal of pathology, 2019, Volume: 247, Issue:1

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Communication; Chemical an

2019
Deficiency in augmenter of liver regeneration accelerates liver fibrosis by promoting migration of hepatic stellate cell.
    Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:11

    Topics: Actins; Animals; Calcium; Carbon Tetrachloride; Cell Line; Cell Movement; Disease Models, Animal; Ge

2018
Brachychiton populneus (Schott & Endl.) R.Br. ameliorate carbon tetrachloride induced oxidative stress through regulation of endoplasmic reticulum stress markers and inflammatory mediators in Sprague-Dawley male rats.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 107

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Chromatography, High Pressure

2018
DGCR5 attenuates neuropathic pain through sponging miR-330-3p and regulating PDCD4 in CCI rat models.
    Journal of cellular physiology, 2019, Volume: 234, Issue:5

    Topics: Animals; Apoptosis Regulatory Proteins; Carbon Tetrachloride; Disease Models, Animal; Female; Gene E

2019
P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation.
    IUBMB life, 2019, Volume: 71, Issue:1

    Topics: Animals; Apoptosis; Artemether; Carbon Tetrachloride; Cell Death; Cell Proliferation; Disease Models

2019
Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.
    PloS one, 2018, Volume: 13, Issue:10

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Down-Regulation; Gene Expression Regulation;

2018
Protective effects of
    Drug and chemical toxicology, 2021, Volume: 44, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antimutagenic Agents; Bidens; Carbon Tetrachloride; Chemical and

2021
Effects of microRNA-217 on proliferation, apoptosis, and autophagy of hepatocytes in rat models of CCL4-induced liver injury by targeting NAT2.
    Journal of cellular physiology, 2019, Volume: 234, Issue:4

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Arylamine N-Acetyltransferase; Autophagosomes; Au

2019
Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin.
    International journal of pharmaceutics, 2019, Jan-30, Volume: 555

    Topics: Animals; Biological Availability; Carbon Tetrachloride; Chemistry, Pharmaceutical; Disease Models, A

2019
Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats.
    Life sciences, 2019, Jan-01, Volume: 216

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Therapy, Combination; Eugenol; Glutathio

2019
Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure.
    Stem cell research & therapy, 2018, 11-21, Volume: 9, Issue:1

    Topics: Amnion; Animals; Carbon Tetrachloride; Disease Models, Animal; Epithelial Cells; Hepatocytes; Hetero

2018
Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2019, Volume: 134

    Topics: Actins; Animals; Atorvastatin; Azepines; Carbon Tetrachloride; Chitosan; Disease Models, Animal; Dru

2019
Expression, purification, and evaluation of in vivo anti-fibrotic activity for soluble truncated TGF-β receptor II as a cleavable His-SUMO fusion protein.
    World journal of microbiology & biotechnology, 2018, Nov-24, Volume: 34, Issue:12

    Topics: Actins; Animals; Carbon Tetrachloride; Cloning, Molecular; Disease Models, Animal; Down-Regulation;

2018
    Klinichna khirurhiia, 2016, Issue:10

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expre

2016
Enhanced Regeneration and Hepatoprotective Effects of Interleukin 22 Fusion Protein on a Predamaged Liver Undergoing Partial Hepatectomy.
    Journal of immunology research, 2018, Volume: 2018

    Topics: Animals; Carbon Tetrachloride; Cell Survival; Chemical and Drug Induced Liver Injury; Concanavalin A

2018
Conversion of Fibroblasts to Hepatocyte-Like Cells In Vivo.
    Methods in molecular biology (Clifton, N.J.), 2019, Volume: 1905

    Topics: Animals; Carbon Tetrachloride; Cell Lineage; Cellular Reprogramming; Dependovirus; Disease Models, A

2019
Canine Liver Fibrosis Model to Assess the Functions of Infused Autologous Bone Marrow-Derived Cells.
    Methods in molecular biology (Clifton, N.J.), 2019, Volume: 1905

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cells, Cultured; Dise

2019
Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl
    Cell death & disease, 2018, 12-11, Volume: 9, Issue:12

    Topics: Adenoviridae; Animals; Bone Marrow Cells; Carbon Tetrachloride; Disease Models, Animal; Genetic Ther

2018
Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice.
    Molecular pharmaceutics, 2019, 01-07, Volume: 16, Issue:1

    Topics: Animals; Antioxidants; Brassica rapa; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury;

2019
Liver Macrophage Depletion Ameliorates The Effect of Mesenchymal Stem Cell Transplantation in a Murine Model of Injured Liver.
    Scientific reports, 2019, 01-10, Volume: 9, Issue:1

    Topics: Animals; Biometry; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Ani

2019
Muscle wasting and branched-chain amino acid, alpha-ketoglutarate, and ATP depletion in a rat model of liver cirrhosis.
    International journal of experimental pathology, 2018, Volume: 99, Issue:6

    Topics: Adenosine Triphosphate; Amino Acids, Branched-Chain; Animals; Body Weight; Carbon Tetrachloride; Dis

2018
Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells.
    Molecular immunology, 2019, Volume: 107

    Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Carbon Tetrachloride; Cell Cycle Proteins;

2019
Liver regeneration therapy through the hepatic artery-infusion of cultured bone marrow cells in a canine liver fibrosis model.
    PloS one, 2019, Volume: 14, Issue:1

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cells, Cultured; Dise

2019
SVIP alleviates CCl
    Cell death & disease, 2019, 01-25, Volume: 10, Issue:2

    Topics: Animals; Autophagy; Carbon Tetrachloride; Cell Survival; Disease Models, Animal; Hep G2 Cells; Hepat

2019
Matrine ameliorates anxiety and depression-like behaviour by targeting hyperammonemia-induced neuroinflammation and oxidative stress in CCl4 model of liver injury.
    Neurotoxicology, 2019, Volume: 72

    Topics: Alkaloids; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Apoptosis; Carbon Tetrachlo

2019
Tissue Repair in the Mouse Liver Following Acute Carbon Tetrachloride Depends on Injury-Induced Wnt/β-Catenin Signaling.
    Hepatology (Baltimore, Md.), 2019, Volume: 69, Issue:6

    Topics: Animals; Axin Protein; beta Catenin; Biopsy, Needle; Carbon Tetrachloride; Cells, Cultured; Disease

2019
Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex.
    Drug development and industrial pharmacy, 2019, Volume: 45, Issue:6

    Topics: Administration, Oral; Animals; Biological Availability; Carbon Tetrachloride; Chemical and Drug Indu

2019
Total flavonoids, extracted from Polygonum knotweed L, exert beneficial hepatoprotection against liver injury.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:8

    Topics: Adult; Aged; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemi

2019
p66Shc Contributes to Liver Fibrosis through the Regulation of Mitochondrial Reactive Oxygen Species.
    Theranostics, 2019, Volume: 9, Issue:5

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Gene Knockdown Techniques; H

2019
Human bone marrow-derived mesenchymal stromal cells in combination with silymarin regulate hepatocyte growth factor expression and genotoxicity in carbon tetrachloride induced hepatotoxicity in Wistar rats.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:8

    Topics: Animals; Bone Marrow Cells; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver I

2019
Interleukin-1 Receptor Antagonist Modulates Liver Inflammation and Fibrosis in Mice in a Model-Dependent Manner.
    International journal of molecular sciences, 2019, Mar-14, Volume: 20, Issue:6

    Topics: Actins; Animals; Carbon Tetrachloride; Cell Count; Cells, Cultured; Disease Models, Animal; Gene Exp

2019
d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis.
    IUBMB life, 2019, Volume: 71, Issue:9

    Topics: Actins; Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Carbon Tetrachloride; Cell P

2019
Overexpression of Tumor Necrosis Factor-Like Ligand 1 A in Myeloid Cells Aggravates Liver Fibrosis in Mice.
    Journal of immunology research, 2019, Volume: 2019

    Topics: Animals; Apoptosis; Becaplermin; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Fibr

2019
Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
    Antioxidants & redox signaling, 2019, 07-20, Volume: 31, Issue:3

    Topics: Animals; Binding Sites; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Down-Regulati

2019
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs.
    Nature biomedical engineering, 2018, Volume: 2, Issue:11

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Carbon Tetrachloride; Disease Models, Animal; Drug

2018
Mechanistic basis for impaired ferroptosis in cells expressing the African-centric S47 variant of p53.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 04-23, Volume: 116, Issue:17

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Coenzyme A; Disease Models, Animal; Ferroptosis; Hum

2019
Gexia-Zhuyu Decoction Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice Partly via Liver Angiogenesis Mediated by Myeloid Cells.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, Apr-17, Volume: 25

    Topics: Angiogenesis Inducing Agents; Animals; Bone Marrow Cells; Carbon Tetrachloride; Disease Models, Anim

2019
Animal models for hepatocellular carcinoma.
    Biochimica et biophysica acta. Molecular basis of disease, 2019, 05-01, Volume: 1865, Issue:5

    Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Disease Models, Animal; Gene Editing; Huma

2019
Inhibition of the mitochondrial complex-1 protects against carbon tetrachloride-induced acute liver injury.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 115

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Elect

2019
Gas Chromatography-Mass Spectrometry (GC-MS) Analysis of the Volatile Oil of Cichorium Glandulosum Boiss et Huet and its Effects on Carbon Tetrachloride-Induced Liver Fibrosis in Rats.
    Medical science monitor : international medical journal of experimental and clinical research, 2019, May-15, Volume: 25

    Topics: Animals; Carbon Tetrachloride; China; Cichorium intybus; Disease Models, Animal; Ethnicity; Female;

2019
TG101348, a selective JAK2 antagonist, ameliorates hepatic fibrogenesis
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:8

    Topics: 3T3 Cells; Animals; Carbon Tetrachloride; Cell Line, Tumor; Chemical and Drug Induced Liver Injury;

2019
Zerumbone Protects against Carbon Tetrachloride (CCl
    Molecules (Basel, Switzerland), 2019, May-22, Volume: 24, Issue:10

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases;

2019
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis.
    Cells, 2019, 05-24, Volume: 8, Issue:5

    Topics: Actins; Animals; Base Sequence; Carbon Tetrachloride; Cell Cycle Proteins; Cells, Cultured; Chemokin

2019
Combination of CCl
    American journal of physiology. Gastrointestinal and liver physiology, 2019, 08-01, Volume: 317, Issue:2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Fatty Liver; Fatty Liver, Alcoholic;

2019
Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers.
    Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:9

    Topics: Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Fibroblasts; Fibrosis; Hepatic Stel

2019
Hepatoprotective effect of ketoconazole in chronic liver injury model.
    Pakistan journal of pharmaceutical sciences, 2019, Volume: 32, Issue:3

    Topics: Actins; Animals; Carbon Tetrachloride; Cell Death; Chemical and Drug Induced Liver Injury; Disease M

2019
ALDH2 deficiency promotes alcohol-associated liver cancer by activating oncogenic pathways via oxidized DNA-enriched extracellular vesicles.
    Journal of hepatology, 2019, Volume: 71, Issue:5

    Topics: Adult; Alcohol Drinking; Alcoholism; Aldehyde Dehydrogenase, Mitochondrial; Animals; Carbon Tetrachl

2019
Resolution of Murine Toxic Hepatic Injury Quantified With Ultrasound Entropy Metrics.
    Ultrasound in medicine & biology, 2019, Volume: 45, Issue:10

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Entro

2019
A critical role of autophagy in regulating the mesenchymal transition of ductular cells in liver cirrhosis.
    Scientific reports, 2019, 07-23, Volume: 9, Issue:1

    Topics: 2-Acetylaminofluorene; Animals; Autophagy; Carbon Tetrachloride; Disease Models, Animal; Epithelial-

2019
Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy.
    European radiology, 2020, Volume: 30, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Elasticity Imaging Techniques; Humans; Liver;

2020
MSC-triggered metabolomic alterations in liver-resident immune cells isolated from CCl
    Experimental cell research, 2019, 10-15, Volume: 383, Issue:2

    Topics: Acute Lung Injury; Animals; Biomarkers; Carbon Tetrachloride; Cell Separation; Cells, Cultured; Chem

2019
Carbon tetrachloride-induced lipid peroxidation and hyperglycemia in rat: a novel study.
    Toxicology and industrial health, 2015, Volume: 31, Issue:6

    Topics: Amylases; Animals; Antioxidants; Asteraceae; Blood Glucose; Carbon Tetrachloride; Chemical and Drug

2015
Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: In vitro and in vivo studies.
    Journal of ethnopharmacology, 2013, Apr-19, Volume: 146, Issue:3

    Topics: Abelmoschus; Animals; Carbon Tetrachloride; Cell Survival; Cells, Cultured; Chemical and Drug Induce

2013
Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-κB pathway in activated stellate cells: in vivo and in vitro studies.
    Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:7

    Topics: Acetophenones; Animals; Apoptosis; Carbon Tetrachloride; Cell Cycle; Cell Proliferation; Cells, Cult

2013
Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis.
    The American journal of pathology, 2013, Volume: 182, Issue:5

    Topics: Actins; Animals; Bile Ducts; Carbon Tetrachloride; Collagen; Dependovirus; Disease Models, Animal; E

2013
Effect of sinapic acid against carbon tetrachloride-induced acute hepatic injury in rats.
    Archives of pharmacal research, 2013, Volume: 36, Issue:5

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Biphenyl Compounds; Blotting, Western; Body Weight

2013
Marrow-derived mesenchymal stem cells restore biochemical markers of acute liver injury in experimental model.
    Transplantation proceedings, 2013, Volume: 45, Issue:2

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Biomarkers; Bone M

2013
Hepatoprotection of 1β-hydroxyeuscaphic acid - the major constituent from Rubus aleaefolius against CCl4-induced injury in hepatocytes cells.
    Pharmaceutical biology, 2013, Volume: 51, Issue:6

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Line; Disease Models, Animal; Dose-Response Relations

2013
Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression.
    International journal of clinical and experimental pathology, 2013, Volume: 6, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cell Count; Chemokine CCL5; Cytokines; Disease Models, Animal; Liver;

2013
Effect of N-acetyl cysteine (NAC), an organosulfur compound from Allium plants, on experimentally induced hepatic prefibrogenic events in Wistar rat.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2013, Jul-15, Volume: 20, Issue:10

    Topics: Acetylcysteine; Allium; Animals; Carbon Tetrachloride; Disease Models, Animal; Liver Cirrhosis; Male

2013
Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4 -injured rat liver model via increased autophagic mechanism.
    Stem cells (Dayton, Ohio), 2013, Volume: 31, Issue:8

    Topics: Animals; Apoptosis; Autophagy; Carbon Tetrachloride; Cell Differentiation; Cell Growth Processes; Ch

2013
A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Clinical and experimental pharmacology & physiology, 2013, Volume: 40, Issue:7

    Topics: Alanine Transaminase; Animals; Apoptosis; Carbon Tetrachloride; Diet, High-Fat; Disease Models, Anim

2013
Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:4

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Disease Models, Animal; Hemodynamics; Ligation; Liver Cir

2013
Association of age-dependent liver injury and fibrosis with immune cell populations.
    Liver international : official journal of the International Association for the Study of the Liver, 2013, Volume: 33, Issue:8

    Topics: Age Factors; Aging; Alanine Transaminase; Animals; Carbon Tetrachloride; Chemical and Drug Induced L

2013
Jaggery protects hepatorenal injury induced by acute exposure to carbon tetrachloride in Wistar rats.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2013, Volume: 32, Issue:1

    Topics: Acute Kidney Injury; Adenosine Triphosphatases; Administration, Oral; Animals; Carbon Tetrachloride;

2013
Antioxidant, hepatoprotective and hypolipidemic effects of methanolic root extract of Cassia singueana in rats following acute and chronic carbon tetrachloride intoxication.
    Asian Pacific journal of tropical medicine, 2013, Volume: 6, Issue:8

    Topics: Alanine Transaminase; Animals; Antidotes; Antioxidants; Aspartate Aminotransferases; Bilirubin; Carb

2013
[Studying of hepatoprotective properties of dry extract from apricot leaves on the model of liver lesion by tetrachloromethane].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2013, Issue:3

    Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Catalase; Chemical and Drug Induced Liver Injur

2013
Autologous bone marrow stem cell transplantation attenuates hepatocyte apoptosis in a rat model of ex vivo liver resection and liver autotransplantation.
    The Journal of surgical research, 2013, Volume: 184, Issue:2

    Topics: Animals; Apoptosis; Bone Marrow Transplantation; Carbon Tetrachloride; Cells, Cultured; Disease Mode

2013
Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
    Journal of hepatology, 2013, Volume: 59, Issue:5

    Topics: Actins; Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Dise

2013
Molecular MRI of collagen to diagnose and stage liver fibrosis.
    Journal of hepatology, 2013, Volume: 59, Issue:5

    Topics: Animals; Carbon Tetrachloride; Collagen Type I; Disease Models, Animal; Disease Progression; Gadolin

2013
Role of activin A in carbon tetrachloride-induced acute liver injury.
    World journal of gastroenterology, 2013, Jun-28, Volume: 19, Issue:24

    Topics: Activins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical

2013
Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway.
    World journal of gastroenterology, 2013, Jun-28, Volume: 19, Issue:24

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Carbon Tetrachloride; Caspase

2013
Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced chronic injury in rats.
    Pharmaceutical biology, 2013, Volume: 51, Issue:10

    Topics: Alanine Transaminase; Animals; Aprotinin; Aspartate Aminotransferases; Carbon Tetrachloride; Chemica

2013
Protective effect of the herbal medicine Gan‑fu‑kang against carbon tetrachloride‑induced liver fibrosis in rats.
    Molecular medicine reports, 2013, Volume: 8, Issue:3

    Topics: Actins; Animals; beta Catenin; Biomarkers; Carbon Tetrachloride; Collagen Type I; Collagen Type III;

2013
Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury.
    Food chemistry, 2013, Dec-01, Volume: 141, Issue:3

    Topics: Acute Disease; Alanine Transaminase; Animals; Antrodia; Aspartate Aminotransferases; Carbon Tetrachl

2013
Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4

    Topics: Actins; Animals; Carbon Tetrachloride; Cells, Cultured; Desmin; Disease Models, Animal; Glial Fibril

2014
Hepatoprotective action of Orthosiphon diffusus (Benth.) methanol active fraction through antioxidant mechanisms: an in vivo and in vitro evaluation.
    Journal of ethnopharmacology, 2013, Oct-07, Volume: 149, Issue:3

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Cell Survival; Chemical and Drug Induced Liver Injury;

2013
[Protective effect of Tanreqing injection on acute hepatic injury induced by CCl4 in rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2013, Volume: 38, Issue:8

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug

2013
Efficacy of herbal coded Hepcon on drug induced hepatitis in experimental animals through histopathological and biochemical analysis.
    Pakistan journal of pharmaceutical sciences, 2013, Volume: 26, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Carbon Tetrachloride; Chemical and Dru

2013
Study of the hepatoprotective effect of Juniperus phoenicea constituents.
    Pakistan journal of pharmaceutical sciences, 2013, Volume: 26, Issue:5

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytoprotection; D

2013
A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury.
    Journal of hepatology, 2014, Volume: 60, Issue:2

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chemokine CXCL1; Disease Mode

2014
Two-stage model of chemically induced hepatocellular carcinoma in mouse.
    Oncology research, 2013, Volume: 20, Issue:11

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Carcinogenesis; Carcinoma, Hepatocellular; Cell Proliferat

2013
Effect of collagen I gel on apoptosis of rat hepatic stellate cells.
    Acta medica (Hradec Kralove), 2013, Volume: 56, Issue:2

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Culture Techniques; Collagen Type I; Cycloheximide; C

2013
Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:3

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Concanavalin A; Disease Model

2014
Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
    Cell biology international, 2014, Volume: 38, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Carbon Tetrachlori

2014
[Effect of shuganjianpifang on the expression of BCL-2 and BAX in rats livers with hepatic fibrosis].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2013, Volume: 36, Issue:5

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; bcl-2-Associated X Protein; C

2013
Protective effect of selected calcium channel blockers and prednisolone, a phospholipase-A2 inhibitor, against gentamicin and carbon tetrachloride-induced nephrotoxicity.
    Human & experimental toxicology, 2014, Volume: 33, Issue:8

    Topics: Animals; Antioxidants; Biomarkers; Calcium Channel Blockers; Carbon Tetrachloride; Cytoprotection; D

2014
Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.
    International journal of cancer, 2014, Jun-15, Volume: 134, Issue:12

    Topics: Animals; beta Catenin; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Transformation, Neoplas

2014
Differential effects of sorafenib on liver versus tumor fibrosis mediated by stromal-derived factor 1 alpha/C-X-C receptor type 4 axis and myeloid differentiation antigen-positive myeloid cell infiltration in mice.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4

    Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; CD11b Antigen; Cell Line, Tumor; Cell Move

2014
Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.
    Nature, 2014, Jan-02, Volume: 505, Issue:7481

    Topics: Acute Disease; Animals; Bile Ducts; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Ch

2014
Microbiome composition by pyrosequencing in mesenteric lymph nodes of rats with CCl4-induced cirrhosis.
    Journal of innate immunity, 2014, Volume: 6, Issue:3

    Topics: Animals; Bifidobacterium; Biodiversity; Carbon Tetrachloride; Cells, Cultured; Disease Models, Anima

2014
The effects of L-carnitine and N-acetylcysteine on carbontetrachloride induced acute liver damage in rats.
    Bratislavske lekarske listy, 2013, Volume: 114, Issue:12

    Topics: Acetylcysteine; Animals; Carbon Tetrachloride; Carnitine; Chemical and Drug Induced Liver Injury; Di

2013
A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse.
    Journal of hepatology, 2014, Volume: 60, Issue:4

    Topics: Animals; Calgranulin A; Calgranulin B; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury;

2014
Toll-like receptor 7-mediated type I interferon signaling prevents cholestasis- and hepatotoxin-induced liver fibrosis.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:1

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cholestasis; Chronic Disease;

2014
Protective effects of Ephedra pachyclada extract on mouse models of carbon tetrachloride- induced chronic and acute liver failure.
    Tissue & cell, 2014, Volume: 46, Issue:1

    Topics: Acute Disease; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Che

2014
Alteration of the microRNA-122 regulatory network in rat models of hepatotoxicity.
    Environmental toxicology and pharmacology, 2014, Volume: 37, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cationic Amino Acid Transporter 1; CCAAT-Enhancer-Binding Protein-alp

2014
[Effect of Panax notoginseng saponins on cytokines in liver fibrosis rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2013, Volume: 36, Issue:7

    Topics: Animals; Carbon Tetrachloride; Colchicine; Cytokines; Disease Models, Animal; Gene Expression Regula

2013
[Study on the liver-protective and choleretic effect of zhizi baipi soup and its disassembled prescription].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2013, Volume: 36, Issue:7

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile; Bilirubin; Carbon Tetrachloride; C

2013
[Protective effect of purple sweet potato flavonoids on CCL4-induced acute liver injury in mice].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2013, Volume: 42, Issue:6

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Flavo

2013
Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt.
    World journal of gastroenterology, 2013, Volume: 19, Issue:43

    Topics: Adenoviridae; Animals; Apoptosis; Apoptosis Regulatory Proteins; Carbon Tetrachloride; Disease Model

2013
Protective effects of melatonin and quercetin on experimental lung injury induced by carbon tetrachloride in rats.
    Experimental lung research, 2014, Volume: 40, Issue:2

    Topics: Acute Lung Injury; Animals; Antioxidants; Carbon Tetrachloride; Catalase; Disease Models, Animal; Fe

2014
Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:1

    Topics: Age Factors; Animals; Basic Helix-Loop-Helix Transcription Factors; Carbon Tetrachloride; Cell Diffe

2014
CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.
    Gut, 2014, Volume: 63, Issue:12

    Topics: Animals; Aptamers, Nucleotide; Carbon Tetrachloride; Chemokine CCL2; Disease Models, Animal; Disease

2014
A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease.
    Journal of hepatology, 2014, Volume: 60, Issue:6

    Topics: Adenosine Triphosphate; Amino Acids; Animals; Anticonvulsants; Carbon Tetrachloride; Chemical and Dr

2014
Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:1

    Topics: Angiotensin II; Animals; Bile Ducts; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; D

2014
Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
    Hepatology (Baltimore, Md.), 2014, Volume: 59, Issue:4

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Proliferation; Cells, Cul

2014
FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells.
    Inflammation, 2014, Volume: 37, Issue:4

    Topics: Animals; Bone Marrow Cells; Carbon Tetrachloride; Cell Movement; Disease Models, Animal; Fibrosis; F

2014
The biliary epithelium gives rise to liver progenitor cells.
    Hepatology (Baltimore, Md.), 2014, Volume: 60, Issue:4

    Topics: Acetaminophen; Animals; Bile Ducts; Carbon Tetrachloride; Cell Differentiation; Cell Lineage; Cells,

2014
High-mobility group box 1 exacerbates CCl₄-induced acute liver injury in mice.
    Clinical immunology (Orlando, Fla.), 2014, Volume: 153, Issue:1

    Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Carbon Tetrachloride; Chemical and Drug Induc

2014
VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:3

    Topics: Animals; Ascites; Bacterial Translocation; Carbon Tetrachloride; Disease Models, Animal; Intestinal

2015
Pathological changes in pulmonary circulation in carbon tetrachloride (CCl4)-induced cirrhotic mice.
    PloS one, 2014, Volume: 9, Issue:4

    Topics: Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Fatty Acids, Unsaturated; Hydroxy A

2014
Effects of fish oil on cell proliferation and liver injury in an experimental model of acute hepatic injury induced by carbon tetrachloride.
    Bratislavske lekarske listy, 2014, Volume: 115, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cell Cycle; Cell Proliferation; Chemical and Drug Induced Liver Injur

2014
Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis.
    Molecular medicine reports, 2014, Volume: 10, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Carbon

2014
MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    The Journal of pathology, 2014, Volume: 234, Issue:1

    Topics: Animals; Base Sequence; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Gene Expressi

2014
Determination of DNA damage in experimental liver intoxication and role of N-acetyl cysteine.
    Cell biochemistry and biophysics, 2014, Volume: 70, Issue:2

    Topics: Acetylation; Acetylcysteine; Animals; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liv

2014
Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Life sciences, 2014, Jul-17, Volume: 108, Issue:2

    Topics: Actins; Animals; Benzopyrans; Butyrates; Carbon Tetrachloride; Cell Line; Collagen Type I; Disease M

2014
The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
    Life sciences, 2014, Jul-17, Volume: 108, Issue:2

    Topics: Analysis of Variance; Animals; Carbon Tetrachloride; Contrast Media; Disease Models, Animal; Gadolin

2014
Fast food diet with CCl4 micro-dose induced hepatic-fibrosis--a novel animal model.
    BMC gastroenterology, 2014, May-10, Volume: 14

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Fast Foods; Female; Gene Expression Profiling

2014
Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models.
    Stem cell research & therapy, 2014, Jun-10, Volume: 5, Issue:3

    Topics: Acetaminophen; Animals; Blotting, Western; Carbon Tetrachloride; Cell Proliferation; Chemical and Dr

2014
The effects of grape seed and colchicine on carbon tetrachloride induced hepatic damage in rats.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2014, Volume: 66, Issue:8

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Colchicine; Dis

2014
The protective effect of Phoenix dactylifera L. seeds against CCl4-induced hepatotoxicity in rats.
    Journal of ethnopharmacology, 2014, Aug-08, Volume: 155, Issue:1

    Topics: Administration, Oral; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver I

2014
Effect of experimentally induced hepatic and renal failure on the pharmacokinetics of topiramate in rats.
    BioMed research international, 2014, Volume: 2014

    Topics: Animals; Anti-Obesity Agents; Antineoplastic Agents; Carbon Tetrachloride; Carbon Tetrachloride Pois

2014
Therapeutic potential of amniotic-fluid-derived stem cells on liver fibrosis model in mice.
    Taiwanese journal of obstetrics & gynecology, 2014, Volume: 53, Issue:2

    Topics: Alanine Transaminase; Amniotic Fluid; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Di

2014
Liver X receptor α (LXRα/NR1H3) regulates differentiation of hepatocyte-like cells via reciprocal regulation of HNF4α.
    Journal of hepatology, 2014, Volume: 61, Issue:6

    Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Cell Line; Cell Transplantation; Disease Models

2014
Origin of myofibroblasts in the fibrotic liver in mice.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Aug-12, Volume: 111, Issue:32

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cholestasis; Collagen Type I;

2014
[Metabonomic study on protective effect of xiaoyao powder for acute hepatic injury in rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2014, Volume: 37, Issue:2

    Topics: Amino Acids; Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dise

2014
Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.
    The American journal of pathology, 2014, Volume: 184, Issue:10

    Topics: Animals; Carbon Tetrachloride; Chronic Disease; Collagen Type I; Connective Tissue Growth Factor; Di

2014
BMP-7 attenuates liver fibrosis via regulation of epidermal growth factor receptor.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:7

    Topics: Animals; Blotting, Western; Bone Morphogenetic Protein 7; Carbon Tetrachloride; Disease Models, Anim

2014
Ischemic preconditioning affects long-term cell fate through DNA damage-related molecular signaling and altered proliferation.
    The American journal of pathology, 2014, Volume: 184, Issue:10

    Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Dipeptidyl Peptidase 4; Disease Models, Animal; D

2014
Prevention of carbon tetrachloride (CCl4)-induced toxicity in testes of rats treated with Physalis peruviana L. fruit.
    Toxicology and industrial health, 2016, Volume: 32, Issue:6

    Topics: Animals; Carbon Tetrachloride; Caspase 3; Catalase; Disease Models, Animal; Fruit; Fruit and Vegetab

2016
The DEN and CCl4 -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
    Current protocols in pharmacology, 2014, Sep-02, Volume: 66

    Topics: Animals; Carbon Tetrachloride; Carcinogens; Carcinoma, Hepatocellular; Chemical and Drug Induced Liv

2014
Hesperidin prevents liver fibrosis in rats by decreasing the expression of nuclear factor-κB, transforming growth factor-β and connective tissue growth factor.
    Pharmacology, 2014, Volume: 94, Issue:1-2

    Topics: Animals; Antioxidants; Blotting, Western; Carbon Tetrachloride; Connective Tissue Growth Factor; Dis

2014
Hepatoprotective and antioxidant activity of Melaleuca styphelioides on carbon tetrachloride-induced hepatotoxicity in mice.
    Pharmaceutical biology, 2014, Volume: 52, Issue:12

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Dru

2014
Prevention of liver fibrosis by intrasplenic injection of high-density cultured bone marrow cells in a rat chronic liver injury model.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Animals; Blood Vessels; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cell C

2014
Hepato- and nephroprotective activities of a Nigerian local king tuber oyster mushroom, Pleurotus tuberregium (higher Basidiomycetes), in chemically induced organ toxicities in rats.
    International journal of medicinal mushrooms, 2014, Volume: 16, Issue:4

    Topics: Acetaminophen; Animals; Anti-Bacterial Agents; Carbon Tetrachloride; Complex Mixtures; Disease Model

2014
Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice.
    PloS one, 2014, Volume: 9, Issue:10

    Topics: Actins; Adiponectin; AMP-Activated Protein Kinases; Animals; Carbon Tetrachloride; Collagen; Disease

2014
In vitro antioxidant and in vivo hepatoprotective activity of leave extract of Raphanus sativus in rats using CCL4 model.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2014, Volume: 11, Issue:3

    Topics: Alanine Transaminase; Aldehydes; Animals; Antioxidants; Aspartate Aminotransferases; Carbon Tetrachl

2014
Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice.
    Mediators of inflammation, 2014, Volume: 2014

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Col

2014
Carbon tetrachloride-induced kidney damage and protective effect of Amaranthus lividus L. in rats.
    Toxicology and industrial health, 2016, Volume: 32, Issue:6

    Topics: Amaranthus; Animals; Antioxidants; Carbon Tetrachloride; Catalase; Disease Models, Animal; Glutathio

2016
Association between paraoxonases gene expression and oxidative stress in hepatotoxicity induced by CCl4.
    Oxidative medicine and cellular longevity, 2014, Volume: 2014

    Topics: Animals; Aryldialkylphosphatase; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical and

2014
Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:8

    Topics: Adaptor Proteins, Signal Transducing; Analysis of Variance; Animals; Carbon Tetrachloride; Cell Move

2015
Portal blood arterialization with an extracorporeal device to treat toxic acute hepatic failure in a swine model.
    The International journal of artificial organs, 2014, Volume: 37, Issue:11

    Topics: Animals; Biomarkers; Biopsy; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease M

2014
Pharmacological Potential of Tetrahydrofurano/Pyrano Quinoline and Benzo[b]furoindolyl Derivatives in Acute Inflammation, Pain and Oxidative Stress.
    Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2015, Volume: 13, Issue:3

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Benzofurans; Carbon Tetrachloride; Carr

2015
Systemic treatment of acute liver failure with adipose derived stem cells.
    Journal of investigative surgery : the official journal of the Academy of Surgical Research, 2015, Volume: 28, Issue:2

    Topics: Adipose Tissue; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Ce

2015
Role of Fn14 in acute alcoholic steatohepatitis in mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2015, Feb-15, Volume: 308, Issue:4

    Topics: Acute Disease; Animals; Apoptosis; Carbon Tetrachloride; Cell Proliferation; Disease Models, Animal;

2015
Mesenteric and splenic contributions to portal venous CT perfusion in hepatic diffuse disease.
    International journal of clinical and experimental pathology, 2014, Volume: 7, Issue:11

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Dogs; Hepatitis, Animal; Liver Cirrhosis; Mes

2014
Caspase-12 mediates carbon tetrachloride-induced hepatocyte apoptosis in mice.
    World journal of gastroenterology, 2014, Dec-28, Volume: 20, Issue:48

    Topics: Animals; Apoptosis; Biomarkers; Carbon Tetrachloride; Caspase 12; Caspase 3; Caspase 9; Chemical and

2014
Histamine restores biliary mass following carbon tetrachloride-induced damage in a cholestatic rat model.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:3

    Topics: Animals; Apoptosis; Bile Ducts; Bile Ducts, Intrahepatic; Carbon Tetrachloride; Cell Proliferation;

2015
Mouse models of liver cancer.
    Methods in molecular biology (Clifton, N.J.), 2015, Volume: 1267

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4;

2015
Evaluation of the effectiveness of Piper cubeba extract in the amelioration of CCl4-induced liver injuries and oxidative damage in the rodent model.
    BioMed research international, 2015, Volume: 2015

    Topics: Animals; Antioxidants; Biphenyl Compounds; Carbon Tetrachloride; Catalase; Chemical and Drug Induced

2015
Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis.
    European journal of nutrition, 2016, Volume: 55, Issue:1

    Topics: Animals; Bifidobacterium; Carbon Tetrachloride; Disease Models, Animal; Female; Gastrointestinal Mic

2016
Inhibitory effect of dietary capsaicin on liver fibrosis in mice.
    Molecular nutrition & food research, 2015, Volume: 59, Issue:6

    Topics: Animals; Bile Ducts; Capsaicin; Carbon Tetrachloride; Cholestasis; Diet; Disease Models, Animal; Dow

2015
Hyperbaric oxygen treatment at various stages following chronic constriction injury produces different antinociceptive effects via regulation of P2X4R expression and apoptosis.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Analgesics; Animals; Apoptosis; Behavior, Animal; Carbon Tetrachloride; Caspase 3; Constriction; Dis

2015
The carbon tetrachloride model in mice.
    Laboratory animals, 2015, Volume: 49, Issue:1 Suppl

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; European Union; Guidelines as Topic; Humans;

2015
Optical diagnosis of the progression and reversal of CCl4-induced liver injury in rodent model using minimally invasive autofluorescence spectroscopy.
    The Analyst, 2015, Jun-07, Volume: 140, Issue:11

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disea

2015
Antioxidant and hepatoprotective activities of the oil fractions from wild carrot (Daucus carota ssp. carota).
    Pharmaceutical biology, 2015, Volume: 53, Issue:9

    Topics: Animals; Antioxidants; Biomarkers; Biphenyl Compounds; Carbon Tetrachloride; Chemical and Drug Induc

2015
Secreted IL-1α promotes T-cell activation and expansion of CD11b(+) Gr1(+) cells in carbon tetrachloride-induced liver injury in mice.
    European journal of immunology, 2015, Volume: 45, Issue:7

    Topics: Animals; Carbon Tetrachloride; CD11b Antigen; Chemical and Drug Induced Liver Injury; Disease Models

2015
Effect of CCl4 and blocking H2S biosynthesis on oesophageal mucosa rats: model of nonerosive oesophagitis.
    Folia medica Cracoviensia, 2014, Volume: 54, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Disease Models, Animal; Enzy

2014
Hepatocyte-specific Bid depletion reduces tumor development by suppressing inflammation-related compensatory proliferation.
    Cell death and differentiation, 2015, Volume: 22, Issue:12

    Topics: Animals; BH3 Interacting Domain Death Agonist Protein; Carbon Tetrachloride; Cell Proliferation; Cel

2015
[Protective effects and possible mechanisms of hepatic fibrosis against APAP-induced lethal injury].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2015, Volume: 23, Issue:3

    Topics: Acetaminophen; Alanine Transaminase; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver

2015
Deceleration of liver regeneration by knockdown of augmenter of liver regeneration gene is associated with impairment of mitochondrial DNA synthesis in mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2015, Jul-15, Volume: 309, Issue:2

    Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Chemical and Drug Induced Liver Injury; Disease M

2015
Carbon tetrachloride-induced liver injury in mice is tissue factor dependent.
    Environmental toxicology and pharmacology, 2015, Volume: 39, Issue:3

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; DNA,

2015
Phycocyanobilin accelerates liver regeneration and reduces mortality rate in carbon tetrachloride-induced liver injury mice.
    World journal of gastroenterology, 2015, May-14, Volume: 21, Issue:18

    Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Biomarkers; Carbon Tetrachloride; Cell Proliferation;

2015
Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.
    World journal of gastroenterology, 2015, May-14, Volume: 21, Issue:18

    Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Carbon Tetrachloride; Caspase Inhibitors; Cell Prolif

2015
Bile duct-ligated mice exhibit multiple phenotypic similarities to acute decompensation patients despite histological differences.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:6

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Cholestasis; Disease Models, Animal; Humans; Ligation; Li

2016
Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Alcohol Dehydrogenase; Animals; Apoptosis; Bile Ducts; Carbon Tetrachloride; Disease Models, Animal;

2015
Effects of polysaccharides from selenium-enriched Pyracantha fortuneana on mice liver injury.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2015, Volume: 11, Issue:8

    Topics: Animals; Biphenyl Compounds; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease M

2015
Comparison of TGF-β, PDGF, and CTGF in hepatic fibrosis models using DMN, CCl4, and TAA.
    Drug and chemical toxicology, 2016, Volume: 39, Issue:1

    Topics: Animals; Carbon Tetrachloride; Connective Tissue Growth Factor; Dimethylnitrosamine; Disease Models,

2016
Macrophage autophagy protects against liver fibrosis in mice.
    Autophagy, 2015, Volume: 11, Issue:8

    Topics: Animals; Autophagy; Autophagy-Related Protein 5; Carbon Tetrachloride; Cell Lineage; Culture Media,

2015
Cyanidin-3-O-β-glucoside Purified from Black Rice Protects Mice against Hepatic Fibrosis Induced by Carbon Tetrachloride via Inhibiting Hepatic Stellate Cell Activation.
    Journal of agricultural and food chemistry, 2015, Jul-15, Volume: 63, Issue:27

    Topics: Animals; Anthocyanins; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Glucosides; Hepatic

2015
Anti-oxidative and hepatoprotective effects of lithospermic acid against carbon tetrachloride-induced liver oxidative damage in vitro and in vivo.
    Oncology reports, 2015, Volume: 34, Issue:2

    Topics: Animals; Antioxidants; Benzofurans; Carbon Tetrachloride; Cell Line; Depsides; Disease Models, Anima

2015
Useful properties of undifferentiated mesenchymal stromal cells and adipose tissue as the source in liver-regenerative therapy studied in an animal model of severe acute fulminant hepatitis.
    Cytotherapy, 2015, Volume: 17, Issue:8

    Topics: Adipose Tissue; Animals; Biomarkers; Bone Marrow Cells; Carbon Tetrachloride; Cell Differentiation;

2015
Effects of Pistacia Atlantica Extract on Erythrocyte Membrane Rigidity, Oxidative Stress, and Hepatotoxicity Induced by CCl4 in Rats.
    Global journal of health science, 2015, Mar-26, Volume: 7, Issue:7 Spec No

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Catalase; Chemical and Drug Induced Liver Injury; Disea

2015
Geranylgeranylacetone attenuates hepatic fibrosis by increasing the expression of heat shock protein 70.
    Molecular medicine reports, 2015, Volume: 12, Issue:4

    Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbon Tetrachloride;

2015
Sesamin ameliorates oxidative liver injury induced by carbon tetrachloride in rat.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:5

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dioxoles; Disea

2015
Human recombinant endostatin Endostar attenuates hepatic sinusoidal endothelial cell capillarization in CCl4‑induced fibrosis in mice.
    Molecular medicine reports, 2015, Volume: 12, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dise

2015
N-acetylcysteine protects against liver injure induced by carbon tetrachloride via activation of the Nrf2/HO-1 pathway.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:7

    Topics: Acetylcysteine; Animals; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced L

2015
The role of CYP2A5 in liver injury and fibrosis: chemical-specific difference.
    Naunyn-Schmiedeberg's archives of pharmacology, 2016, Volume: 389, Issue:1

    Topics: Alanine Transaminase; Animals; Aryl Hydrocarbon Hydroxylases; Aspartate Aminotransferases; Carbon Te

2016
Effect of flavonoid compounds extracted from Iris species in prevention of carbon tetrachloride-induced liver fibrosis in rats.
    Genetics and molecular research : GMR, 2015, Sep-21, Volume: 14, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Flavonoids; Iris Plant; Liver; Liver Cirrhosi

2015
Abnormal Expression of Urea Transporter Protein in a Rat Model of Hepatorenal Syndrome Induced by Succinylated Gelatin.
    Medical science monitor : international medical journal of experimental and clinical research, 2015, Sep-28, Volume: 21

    Topics: Animals; Blood Urea Nitrogen; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease

2015
Hepatoprotective effect of cold-pressed Syzygium aromaticum oil against carbon tetrachloride (CCl4)-induced hepatotoxicity in rats.
    Pharmaceutical biology, 2016, Volume: 54, Issue:8

    Topics: Animals; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyt

2016
Hepatoprotective effects of polysaccharide isolated from Agaricus bisporus industrial wastewater against CCl₄-induced hepatic injury in mice.
    International journal of biological macromolecules, 2016, Volume: 82

    Topics: Agaricus; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical

2016
Transplantation of mesenchymal stem cells expressing TIMP-1-shRNA improves hepatic fibrosis in CCl₄-treated rats.
    International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:8

    Topics: Animals; Blotting, Western; Carbon Tetrachloride; Disease Models, Animal; Genetic Therapy; Genetic V

2015
Protective effects of extracts from Pomegranate peels and seeds on liver fibrosis induced by carbon tetrachloride in rats.
    BMC complementary and alternative medicine, 2015, Oct-27, Volume: 15

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis; Liver Fun

2015
Protective Effect of Zingiber Officinale against CCl4-Induced Liver Fibrosis Is Mediated through Downregulating the TGF-β1/Smad3 and NF-ĸB/IĸB Pathways.
    Pharmacology, 2016, Volume: 97, Issue:1-2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regula

2016
A model of acute kidney injury in mice with cirrhosis and infection.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:6

    Topics: Acute Kidney Injury; Animals; Carbon Tetrachloride; Creatinine; Disease Models, Animal; Echocardiogr

2016
Autophagy-deficiency in hepatic progenitor cells leads to the defects of stemness and enhances susceptibility to neoplastic transformation.
    Cancer letters, 2016, Feb-01, Volume: 371, Issue:1

    Topics: Animals; Autophagy; Autophagy-Related Protein 5; Autophagy-Related Protein 7; Carbon Tetrachloride;

2016
Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
    Scientific reports, 2015, Dec-08, Volume: 5

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Movement; Chemok

2015
Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
    Gastroenterology, 2016, Volume: 150, Issue:4

    Topics: Acetaminophen; AMP-Activated Protein Kinases; Animals; Carbon Tetrachloride; Case-Control Studies; C

2016
Involvement of fibroblast-specific protein 1 (S100A4) and matrix metalloproteinase-13 (MMP-13) in CCl4-induced reversible liver fibrosis.
    Gene, 2016, Mar-15, Volume: 579, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Gene Expression Regulation; Liver; Liver Cirr

2016
Hepatoprotective effect of trimethylgallic acid esters against carbon tetrachloride-induced liver injury in rats.
    Indian journal of experimental biology, 2015, Volume: 53, Issue:12

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemical and Drug

2015
Resveratrol can prevent CCl₄-induced liver injury by inhibiting Notch signaling pathway.
    Histology and histopathology, 2016, Volume: 31, Issue:7

    Topics: Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dise

2016
D-Pinitol Protects Against Carbon Tetrachloride-Induced Hepatotoxicity in Rats.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2015, Volume: 34, Issue:4

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models,

2015
The effects of Tao-Hong-Si-Wu on hepatic necroinflammatory activity and fibrosis in a murine model of chronic liver disease.
    Journal of ethnopharmacology, 2016, Mar-02, Volume: 180

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dis

2016
Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background.
    BMC gastroenterology, 2016, 01-29, Volume: 16

    Topics: Animals; Carbon Tetrachloride; Carcinogenesis; Carcinoma, Hepatocellular; Disease Models, Animal; Ge

2016
Hepatic IGF-1R overexpression combined with the activation of GSK-3β and FOXO3a in the development of liver cirrhosis.
    Life sciences, 2016, Feb-15, Volume: 147

    Topics: Aged; Animals; Carbon Tetrachloride; Case-Control Studies; Disease Models, Animal; Enzyme-Linked Imm

2016
Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2.
    Journal of immunotoxicology, 2016, Volume: 13, Issue:4

    Topics: Alanine; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Carbo

2016
Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl₄-Induced Skeletal Muscle Injury.
    International journal of molecular sciences, 2016, Feb-08, Volume: 17, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biomarkers; Carbon Tetrachloride; Disease Models,

2016
Melatonin enhances mitophagy and mitochondrial biogenesis in rats with carbon tetrachloride-induced liver fibrosis.
    Journal of pineal research, 2016, Volume: 60, Issue:4

    Topics: Animals; Antioxidants; Blotting, Western; Carbon Tetrachloride; Disease Models, Animal; Liver Cirrho

2016
Autophagy-Modulated Human Bone Marrow-Derived Mesenchymal Stem Cells Accelerate Liver Restoration in Mouse Models of Acute Liver Failure.
    Iranian biomedical journal, 2016, Volume: 20, Issue:3

    Topics: Animals; Autophagy; Autophagy-Related Protein 7; Bone Marrow Cells; Carbon Tetrachloride; Cell Diffe

2016
Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Animals; Carbon Tetrachloride; Cell Death; Cell Proliferation; Chemokine CCL2; Chemokine CCL5; Chole

2016
4-Phenylbutyric acid regulates CCl4-induced acute hepatic dyslipidemia in a mouse model: A mechanism-based PK/PD study.
    European journal of pharmacology, 2016, Apr-15, Volume: 777

    Topics: Animals; Apolipoproteins B; Carbon Tetrachloride; Cytochrome P-450 CYP2E1; Disease Models, Animal; D

2016
Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Aminoquinolines; Animals; Benzimidazoles; Bleomycin; Butylamines; Carbon Tetrachloride; Chemokine CX

2016
The Effect of rhCygb on CCl4-Induced Hepatic Fibrogenesis in Rat.
    Scientific reports, 2016, Mar-23, Volume: 6

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Cytogl

2016
Molecular magnetic resonance imaging of activated hepatic stellate cells with ultrasmall superparamagnetic iron oxide targeting integrin αvβ₃ for staging liver fibrosis in rat model.
    International journal of nanomedicine, 2016, Volume: 11

    Topics: Animals; Carbon Tetrachloride; Dextrans; Disease Models, Animal; Hepatic Stellate Cells; Integrin al

2016
MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 38, Issue:4

    Topics: Actins; Animals; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Collagen Type I; Disease

2016
Protective effects of L-carnosine on CCl4 -induced hepatic injury in rats.
    European cytokine network, 2016, Mar-01, Volume: 27, Issue:1

    Topics: Actins; Animals; Biomarkers; Carbon Tetrachloride; Carnosine; Chemical and Drug Induced Liver Injury

2016
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.
    Molecular pharmaceutics, 2016, 07-05, Volume: 13, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Benzylamines; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cyc

2016
Metabolic Profile Changes of CCl₄-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule.
    Molecules (Basel, Switzerland), 2016, May-30, Volume: 21, Issue:6

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Chromatography, Liquid; Disease Models, Animal; Drugs, Ch

2016
Effects of platelet-rich plasma on liver regeneration in CCl
    Platelets, 2016, Volume: 27, Issue:8

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Connective Tissue; Disease Mo

2016
Macrophage Migration Inhibitor Factor Upregulates MCP-1 Expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury.
    Scientific reports, 2016, 06-08, Volume: 6

    Topics: Animals; Autocrine Communication; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver

2016
Vesicular (liposomal and nanoparticulated) delivery of curcumin: a comparative study on carbon tetrachloride-mediated oxidative hepatocellular damage in rat model.
    International journal of nanomedicine, 2016, Volume: 11

    Topics: Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Curc

2016
Multifaceted Therapeutic Benefits of Factors Derived From Dental Pulp Stem Cells for Mouse Liver Fibrosis.
    Stem cells translational medicine, 2016, Volume: 5, Issue:10

    Topics: Animals; Carbon Tetrachloride; Culture Media, Conditioned; Dental Pulp; Disease Models, Animal; Fema

2016
Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance.
    Molecular medicine reports, 2016, Volume: 14, Issue:2

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Cell Communication; Coculture Techniques; Cytokines; Dise

2016
Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    International journal of molecular sciences, 2016, Jul-13, Volume: 17, Issue:7

    Topics: Animals; Blotting, Western; Carbon Tetrachloride; Carrier Proteins; Cholesterol; Disease Models, Ani

2016
Pharmacological safety evaluation of a traditional herbal medicine "Zereshk-e-Saghir" and assessment of its hepatoprotective effects on carbon tetrachloride induced hepatic damage in rats.
    Journal of ethnopharmacology, 2016, Aug-22, Volume: 190

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Berb

2016
Curcumin protects against liver fibrosis by attenuating infiltration of Gr1hi monocytes through inhibition of monocyte chemoattractant protein-1.
    Discovery medicine, 2016, Volume: 21, Issue:118

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Ly; Carbon Tetrachloride; Chemokine CCL2

2016
MiR-29a Assists in Preventing the Activation of Human Stellate Cells and Promotes Recovery From Liver Fibrosis in Mice.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2016, Volume: 24, Issue:10

    Topics: Animals; Carbon Tetrachloride; Cell Line; Cell Survival; Collagen; Collagen Type I; Collagen Type I,

2016
Haloalkane induced hepatic insult in murine model: amelioration by Oleander through antioxidant and anti-inflammatory activities, an in vitro and in vivo study.
    BMC complementary and alternative medicine, 2016, Aug-11, Volume: 16, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Carbon Tetrachloride; Cell Survival; C

2016
Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition.
    Gut and liver, 2017, Jan-15, Volume: 11, Issue:1

    Topics: Actins; Animals; Antigens, CD; Blotting, Western; Cadherins; Carbon Tetrachloride; Cdh1 Proteins; Ce

2017
Gadoxetate-enhanced MR imaging and compartmental modelling to assess hepatocyte bidirectional transport function in rats with advanced liver fibrosis.
    European radiology, 2017, Volume: 27, Issue:5

    Topics: Animals; Bile Ducts, Intrahepatic; Biomarkers; Carbon Tetrachloride; Case-Control Studies; Contrast

2017
Collagen-binding vascular endothelial growth factor attenuates CCl4-induced liver fibrosis in mice.
    Molecular medicine reports, 2016, Volume: 14, Issue:5

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Collagen; Disease Models, Animal; Hepatic Stellate Cells;

2016
Deficiency of DJ-1 Ameliorates Liver Fibrosis through Inhibition of Hepatic ROS Production and Inflammation.
    International journal of biological sciences, 2016, Volume: 12, Issue:10

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hepat

2016
mTOR Overactivation in Mesenchymal cells Aggravates CCl
    Scientific reports, 2016, 11-07, Volume: 6

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Gene Deletion; Liver; Liver Cirrhosis; Mice;

2016
Cystathionine γ-Lyase Deficiency Exacerbates CCl
    Antioxidants & redox signaling, 2017, Jul-20, Volume: 27, Issue:3

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug

2017
miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis.
    Scientific reports, 2016, 11-23, Volume: 6

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Gene Expression Regulation; Hepatocytes; Huma

2016
The chronic hepatotoxicity assessment of the herbal formula Zishen Yutai pill.
    Regulatory toxicology and pharmacology : RTP, 2017, Volume: 83

    Topics: Administration, Oral; Alanine Transaminase; Animals; Biomarkers; Body Weight; Carbon Tetrachloride;

2017
Automated evaluation of liver fibrosis in thioacetamide, carbon tetrachloride, and bile duct ligation rodent models using second-harmonic generation/two-photon excited fluorescence microscopy.
    Laboratory investigation; a journal of technical methods and pathology, 2017, Volume: 97, Issue:1

    Topics: Animals; Automation, Laboratory; Bile Ducts; Carbon Tetrachloride; Disease Models, Animal; Hydroxypr

2017
Evaluation of antioxidant and hepatoprotective effects of white cabbage essential oil.
    Pharmaceutical biology, 2017, Volume: 55, Issue:1

    Topics: Allyl Compounds; Animals; Antioxidants; Brain; Brassica; Carbon Tetrachloride; Chemical and Drug Ind

2017
Polyphenols from Lonicera caerulea L. berry attenuate experimental nonalcoholic steatohepatitis by inhibiting proinflammatory cytokines productions and lipid peroxidation.
    Molecular nutrition & food research, 2017, Volume: 61, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Fruit; Heme Oxygenase-1; Interleuk

2017
Mesenchymal Stem Cells with Enhanced Bcl-2 Expression Promote Liver Recovery in a Rat Model of Hepatic Cirrhosis.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2016, Volume: 40, Issue:5

    Topics: Animals; Antigens; Biomarkers; Carbon Tetrachloride; Cell Shape; Disease Models, Animal; Gene Expres

2016
The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice.
    Molecular nutrition & food research, 2017, Volume: 61, Issue:4

    Topics: Animals; Antifibrinolytic Agents; Becaplermin; Carbon Tetrachloride; Cell Movement; Collagen Type I;

2017
Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis.
    British journal of pharmacology, 2017, Volume: 174, Issue:5

    Topics: Animals; Benzoquinones; Carbon Tetrachloride; Disease Models, Animal; Hedgehog Proteins; Hepatic Ste

2017
Augmenter of liver regeneration protects against carbon tetrachloride-induced liver injury by promoting autophagy in mice.
    Oncotarget, 2017, Feb-21, Volume: 8, Issue:8

    Topics: Animals; Autophagy; Blotting, Western; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury;

2017
Optimized Mouse Models for Liver Fibrosis.
    Methods in molecular biology (Clifton, N.J.), 2017, Volume: 1559

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4;

2017
Systematic quantification of histological patterns shows accuracy in reflecting cirrhotic remodeling.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:9

    Topics: Algorithms; Animals; Carbon Tetrachloride; Diagnostic Imaging; Disease Models, Animal; Disease Progr

2017
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis.
    Scientific reports, 2017, 01-24, Volume: 7

    Topics: 1-Naphthylisothiocyanate; Animals; Carbon Tetrachloride; Disease Models, Animal; Extracellular Matri

2017
A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2017, 01-04, Volume: 25, Issue:1

    Topics: Adenosine; Animals; Biomarkers; Carbon Tetrachloride; Collagen Type I; Disease Models, Animal; Disea

2017
Reduced SHARPIN and LUBAC Formation May Contribute to CCl₄- or Acetaminophen-Induced Liver Cirrhosis in Mice.
    International journal of molecular sciences, 2017, Feb-04, Volume: 18, Issue:2

    Topics: Acetaminophen; Animals; Apoptosis; Carbon Tetrachloride; Carrier Proteins; Cell Line, Tumor; Disease

2017
Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
    Molecular and cellular biochemistry, 2017, Volume: 429, Issue:1-2

    Topics: Animals; Benzamides; Carbon Tetrachloride; Cell Movement; Cell Proliferation; Cells, Cultured; Combi

2017
Deregulation of Regulatory T Cells in Acute-on-Chronic Liver Failure: A Rat Model.
    Mediators of inflammation, 2017, Volume: 2017

    Topics: Acute-On-Chronic Liver Failure; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon T

2017
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis.
    Scientific reports, 2017, 02-16, Volume: 7

    Topics: 3T3-L1 Cells; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Biomarkers; Carbon Tetrachlorid

2017
Study on the effects of blueberry treatment on histone acetylation modification of CCl
    Genetics and molecular research : GMR, 2017, Feb-16, Volume: 16, Issue:1

    Topics: Acetylation; Animals; Aspartate Aminotransferases; Blueberry Plants; Carbon Tetrachloride; Disease M

2017
C57BL/6 Substrains Exhibit Different Responses to Acute Carbon Tetrachloride Exposure: Implications for Work Involving Transgenic Mice.
    Gene expression, 2017, Jul-07, Volume: 17, Issue:3

    Topics: Adaptation, Physiological; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Li

2017
Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl
    Scientific reports, 2017, 03-14, Volume: 7

    Topics: 3T3 Cells; Animals; Carbon Tetrachloride; Disease Models, Animal; Humans; Indoles; Inflammation; Liv

2017
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis.
    Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:6

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells

2008
Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:7

    Topics: Animals; Carbon Tetrachloride; Caspase 3; Chemical and Drug Induced Liver Injury; Collagen Type IV;

2008
Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
    Gastroenterology, 2008, Volume: 135, Issue:2

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Line; Cell Survival; Cell Transdifferentiation; Cells

2008
Hepatotoxicity of carbon tetrachloride: protective effect of Gongronema latifolium.
    Pakistan journal of pharmaceutical sciences, 2008, Volume: 21, Issue:3

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Carbon Tetrachlori

2008
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 105, Issue:2

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Chemical and Drug In

2008
Platelets contribute to the reduction of liver fibrosis in mice.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:1

    Topics: Animals; Blood Platelets; Carbon Tetrachloride; Cell Proliferation; Disease Models, Animal; Female;

2009
Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:1

    Topics: Adult; Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetra

2009
The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4

    Topics: Amphiregulin; Animals; Apoptosis; Carbon Tetrachloride; Cell Line; Cells, Cultured; Disease Models,

2008
Red wine polyphenols affect the collagen composition in the aorta after oxidative damage induced by chronic administration of CCl(4).
    Physiological research, 2009, Volume: 58, Issue:3

    Topics: Animals; Aorta; Aortic Diseases; Carbon Tetrachloride; Collagen Type I; Collagen Type III; Disease M

2009
Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4

    Topics: Acute Disease; Alanine; Ammonia; Animals; Carbon Tetrachloride; Chronic Disease; Disease Models, Ani

2008
Ultrastructural changes in hepatocytes after taurine treatment in CCl4 induced liver injury.
    World journal of gastroenterology, 2008, Aug-21, Volume: 14, Issue:31

    Topics: Animals; Carbon Tetrachloride; Cell Nucleus; Disease Models, Animal; Endoplasmic Reticulum; Hepatocy

2008
Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:12

    Topics: Actins; Animals; Carbon Tetrachloride; Cell Line; Cell Proliferation; Collagen Type I; Collagen Type

2008
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-alpha in murine hepatitis models.
    Cytokine, 2008, Volume: 44, Issue:2

    Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Cell Line; Concanavalin A; Cytokines; Disease M

2008
The hepatic apelin system: a new therapeutic target for liver disease.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4

    Topics: Adult; Animals; Apelin; Blood Pressure; Carbon Tetrachloride; Carrier Proteins; Case-Control Studies

2008
Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation.
    Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:4

    Topics: Animals; Antioxidants; Biological Availability; Carbon Tetrachloride; Chemical and Drug Induced Live

2009
Hepatoprotective activity of Phyllanthus reticulatus.
    Pakistan journal of pharmaceutical sciences, 2008, Volume: 21, Issue:4

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, A

2008
[Comparison of two rat models of IgA nephropathy].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:10

    Topics: Animals; Bacterial Toxins; Carbon Tetrachloride; Disease Models, Animal; Female; Glomerulonephritis,

2008
Development of a new animal model of liver cirrhosis in swine.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2009, Volume: 42, Issue:1

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Disease Models, An

2009
Effect of unfiltered coffee on carbon tetrachloride-induced liver injury in rats.
    Inflammation, 2008, Volume: 31, Issue:6

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug

2008
Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.
    Pharmaceutical research, 2009, Volume: 26, Issue:4

    Topics: Administration, Oral; Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Caspases; Chemistry, P

2009
Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry.
    Chemical research in toxicology, 2008, Volume: 21, Issue:12

    Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bile Acids and

2008
Transplantation of basic fibroblast growth factor-pretreated adipose tissue-derived stromal cells enhances regression of liver fibrosis in mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:2

    Topics: Albumins; Animals; Carbon Tetrachloride; Cell Culture Techniques; Cell Lineage; Cell Transdifferenti

2009
Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:2

    Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atorvastatin; Carbon Tetrachloride; Cell Prolifer

2009
Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats.
    World journal of gastroenterology, 2008, Dec-07, Volume: 14, Issue:45

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatectomy; Liver Cirrhosis, Experimental; M

2008
Bone marrow cell transplant does not prevent or reverse murine liver cirrhosis.
    Cell transplantation, 2008, Volume: 17, Issue:8

    Topics: Albumins; Animals; Azo Compounds; Bone Marrow Transplantation; Carbon Tetrachloride; Central Nervous

2008
Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration.
    Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:3

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carbon Tetrachloride; Disease Models, Animal; Hepato

2009
Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha.
    Gastroenterology, 2009, Volume: 136, Issue:4

    Topics: Actins; Animals; Apoptosis; Carbon Tetrachloride; Cell Line; Cell Proliferation; Cells, Cultured; Co

2009
[Effect of aspartame on the liver cirrhosis model induced by the complex factors].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:3

    Topics: Animals; Aspartame; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Liver; Liver Cirrhosis, E

2009
Carbon tetrachloride-induced hepatotoxicity in pregnant and lactating rats.
    The Journal of toxicological sciences, 2009, Volume: 34, Issue:2

    Topics: Animals; Animals, Suckling; Blood Chemical Analysis; Blotting, Western; Carbon Tetrachloride; Carbon

2009
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
    Gastroenterology, 2009, Volume: 137, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemokine CXCL9; Cohort Studies; Collagen; Disease M

2009
Protective effects of transgene expressed human PON3 against CCl4-induced subacute liver injury in mice.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2009, Volume: 63, Issue:8

    Topics: Alanine Transaminase; Animals; Aryldialkylphosphatase; Aspartate Aminotransferases; Carbon Tetrachlo

2009
A novel function of thrombin-activatable fibrinolysis inhibitor during rat liver regeneration and in growth-promoted hepatocytes in primary culture.
    The Journal of biological chemistry, 2009, Jun-12, Volume: 284, Issue:24

    Topics: Acute Disease; Animals; Carbon Tetrachloride; Carboxypeptidase B2; Cell Division; Cells, Cultured; C

2009
Neutral sphingomyelinase-induced ceramide accumulation by oxidative stress during carbon tetrachloride intoxication.
    Toxicology, 2009, Jun-30, Volume: 261, Issue:1-2

    Topics: Alanine Transaminase; Animals; Ascorbic Acid; Aspartate Aminotransferases; Blood Urea Nitrogen; Brai

2009
The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2009, Volume: 15, Issue:5

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cell Differentiati

2009
Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis.
    Annals of the New York Academy of Sciences, 2009, Volume: 1160

    Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Hydroxyproline; Liver; Live

2009
Hepatoprotective effect of Trichosanthes cucumerina Var cucumerina L. on carbon tetrachloride induced liver damage in rats.
    Journal of ethnopharmacology, 2009, Jun-22, Volume: 123, Issue:2

    Topics: Administration, Oral; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease

2009
Involvement of IQGAP3, a regulator of Ras/ERK-related cascade, in hepatocyte proliferation in mouse liver regeneration and development.
    Journal of cellular physiology, 2009, Volume: 220, Issue:3

    Topics: Animals; Carbon Tetrachloride; cdc42 GTP-Binding Protein; Cell Proliferation; Chemical and Drug Indu

2009
Overexpression of beta-catenin is responsible for the development of portal hypertension during liver cirrhosis.
    Anatomical record (Hoboken, N.J. : 2007), 2009, Volume: 292, Issue:6

    Topics: Adenoviridae; Animals; beta Catenin; Carbon Tetrachloride; Disease Models, Animal; Disease Progressi

2009
Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow.
    Cell transplantation, 2009, Volume: 18, Issue:1

    Topics: Animals; Bone Marrow Cells; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Cell Line, Tumor;

2009
[Establishment of liver fibrosis in rabbit model and quantitative study on hepatic perfusion with dynamic whole-liver 3D MR imaging].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:5

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Image Interpretation, Computer-Assisted; Imag

2009
[Effects of transforming growth factor beta 3 on the histopathology and expression of collagen I in experimental hepatic fibrotic rats].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:6

    Topics: Animals; Carbon Tetrachloride; Collagen Type I; Dependovirus; Disease Models, Animal; Genetic Therap

2009
Comparative study on the protective effects of Yinchenhao Decoction against liver injury induced by alpha-naphthylisothiocyanate and carbon tetrachloride.
    Chinese journal of integrative medicine, 2009, Volume: 15, Issue:3

    Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Alkaline Phosphatase; Animals; Annonaceae; Aspartate

2009
[Effects of Qushi Huayu Decoction in prevention and treatment of fatty liver in rats based on adiponectin-free fatty acid pathway].
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2009, Volume: 7, Issue:6

    Topics: Adiponectin; Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models, Animal;

2009
Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis.
    Biochemical and biophysical research communications, 2009, Oct-09, Volume: 388, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Liver Cirrhosis; Male; Panax notog

2009
Comparative antihypertensive activities of losartan and HM70186 in rats with hepatic dysfunction.
    Archives of pharmacal research, 2009, Volume: 32, Issue:7

    Topics: Administration, Oral; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Carbon Tetra

2009
Carbon tetrachloride-induced liver disease in rats: the potential effect of supplement oils with vitamins E and C on the nutritional status.
    German medical science : GMS e-journal, 2009, Jun-30, Volume: 7

    Topics: Animals; Ascorbic Acid; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Chronic; Dieta

2009
Effect of Laggera alata on hepatocyte damage induced by carbon tetrachloride in vitro and in vivo.
    Journal of ethnopharmacology, 2009, Oct-29, Volume: 126, Issue:1

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Asteraceae; Blood Proteins; Carbon Tetra

2009
The hepatoprotective and antifibrotic effects of Saururus chinensis against carbon tetrachloride induced hepatic fibrosis in rats.
    Journal of ethnopharmacology, 2009, Dec-10, Volume: 126, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis; Male; Plant Extracts;

2009
Superoxide anion production by the mitochondrial respiratory chain of hepatocytes of rats with experimental toxic hepatitis.
    Journal of bioenergetics and biomembranes, 2009, Volume: 41, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Mode

2009
Emodin protects rat liver from CCl(4)-induced fibrogenesis via inhibition of hepatic stellate cells activation.
    World journal of gastroenterology, 2009, Oct-14, Volume: 15, Issue:38

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Disease Models, An

2009
MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.
    Gastroenterology, 2010, Volume: 138, Issue:2

    Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Cell Transdifferentiation; Disease Models, Anim

2010
A novel model of CCl4-induced cirrhosis with ascites in the mouse.
    Journal of hepatology, 2009, Volume: 51, Issue:6

    Topics: Administration, Inhalation; Animals; Ascites; Carbon Tetrachloride; Cytokines; Disease Models, Anima

2009
Modification of sleep architecture in an animal model of experimental cirrhosis.
    World journal of gastroenterology, 2009, Nov-07, Volume: 15, Issue:41

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Disease Progression; Dose-Response Relationsh

2009
Synergistic antifibrotic efficacy of statin and protein kinase C inhibitor in hepatic fibrosis.
    American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 298, Issue:1

    Topics: Animals; Apoptosis; Body Weight; Carbon Tetrachloride; Cell Line, Transformed; Disease Models, Anima

2010
Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
    Journal of hepatology, 2010, Volume: 52, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Hepatocytes; Intercellular S

2010
[Comparative morphofunctional analysis of rat hepatocyte cultures isolated from the normal and pathologically changed liver due to experimental toxic hepatitis].
    Tsitologiia, 2009, Volume: 51, Issue:10

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury, Chronic; Dis

2009
[The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:11

    Topics: Adiponectin; Animals; Carbon Tetrachloride; Dietary Fats; Disease Models, Animal; Drug Combinations;

2009
Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:8

    Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Cystamine; Disease Models, Animal; Down-Regulation;

2010
Multipotent progenitor cells derived from human umbilical cord blood can differentiate into hepatocyte-like cells in a liver injury rat model.
    Transplantation proceedings, 2009, Volume: 41, Issue:10

    Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Disease Models, Animal; Fetal Blood; Hematopoie

2009
Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models.
    Surgery, 2010, Volume: 147, Issue:5

    Topics: Acute Disease; Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injur

2010
Comparative evaluation of different extracts of leaves of Psidium guajava Linn. for hepatoprotective activity.
    Pakistan journal of pharmaceutical sciences, 2010, Volume: 23, Issue:1

    Topics: Acetaminophen; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bil

2010
Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
    Fundamental & clinical pharmacology, 2011, Volume: 25, Issue:1

    Topics: Analgesics; Animals; Antioxidants; Carbon Tetrachloride; Cimetidine; Disease Models, Animal; Dose-Re

2011
Taohe Chengqi Tang ameliorates acute liver injury induced by carbon tetrachloride in rats.
    Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2010, Volume: 8, Issue:1

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs

2010
Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
    Gastroenterology, 2010, Volume: 138, Issue:5

    Topics: Adenovirus E1A Proteins; Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Cell Cycle; Cell

2010
Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats.
    BMC veterinary research, 2010, Jan-29, Volume: 6

    Topics: Animals; Ascites; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Fatty Liver; Female; Liver

2010
Effect of purified saponin mixture from Astragalus corniculatus on enzyme- and non-enzyme-induced lipid peroxidation in liver microsomes from spontaneously hypertensive rats and normotensive rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2010, Volume: 17, Issue:5

    Topics: Animals; Antioxidants; Ascorbic Acid; Astragalus Plant; Carbon Tetrachloride; Disease Models, Animal

2010
Granulocyte colony-stimulating factor enhances bone marrow mononuclear cell homing to the liver in a mouse model of acute hepatic injury.
    Digestive diseases and sciences, 2010, Volume: 55, Issue:10

    Topics: Albumins; Animals; Biopsy; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cel

2010
Generation of a novel transgenic mouse model for bioluminescent monitoring of survivin gene activity in vivo at various pathophysiological processes: survivin expression overlaps with stem cell markers.
    The American journal of pathology, 2010, Volume: 176, Issue:4

    Topics: Androgens; Animals; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug;

2010
Therapeutic effect of transplanting beta(2)m(-)/Thy1(+) bone marrow-derived hepatocyte stem cells transduced with lentiviral-mediated HGF gene into CCl(4)-injured rats.
    The journal of gene medicine, 2010, Volume: 12, Issue:3

    Topics: Animals; beta 2-Microglobulin; Bone Marrow; Carbon Tetrachloride; Disease Models, Animal; Female; Ge

2010
Striking LD50 variation associated with fluctuations of CYP2E1-positive cells in hepatic lobule during chronic CCl4 exposure in mice.
    Virchows Archiv : an international journal of pathology, 2010, Volume: 456, Issue:4

    Topics: Acute Disease; Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Carbon Tetrach

2010
TOP1 and 2, polysaccharides from Taraxacum officinale, attenuate CCl(4)-induced hepatic damage through the modulation of NF-kappaB and its regulatory mediators.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2010, Volume: 48, Issue:5

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Carbon Tetrachloride; Carbon

2010
Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
    Cell biology international, 2010, Apr-27, Volume: 34, Issue:6

    Topics: Actins; Animals; Bone Marrow Cells; Carbon Tetrachloride; Collagen; Disease Models, Animal; Down-Reg

2010
Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model.
    Stem cell reviews and reports, 2011, Volume: 7, Issue:1

    Topics: Animals; Biomarkers; Bone Marrow Cells; Carbon Tetrachloride; Cell Differentiation; Cells, Cultured;

2011
[Effects of Smad4 on liver fibrosis and hepatocarcinogenesis in mice treated with CCl4/ethanol].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010, Volume: 18, Issue:2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Female; Liver Cirrhosis, Experimenta

2010
Effects of Haobie Yangyin Ruanjian decoction on hepatic fibrosis induced by carbon tetrachloride in rats.
    World journal of gastroenterology, 2010, Mar-28, Volume: 16, Issue:12

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Blotting, Western; Carbon Te

2010
Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARgamma agonist KR62776.
    Archives of pharmacal research, 2010, Volume: 33, Issue:3

    Topics: Actins; Animals; Apoptosis; Carbon Tetrachloride; Cell Cycle; Cell Cycle Proteins; Cell Proliferatio

2010
CCl4-induced hepatic injury in mice fed a Western diet is associated with blunted healing.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:3

    Topics: Alanine Transaminase; Animals; Biomarkers; Blotting, Western; Carbon Tetrachloride; Chemical and Dru

2010
[The approaches for making acute-on-chronic liver failure in rat].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2009, Volume: 23, Issue:5

    Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Disease Models, Animal; Galactosamine; Humans;

2009
Activation of natural killer cells inhibits liver regeneration in toxin-induced liver injury model in mice via a tumor necrosis factor-alpha-dependent mechanism.
    American journal of physiology. Gastrointestinal and liver physiology, 2010, Volume: 299, Issue:1

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Inter

2010
[Observation on experimental liver fibrosis and hepatic carcinogenesis of HBV gene knock-in transgenic mice induced by CCl4/ethanol].
    Zhonghua yi xue za zhi, 2010, Mar-30, Volume: 90, Issue:12

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Female; Gene Knock-In Techniques; He

2010
Rat CCl(4)-induced cirrhosis plus total portal vein ligation: a new model for the study of hyperammonaemia and brain oedema.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:7

    Topics: Animals; Ascites; Biomarkers; Brain; Brain Edema; Carbon Tetrachloride; Disease Models, Animal; Endo

2010
A distinct nitric oxide and adenosine A1 receptor dependent hepatic artery vasodilatatory response in the CCl-cirrhotic liver.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:7

    Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Blotting, Western; Caffeine; Carbon Tetrachlo

2010
Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat.
    Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:7

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases;

2010
Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice.
    Gastroenterology, 2010, Volume: 139, Issue:3

    Topics: Animals; Bile Ducts; Biomarkers; Calcium-Binding Proteins; Carbon Tetrachloride; Cell Lineage; Cell

2010
Enhanced effect of soluble transforming growth factor-beta receptor II and IFN-gamma fusion protein in reversing hepatic fibrosis.
    European journal of medical research, 2010, Apr-08, Volume: 15, Issue:4

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; DNA Primers; Gene Amplification; Interferon-g

2010
Antifibrotic activity of Taraxacum officinale root in carbon tetrachloride-induced liver damage in mice.
    Journal of ethnopharmacology, 2010, Aug-09, Volume: 130, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Hepatic Ste

2010
Leukamenin F suppresses liver fibrogenesis by inhibiting both hepatic stellate cell proliferation and extracellular matrix production.
    Acta pharmacologica Sinica, 2010, Volume: 31, Issue:7

    Topics: Actins; Animals; Carbon Tetrachloride; Cell Proliferation; Collagen Type I; Disease Models, Animal;

2010
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:3

    Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Cannabinoids; Carbon Tetrachl

2010
Integral pharmacokinetics of multiple lignan components in normal, CCl4-induced hepatic injury and hepatoprotective agents pretreated rats and correlations with hepatic injury biomarkers.
    Journal of ethnopharmacology, 2010, Sep-15, Volume: 131, Issue:2

    Topics: Alanine Transaminase; Animals; Area Under Curve; Aspartate Aminotransferases; Biomarkers; Carbon Tet

2010
Bone marrow cells reduce fibrogenesis and enhance regeneration in fibrotic rat liver.
    The Journal of surgical research, 2011, Volume: 169, Issue:1

    Topics: Animals; Bone Marrow Cells; Carbon Tetrachloride; Cell- and Tissue-Based Therapy; Cells, Cultured; C

2011
Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice.
    Journal of hepatology, 2010, Volume: 53, Issue:4

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Early Growth Response Protein 1; Female; Gene

2010
Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.
    BMC gastroenterology, 2010, Jul-09, Volume: 10

    Topics: AC133 Antigen; Amphiregulin; Animals; Antigens, CD; Carbon Tetrachloride; Cell Differentiation; Desm

2010
Hepatoprotective activities of two Ethiopian medicinal plants.
    Pharmaceutical biology, 2010, Volume: 48, Issue:4

    Topics: Acanthaceae; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models,

2010
Carotenoid lutein protects rats from paracetamol-, carbon tetrachloride- and ethanol-induced hepatic damage.
    The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:8

    Topics: Acetaminophen; Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotra

2010
Antioxidant, free radical scavenging, anti-inflammatory and hepatoprotective potential of the extract from Parathelypteris nipponica (Franch. et Sav.) Ching.
    Journal of ethnopharmacology, 2010, Aug-09, Volume: 130, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-

2010
Protective effects of baicalin on carbon tetrachloride induced liver injury by activating PPARγ and inhibiting TGFβ1.
    Pharmaceutical biology, 2011, Volume: 49, Issue:1

    Topics: Animals; Blotting, Western; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship

2011
Antioxidant and hepatoprotective activities of Egyptian moraceous plants against carbon tetrachloride-induced oxidative stress and liver damage in rats.
    Pharmaceutical biology, 2010, Volume: 48, Issue:11

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models,

2010
Protective effects of Pergularia daemia roots against paracetamol and carbon tetrachloride-induced hepatotoxicity in rats.
    Pharmaceutical biology, 2010, Volume: 48, Issue:11

    Topics: Acetaminophen; Administration, Oral; Animals; Antioxidants; Apocynaceae; Carbon Tetrachloride; Chemi

2010
The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis.
    Cytotherapy, 2010, Volume: 12, Issue:8

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Cell Differentiation; Cell Proliferation; Disease Models,

2010
Immune modulation of ovalbumin-induced lung injury in mice using β-glucosylceramide and a potential role of the liver.
    Immunobiology, 2011, Volume: 216, Issue:5

    Topics: Allergens; Animals; Asthma; Carbon Tetrachloride; CD4-Positive T-Lymphocytes; Cell Proliferation; Ce

2011
Antioxidant effects of Citharexylum spinosum in CCl₄ induced nephrotoxicity in rat.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2012, Volume: 64, Issue:4

    Topics: Animals; Antioxidants; Blood Chemical Analysis; Carbon Tetrachloride; Carbon Tetrachloride Poisoning

2012
MRI of magnetically labeled mesenchymal stem cells in hepatic failure model.
    World journal of gastroenterology, 2010, Nov-28, Volume: 16, Issue:44

    Topics: Animals; Carbon Tetrachloride; Cell Movement; Cells, Cultured; Contrast Media; Dextrans; Disease Mod

2010
Identification of liver proteins and their roles associated with carbon tetrachloride-induced hepatotoxicity.
    Human & experimental toxicology, 2011, Volume: 30, Issue:9

    Topics: Amino Acids; Animals; Blotting, Western; Body Weight; Carbon Tetrachloride; Chemical and Drug Induce

2011
Protective effect of Sonchus asper extracts against experimentally induced lung injuries in rats: a novel study.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2012, Volume: 64, Issue:7-8

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; DNA Damage; Lipid Peroxidation;

2012
Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice.
    Journal of hepatology, 2011, Volume: 55, Issue:4

    Topics: Animals; Bile Acids and Salts; Carbon Tetrachloride; Cell Proliferation; Chemical and Drug Induced L

2011
Evaluation of the antioxidant and hepatoprotective effect of Majoon-e-Dabeed-ul-ward against carbon tetrachloride induced liver injury.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2012, Volume: 64, Issue:7-8

    Topics: Animals; Antioxidants; Biphenyl Compounds; Carbon Tetrachloride; Chemical and Drug Induced Liver Inj

2012
Anti-inflammatory properties of Ajuga bracteosa in vivo and in vitro study and their effects on mouse model of liver fibrosis.
    Journal of ethnopharmacology, 2011, Apr-26, Volume: 135, Issue:1

    Topics: Ajuga; Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Inju

2011
Early growth response (EGR)-1 is required for timely cell-cycle entry and progression in hepatocytes after acute carbon tetrachloride exposure in mice.
    American journal of physiology. Gastrointestinal and liver physiology, 2011, Volume: 300, Issue:6

    Topics: Animals; Carbon Tetrachloride; Cell Cycle; Cell Proliferation; Chemical and Drug Induced Liver Injur

2011
Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.
    Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:6

    Topics: Animals; Carbon Tetrachloride; Cell- and Tissue-Based Therapy; Chemokines; Cytokine TWEAK; Disease M

2011
Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:1

    Topics: Alanine Transaminase; Animals; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Inju

2011
Protective effect of chrysin on carbon tetrachloride (CCl4)-induced tissue injury in male Wistar rats.
    Toxicology and industrial health, 2011, Volume: 27, Issue:10

    Topics: Animals; Antioxidants; Ascorbic Acid; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury;

2011
Inflammation does not always kill hepatocytes during liver damage.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:1

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, An

2011
Pre-existing liver cirrhosis reduced the toxic effect of diethylene glycol in a rat model due to the impaired hepatic alcohol dehydrogenase.
    Toxicology and industrial health, 2011, Volume: 27, Issue:8

    Topics: Alcohol Dehydrogenase; Animals; Carbon Tetrachloride; Disease Models, Animal; Ethylene Glycols; Hepa

2011
Effects and mechanisms of Acremoniumterricola milleretal mycelium on liver fibrosis induced by carbon tetrachloride in rats.
    The American journal of Chinese medicine, 2011, Volume: 39, Issue:3

    Topics: Acremonium; Animals; Antioxidants; Biological Products; Carbon Tetrachloride; Disease Models, Animal

2011
Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis.
    Acta physiologica Hungarica, 2011, Volume: 98, Issue:2

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, A

2011
Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis.
    Frontiers of medicine, 2011, Volume: 5, Issue:1

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; China; Curcuma; Disease Models, Anima

2011
The roles of ER stress and P450 2E1 in CCl(4)-induced steatosis.
    The international journal of biochemistry & cell biology, 2011, Volume: 43, Issue:10

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Cytochrome P-450 CYP2E1; Disease Models, Animal; Endopl

2011
Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence.
    British journal of pharmacology, 2012, Volume: 165, Issue:4b

    Topics: Angiotensin II; Animals; Antioxidants; Azetidinecarboxylic Acid; Calcium; Calcium Channel Blockers;

2012
Effects of Shugan-Huayu powder, a traditional Chinese medicine, on hepatic fibrosis in rat model.
    The Chinese journal of physiology, 2010, Aug-31, Volume: 53, Issue:4

    Topics: Actins; Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis, Experimental;

2010
Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:6

    Topics: ADAM Proteins; ADAMTS1 Protein; Aged; Amino Acid Motifs; Animals; Carbon Tetrachloride; Collagen Typ

2011
Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.
    Metabolic brain disease, 2011, Volume: 26, Issue:4

    Topics: Acetylcholinesterase; Adenosine Triphosphatases; Animals; Blood Glucose; Brain; Brain Chemistry; Car

2011
A comparative study on the tissue distributions of rhubarb anthraquinones in normal and CCl4-injured rats orally administered rhubarb extract.
    Journal of ethnopharmacology, 2011, Oct-11, Volume: 137, Issue:3

    Topics: Administration, Oral; Animals; Anthraquinones; Carbon Tetrachloride; Chemical and Drug Induced Liver

2011
Blackberry extract attenuates oxidative stress through up-regulation of Nrf2-dependent antioxidant enzymes in carbon tetrachloride-treated rats.
    Journal of agricultural and food chemistry, 2011, Nov-09, Volume: 59, Issue:21

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Catalase; Chemical and Drug Induced Liver Injury; Disea

2011
A novel fluorinated stilbene exerts hepatoprotective properties in CCl(4)-induced acute liver damage.
    Canadian journal of physiology and pharmacology, 2011, Volume: 89, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cho

2011
A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
    Gastroenterology, 2012, Volume: 142, Issue:1

    Topics: Animals; Apoptosis; Bile Ducts; Carbon Tetrachloride; Cholesterol, Dietary; Disease Models, Animal;

2012
Resveratrol regulates antioxidant status, inhibits cytokine expression and restricts apoptosis in carbon tetrachloride induced rat hepatic injury.
    Oxidative medicine and cellular longevity, 2011, Volume: 2011

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Carbon Tetrachlor

2011
Effect of flavonoids from Prosthechea michuacana on carbon tetrachloride induced acute hepatotoxicity in mice.
    Pharmaceutical biology, 2011, Volume: 49, Issue:11

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chromatography; C

2011
Effect of aqueous extract of Tinospora cordifolia on functions of peritoneal macrophages isolated from CCl4 intoxicated male albino mice.
    BMC complementary and alternative medicine, 2011, Oct-28, Volume: 11

    Topics: Animals; Carbon Tetrachloride; Cell Adhesion; Cells, Cultured; Chemical and Drug Induced Liver Injur

2011
Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.
    Stem cell reviews and reports, 2013, Volume: 9, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Cell Line; Disease Models, Animal; Embryonic St

2013
CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis.
    Gastroenterology, 2012, Volume: 142, Issue:2

    Topics: Animals; Carbon Tetrachloride; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury; C

2012
Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation.
    International journal of pharmaceutics, 2012, Jan-17, Volume: 422, Issue:1-2

    Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Calori

2012
Hot water extracted Lycium barbarum and Rehmannia glutinosa inhibit liver inflammation and fibrosis in rats.
    The American journal of Chinese medicine, 2011, Volume: 39, Issue:6

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Down-Regulation; Fibrosis; Humans; Interleuki

2011
Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense.
    Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:4

    Topics: Animals; Bacterial Translocation; Bacteroides fragilis; beta-Defensins; Bifidobacterium; Carbon Tetr

2012
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.
    Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cell Differentiation; Cell Lineage; Cell Transplantation; Cells, Cult

2012
Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
    Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:3

    Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Collagen; Cytokines; Disease Mod

2012
Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease.
    The Journal of biological chemistry, 2012, Jan-06, Volume: 287, Issue:2

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Cathepsin B; Cathepsin D;

2012
Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis.
    Pharmaceutical biology, 2012, Volume: 50, Issue:4

    Topics: Animals; Benzaldehydes; Blotting, Western; Carbon Tetrachloride; Catechols; Cell Proliferation; Cell

2012
Direct and indirect contribution of human embryonic stem cell-derived hepatocyte-like cells to liver repair in mice.
    Gastroenterology, 2012, Volume: 142, Issue:3

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Cell Differentiation; Cell Proliferation; Cell Separation

2012
Lycium barbarum polysaccharides protect mice liver from carbon tetrachloride-induced oxidative stress and necroinflammation.
    Journal of ethnopharmacology, 2012, Jan-31, Volume: 139, Issue:2

    Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Chemica

2012
Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver.
    Gastroenterology, 2012, Volume: 142, Issue:4

    Topics: Animals; Apoptosis; Binding Sites; Carbon Tetrachloride; Caspase 3; Caspase 7; Cell Proliferation; C

2012
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
    Laboratory investigation; a journal of technical methods and pathology, 2012, Volume: 92, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Evaluation, Preclinical; Extracellular M

2012
Effects of manual acupuncture at GB34 on carbon tetrachloride-induced acute liver injury in rats.
    Journal of acupuncture and meridian studies, 2011, Volume: 4, Issue:4

    Topics: Acupuncture Points; Acupuncture Therapy; Animals; Carbon Tetrachloride; Chemical and Drug Induced Li

2011
Thromboxane A(2) receptor signaling promotes liver tissue repair after toxic injury through the enhancement of macrophage recruitment.
    Toxicology and applied pharmacology, 2012, Feb-15, Volume: 259, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Carbon Tetrachloride; C

2012
Preventive and therapeutic effects of oleuropein against carbon tetrachloride-induced liver damage in mice.
    Pharmacological research, 2012, Volume: 65, Issue:4

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models,

2012
Hepatoprotective activity of Cyperus alternifolius on carbon tetrachloride-induced hepatotoxicity in rats.
    Pharmaceutical biology, 2012, Volume: 50, Issue:2

    Topics: Administration, Oral; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyperus

2012
1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene induces substantial hyperplasia in fibrotic mouse liver.
    International journal of experimental pathology, 2012, Volume: 93, Issue:2

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Biomarkers; Bromodeoxyuridine; Carbon Tetrachloride; Cell Pr

2012
PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats.
    Journal of hepatology, 2012, Volume: 56, Issue:5

    Topics: Animals; Blood Pressure; Carbon Tetrachloride; Cyclooxygenase 1; Disease Models, Animal; Endothelium

2012
Augmenter of liver regeneration may be a candidate for prognosis of HBV related acute-on-chronic liver failure as a regenerative marker.
    Hepato-gastroenterology, 2012, Volume: 59, Issue:118

    Topics: Analysis of Variance; Animals; Biomarkers; Carbon Tetrachloride; Case-Control Studies; Chemical and

2012
Ex vivo-expanded bone marrow stem cells home to the liver and ameliorate functional recovery in a mouse model of acute hepatic injury.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2012, Volume: 11, Issue:1

    Topics: Acute Disease; Alanine Transaminase; Albumins; Animals; Aspartate Aminotransferases; Biomarkers; Bon

2012
Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model.
    Journal of ethnopharmacology, 2012, Mar-06, Volume: 140, Issue:1

    Topics: Alkaline Phosphatase; Animals; Antioxidants; Artemisia; Carbon Tetrachloride; Chemical and Drug Indu

2012
Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis.
    International journal of clinical and experimental pathology, 2012, Volume: 5, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Disease Models, Animal; Fatty Liver; Female

2012
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.
    Journal of hepatology, 2012, Volume: 56, Issue:6

    Topics: Animals; Bacterial Translocation; Carbon Tetrachloride; Cholestasis; Disease Models, Animal; Intesti

2012
[Dynamic expression of TGF-beta1/Smad protein in CCl4-induced liver fibrosis and its significance in rats].
    Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 2011, Volume: 25, Issue:5

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Humans; Liver Cirrhosis; Male; Random Allocat

2011
Phenacetin O-deethylation is a useful tool for evaluation of hepatic functional reserve in rats with CCl(4)-induced chronic liver injury.
    The Journal of surgical research, 2012, Jun-15, Volume: 175, Issue:2

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chronic Disease;

2012
In vitro and in vivo antioxidant activity of the ethanolic extract from Meconopsis quintuplinervia.
    Journal of ethnopharmacology, 2012, May-07, Volume: 141, Issue:1

    Topics: Animals; Antioxidants; Benzothiazoles; Biphenyl Compounds; Carbon Tetrachloride; Catalase; Chelating

2012
Adenovirus-mediated dual gene expression of human interleukin-10 and hepatic growth factor exerts protective effect against CCl4-induced hepatocyte injury in rats.
    Digestive diseases and sciences, 2012, Volume: 57, Issue:7

    Topics: Adenoviridae; Animals; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced Liver Injury

2012
Expression patterns of heat shock protein 25 in carbon tetrachloride-induced rat liver injury.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2013, Volume: 65, Issue:5

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Data Interpretatio

2013
Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
    International journal of molecular sciences, 2012, Volume: 13, Issue:3

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Cell Differentiation; Cell Survival; Cell- and Tissue-B

2012
Pharmacological study of the effect of licorice alone and in combination with diclofenac sodium on hepatotoxicity-induced experimentally in rats.
    Journal of complementary & integrative medicine, 2011, Dec-16, Volume: 8

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Diclofenac; Dis

2011
Impairment of α(2)-macroglobulin synthesis in experimental hepatopathic rats treated with turpentine oil.
    Experimental animals, 2012, Volume: 61, Issue:2

    Topics: Acetaminophen; Acute Disease; alpha-Macroglobulins; Analgesics, Non-Narcotic; Animals; Carbon Tetrac

2012
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, May-22, Volume: 109, Issue:21

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Hepatic Stellate Cells; Hepa

2012
Gadolinium accumulation and fibrosis in the liver after administration of gadoxetate disodium in a rat model of active hepatic fibrosis.
    Radiology, 2012, Volume: 264, Issue:2

    Topics: Analysis of Variance; Animals; Carbon Tetrachloride; Disease Models, Animal; Gadolinium DTPA; Liver

2012
Interference with oligomerization and glycosaminoglycan binding of the chemokine CCL5 improves experimental liver injury.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chemokine CCL5; Disease Model

2012
[Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
    Zhen ci yan jiu = Acupuncture research, 2012, Volume: 37, Issue:1

    Topics: Acupuncture Therapy; Animals; Carbon Tetrachloride; Disease Models, Animal; Down-Regulation; Extrace

2012
Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Hepatology (Baltimore, Md.), 2012, Volume: 56, Issue:5

    Topics: Animals; Antiparkinson Agents; Bile Ducts; Blood Pressure; Carbidopa; Carbon Tetrachloride; Disease

2012
Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models.
    Journal of hepatology, 2012, Volume: 57, Issue:3

    Topics: Animals; Carbon Tetrachloride; Collagen Type I; Contrast Media; Diethylnitrosamine; Disease Models,

2012
Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP.
    American journal of physiology. Gastrointestinal and liver physiology, 2012, Aug-15, Volume: 303, Issue:4

    Topics: Animals; Apoptosis; Carbon Tetrachloride; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase

2012
Fibroblast growth factor 7 inhibits cholesterol 7α-hydroxylase gene expression in hepatocytes.
    Biochemical and biophysical research communications, 2012, Jul-13, Volume: 423, Issue:4

    Topics: Animals; Bile Acids and Salts; Carbon Tetrachloride; Cell Line, Tumor; Cholesterol 7-alpha-Hydroxyla

2012
Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Amnion; Animals; Antibody Formation; Carbon Tetrachloride; Cell Transplantation; Disease Models, Ani

2012
Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles.
    Journal of drug targeting, 2012, Volume: 20, Issue:7

    Topics: Administration, Oral; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransf

2012
Protective role of antithrombin in mouse models of liver injury.
    Journal of hepatology, 2012, Volume: 57, Issue:5

    Topics: Animals; Antithrombins; Apoptosis; Carbon Tetrachloride; Cells, Cultured; Chemical and Drug Induced

2012
Protective effects of Moutan Cortex Radicis against acute hepatotoxicity.
    African journal of traditional, complementary, and alternative medicines : AJTCAM, 2011, Volume: 8, Issue:5 Suppl

    Topics: 1-Naphthylisothiocyanate; Administration, Oral; Animals; Bilirubin; Carbon Tetrachloride; Chemical a

2011
Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis.
    Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:8-9

    Topics: Animals; Carbon Tetrachloride; Cyclooxygenase Inhibitors; Disease Models, Animal; Enzyme Inhibitors;

2012
Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats.
    Journal of hepatology, 2012, Volume: 57, Issue:5

    Topics: Actins; Adenoviridae; Animals; beta-Galactosidase; Carbon Tetrachloride; Collagen; Disease Models, A

2012
Evaluation of liver fibrosis by investigation of hepatic parenchymal perfusion using contrast-enhanced ultrasound: an animal study.
    Journal of clinical ultrasound : JCU, 2012, Volume: 40, Issue:8

    Topics: Animals; Biopsy, Needle; Carbon Tetrachloride; Contrast Media; Disease Models, Animal; Image Enhance

2012
Hepatoprotective and in vivo antioxidant activities of ethanolic extract of whole fruit of Lagenaria breviflora.
    Journal of basic and clinical physiology and pharmacology, 2012, Feb-22, Volume: 23, Issue:1

    Topics: Animals; Antioxidants; Bilirubin; Biomarkers; Blood Urea Nitrogen; Carbon Tetrachloride; Chemical an

2012
Sodium butyrate potentiates carbon tetrachloride-induced acute liver injury in mice.
    Toxicology mechanisms and methods, 2012, Volume: 22, Issue:8

    Topics: Acetylcysteine; Animals; Butyrates; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical a

2012
Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.
    World journal of gastroenterology, 2012, Aug-21, Volume: 18, Issue:31

    Topics: Alkaline Phosphatase; Alkaloids; Animals; Apoptosis; Carbon Tetrachloride; Cell Survival; Cells, Cul

2012
Protective effect of transplantation of neonatal liver cell nuclei on the model of acute toxic hepatitis.
    Bulletin of experimental biology and medicine, 2012, Volume: 153, Issue:4

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug

2012
Comparative study on the inhibitory effects of α-tocopherol and radon on carbon tetrachloride-induced renal damage.
    Renal failure, 2012, Volume: 34, Issue:9

    Topics: Acute Kidney Injury; alpha-Tocopherol; Animals; Antioxidants; Carbon Tetrachloride; Carbon Tetrachlo

2012
Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats.
    Journal of hepatology, 2013, Volume: 58, Issue:2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hypertension, Portal; Liver Cirrhosis; Male;

2013
Antioxidant and hepatoprotective activity of an ethanol extract of Syzygium jambos (L.) leaves.
    Drug discoveries & therapeutics, 2012, Volume: 6, Issue:4

    Topics: Animals; Antioxidants; Biomarkers; Biphenyl Compounds; Carbon Tetrachloride; Chemical and Drug Induc

2012
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
    Journal of hepatology, 2013, Volume: 58, Issue:2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Electric Stimulation; Hypertension, Portal; L

2013
Branched-chain amino acid-enriched nutrients stimulate antioxidant DNA repair in a rat model of liver injury induced by carbon tetrachloride.
    Molecular biology reports, 2012, Volume: 39, Issue:12

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Amino Acids, Branched-Chain; Animals; Antioxidants; Biomarkers; Blottin

2012
Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells.
    Journal of ethnopharmacology, 2013, Jan-09, Volume: 145, Issue:1

    Topics: Actins; Alanine Transaminase; Animals; Aspartate Aminotransferases; Autoantibodies; Carbon Tetrachlo

2013
1H NMR-based metabonomics approach in a rat model of acute liver injury and regeneration induced by CCl4 administration.
    Toxicology, 2013, Jan-07, Volume: 303

    Topics: Acute Lung Injury; Animals; Carbon Tetrachloride; Disease Models, Animal; Energy Metabolism; Folic A

2013
Hepatoprotective and cytoprotective properties of Hyptis suaveolens against oxidative stress-induced damage by CCl(4) and H(2)O(2).
    Asian Pacific journal of tropical medicine, 2012, Volume: 5, Issue:11

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Cell Line; Cell Survival; Chemical and Drug Induced Liv

2012
Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis.
    Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:4

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; ErbB Receptors; Female; Liver Cirrhosis; Male

2013
Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats.
    Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:4

    Topics: Acetylcholine; Animals; Carbon Tetrachloride; Disease Models, Animal; Endothelium, Vascular; Hypoxia

2013
Radix Paeoniae Rubra and Radix Paeoniae Alba Attenuate CCl4-induced acute liver injury: an ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic approach for the pharmacodynamic study of Traditional Chinese Medicines (TCMs)
    International journal of molecular sciences, 2012, Nov-09, Volume: 13, Issue:11

    Topics: Animals; Bile Acids and Salts; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Inj

2012
Hepatoprotective efficacy of Sharbat-e-Deenar against carbon tetrachloride-induced liver damage.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2012, Volume: 31, Issue:2

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models,

2012
[The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2012, Volume: 35, Issue:6

    Topics: Animals; Body Weight; Carbon Tetrachloride; Disease Models, Animal; Hypertension, Portal; Liver; Liv

2012
Protective role of ferulic acid on carbon tetrachloride-induced hyperlipidemia and histological alterations in experimental rats.
    Journal of basic and clinical physiology and pharmacology, 2013, Volume: 24, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cholesterol; Coumaric Acids; Disease Models, Animal; Fatty Acids, Non

2013
Hepatoprotective effect of herbal drug on CCl(4) induced liver damage.
    Pakistan journal of pharmaceutical sciences, 2013, Volume: 26, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Biomarkers; Carbon Tetrachloride; Ch

2013
Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Journal of hepatology, 2013, Volume: 58, Issue:5

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Dru

2013
Nanoemulsified ethanolic extract of Pyllanthus amarus Schum & Thonn ameliorates CCl4 induced hepatotoxicity in Wistar rats.
    Indian journal of experimental biology, 2012, Volume: 50, Issue:11

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug

2012
Antioxidant and hepatoprotective action of Asparagus racemosus Willd. root extracts.
    Indian journal of experimental biology, 2012, Volume: 50, Issue:11

    Topics: Animals; Antioxidants; Asparagus Plant; Biphenyl Compounds; Carbon Tetrachloride; Chemical and Drug

2012
Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice.
    BMC gastroenterology, 2013, Jan-14, Volume: 13

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Movement; Cells, Cultured; Disease Models, Animal; Di

2013
Curcumin reorganizes miRNA expression in a mouse model of liver fibrosis.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:11

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbon Tetrachloride; Curcumin; Disease Models, An

2012
Magnetic resonance-based total liver volume and magnetic resonance-diffusion weighted imaging for staging liver fibrosis in mini-pigs.
    World journal of gastroenterology, 2012, Dec-28, Volume: 18, Issue:48

    Topics: Animals; Area Under Curve; Carbon Tetrachloride; Contrast Media; Diffusion; Diffusion Magnetic Reson

2012
Hepatoprotective effects of Juglans regia extract against CCl4-induced oxidative damage in rats.
    Pharmaceutical biology, 2013, Volume: 51, Issue:5

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antioxidants; Aspartate Aminotransferases; Carb

2013
Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29.
    PloS one, 2013, Volume: 8, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Gene Expression Profiling; Gene Expression Re

2013
Hepatoprotective and immunomodulatory properties of Tinospora cordifolia in CCl4 intoxicated mature albino rats.
    The Journal of toxicological sciences, 2002, Volume: 27, Issue:3

    Topics: Adjuvants, Immunologic; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransfer

2002
Protective effect of carnosol on CCl(4)-induced acute liver damage in rats.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:9

    Topics: Abietanes; Acute Disease; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dis

2002
Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver.
    Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:5

    Topics: Albumins; Animals; Biological Transport; Carbon Radioisotopes; Carbon Tetrachloride; Cell Membrane;

2002
A novel method for preparation of animal models of liver damage: liver targeting of carbon tetrachloride in rats.
    Biological & pharmaceutical bulletin, 2002, Volume: 25, Issue:11

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Delivery Systems; Liver; Male; Rats; Rat

2002
Enzyme release from injured, preserved, and ex vivo reperfused liver does not indicate malfunction.
    Transplantation, 2002, Oct-27, Volume: 74, Issue:8

    Topics: Acute Disease; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Che

2002
Protective effect of rutin on paracetamol- and CCl4-induced hepatotoxicity in rodents.
    Fitoterapia, 2002, Volume: 73, Issue:7-8

    Topics: Acetaminophen; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models

2002
The formation of oxidative stress condition in the experimental chemically induced hepatotoxicity.
    Roczniki Akademii Medycznej w Bialymstoku (1995), 2002, Volume: 47

    Topics: Acetaminophen; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models

2002
Iron overload enhances the development of experimental liver cirrhosis in mice.
    The international journal of biochemistry & cell biology, 2003, Volume: 35, Issue:4

    Topics: Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Iron Carbonyl Compounds; Iron Overl

2003
[Study on hepatic-protective effect of "yinzhihuang" granula].
    Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2001, Volume: 24, Issue:5

    Topics: 1-Naphthylisothiocyanate; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Car

2001
Quantitative diagnosis of fatty liver with dual-energy CT. An experimental study in rabbits.
    Acta radiologica (Stockholm, Sweden : 1987), 2003, Volume: 44, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Fatty Liver; Female; Male; Rabbits; Reproduci

2003
Hepatic osteodystrophy in rats results mainly from portasystemic shunting.
    Gut, 2003, Volume: 52, Issue:4

    Topics: Absorptiometry, Photon; Animals; Bone Density; Carbon Tetrachloride; Disease Models, Animal; Female;

2003
Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
    Toxicological sciences : an official journal of the Society of Toxicology, 2003, Volume: 73, Issue:2

    Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Aspartate Aminotransferases;

2003
Renal effects of selective cyclooxygenase inhibition in experimental liver disease.
    Advances in experimental medicine and biology, 2003, Volume: 525

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclooxygenase 1; Cyclooxygen

2003
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.
    Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Animals; Antigens, CD; Carbon Tetrachloride; Cell Division;

2003
Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute?
    Journal of hepatology, 2003, Volume: 39, Issue:3

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Line; Chimera; D

2003
Effect of spleen on immune function of rats with liver cancer complicated by liver cirrhosis.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2003, Volume: 2, Issue:2

    Topics: Animals; Carbon Tetrachloride; Carcinoma 256, Walker; Disease Models, Animal; Killer Cells, Natural;

2003
Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 308, Issue:2

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injur

2004
Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2003, Volume: 55, Issue:2-3

    Topics: Actins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals;

2003
Hepatoprotective action of PGE1 analogue estimated by measuring the concentrations of acetoacetate and beta-hydroxybutyrate.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2003, Volume: 55, Issue:2-3

    Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acute Disease; Administration, Oral; Alanine Transaminase; Ani

2003
Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats.
    World journal of gastroenterology, 2004, Volume: 10, Issue:1

    Topics: Animals; Antineoplastic Agents; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Interleukin

2004
Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis.
    Gastroenterology, 2004, Volume: 126, Issue:4

    Topics: Adenoviridae; Animals; Carbon Tetrachloride; Collagen; Culture Media; Disease Models, Animal; Gene E

2004
[Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2004, Apr-07, Volume: 42, Issue:7

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hypertension, Portal; Immunohistochemistry; L

2004
Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking.
    Gastroenterology, 2004, Volume: 126, Issue:7

    Topics: Actins; Animals; Apoptosis; Carbon Tetrachloride; Collagen Type I; Cross-Linking Reagents; Dipeptide

2004
The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis.
    Chemico-biological interactions, 2004, Jul-20, Volume: 148, Issue:3

    Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Carbon Tetrachloride; Carb

2004
Effect of dimethyl diphenyl bicarboxylate on normal and chemically-injured liver.
    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2002, Volume: 8, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antioxidants; Carbon Tetrachloride; Chemical

2002
Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.
    The American journal of pathology, 2004, Volume: 165, Issue:4

    Topics: Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Fibroblast Growth Factor 7;

2004
Interferon-alpha gene therapy prevents aflatoxin and carbon tetrachloride promoted hepatic carcinogenesis in rats.
    International journal of molecular medicine, 2005, Volume: 15, Issue:1

    Topics: Aflatoxins; Animals; Carbon Tetrachloride; Cell Line; Cell Transformation, Neoplastic; Disease Model

2005
Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis.
    American journal of physiology. Gastrointestinal and liver physiology, 2005, Volume: 288, Issue:6

    Topics: Administration, Oral; Animals; Carbon Tetrachloride; Disease Models, Animal; Glucose; Glucose Transp

2005
G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs.
    Experimental hematology, 2005, Volume: 33, Issue:1

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Lineage; Cell Mo

2005
Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins.
    Kidney international, 2005, Volume: 67, Issue:2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Epithelial Sodium Channels; Kidney; Liver Cir

2005
Protective effects of 5,4'-dihydroxy-3',5'-dimethoxy-7-O-beta-D -glucopyranosyloxy-flavone on experimental hepatic injury.
    World journal of gastroenterology, 2005, Mar-28, Volume: 11, Issue:12

    Topics: Acute Disease; Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Flavones; Hep

2005
Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
    Journal of gastroenterology, 2005, Volume: 40, Issue:3

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disea

2005
Protective effect of fufanghuangqiduogan against acute liver injury in mice.
    World journal of gastroenterology, 2005, May-21, Volume: 11, Issue:19

    Topics: Acute Disease; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models

2005
[Peritoneal dialysis with allogenic hepatic cell suspension in treatment of hepatic insufficiency].
    Georgian medical news, 2005, Issue:121

    Topics: Acute Disease; Animals; Carbon Tetrachloride; Cell Transplantation; Disease Models, Animal; Female;

2005
Pharmacokinetics of verapamil and its major metabolite, norverapamil from oral administration of verapamil in rabbits with hepatic failure induced by carbon tetrachloride.
    Archives of pharmacal research, 2005, Volume: 28, Issue:4

    Topics: Administration, Oral; Animals; Biological Availability; Calcium Channel Blockers; Carbon Tetrachlori

2005
Garlic oil and DDB, comprised in a pharmaceutical composition for the treatment of patients with viral hepatitis, prevents acute liver injuries potentiated by glutathione deficiency in rats.
    Chemico-biological interactions, 2005, Jun-30, Volume: 155, Issue:1-2

    Topics: Acute Disease; Alanine Transaminase; Allyl Compounds; Animals; Aspartate Aminotransferases; Biphenyl

2005
Anti-lipid peroxidation and protection of liver mitochondria against injuries by picroside II.
    World journal of gastroenterology, 2005, Jun-28, Volume: 11, Issue:24

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cinnamates; Disease Models, A

2005
Mechanism of protective action of bicyclol against CCl-induced liver injury in mice.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:4

    Topics: Administration, Oral; Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases;

2005
Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation.
    World journal of gastroenterology, 2005, Jul-21, Volume: 11, Issue:27

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Dicarbethoxydihydrocollidine; Disease Models, Animal; Fem

2005
Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of Kupffer cells.
    Journal of leukocyte biology, 2005, Volume: 78, Issue:4

    Topics: 5-Lipoxygenase-Activating Proteins; Animals; Arachidonate 5-Lipoxygenase; Carbon Tetrachloride; Carr

2005
Modeling liver fibrosis in rodents.
    Methods in molecular medicine, 2005, Volume: 117

    Topics: Actins; Animals; Animals, Genetically Modified; Apoptosis; Azo Compounds; Carbon Tetrachloride; Colo

2005
Morphological signs of cirrhosis regression. Experimental observations on carbon tetrachloride-induced liver cirrhosis of rats.
    Pathology, research and practice, 2005, Volume: 201, Issue:6

    Topics: Animals; Biomarkers; Biopsy; Carbon Tetrachloride; Disease Models, Animal; Female; Fluorescent Antib

2005
L-[1-13C] phenylalanine breath test results reflect the activity of phenylalanine hydroxylase in carbon tetrachloride acute injured rat liver.
    Life sciences, 2006, Jan-18, Volume: 78, Issue:8

    Topics: Acute Disease; Animals; Breath Tests; Carbon Isotopes; Carbon Tetrachloride; Chemical and Drug Induc

2006
Osteopontin expression in normal and fibrotic liver. altered liver healing in osteopontin-deficient mice.
    Journal of hepatology, 2006, Volume: 44, Issue:2

    Topics: Animals; Blotting, Northern; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Gene Expressio

2006
Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes.
    Cell and tissue research, 2006, Volume: 323, Issue:2

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Differentiation;

2006
Differential gene expression profiles in the steatosis/fibrosis model of rat liver by chronic administration of carbon tetrachloride.
    Toxicology and applied pharmacology, 2005, Nov-01, Volume: 208, Issue:3

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Disease Models, An

2005
Complementary regulation of heme oxygenase-1 and peroxiredoxin I gene expression by oxidative stress in the liver.
    Cellular and molecular biology (Noisy-le-Grand, France), 2005, Oct-03, Volume: 51, Issue:5

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Heme

2005
[Comparing studies on the differences of CCl4 liver injury and immunity liver injury mice models].
    Shi yan sheng wu xue bao, 2005, Volume: 38, Issue:5

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug

2005
Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver.
    Journal of gastroenterology, 2006, Volume: 41, Issue:1

    Topics: 2-Acetylaminofluorene; Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride

2006
Anti-hepato-cytotoxic serum treatment results in acute liver failure.
    Georgian medical news, 2006, Issue:130

    Topics: Animals; Blood Component Transfusion; Carbon Tetrachloride; Disease Models, Animal; Liver Failure, A

2006
Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
    Cancer research, 2006, May-01, Volume: 66, Issue:9

    Topics: Alleles; Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models, Animal; Dise

2006
Cryopreserved fetal liver cell transplants support the chronic failing liver in rats with CCl4-induced cirrhosis.
    Cell transplantation, 2006, Volume: 15, Issue:1

    Topics: Animals; Carbon Tetrachloride; Chronic Disease; Cryopreservation; Cytochrome P-450 Enzyme System; Di

2006
Comparison of the effects of melatonin and pentoxifylline on carbon tetrachloride-induced liver toxicity in mice.
    Cell biology and toxicology, 2006, Volume: 22, Issue:6

    Topics: Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Catalase; Chemical and Drug Induced Liver In

2006
Correlation between TIMP-1 expression and liver fibrosis in two rat liver fibrosis models.
    World journal of gastroenterology, 2006, May-21, Volume: 12, Issue:19

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorb

2006
Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models.
    Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:6

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Disease Models, Animal; Female; Liver Cirrhosis, Experime

2006
Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up-regulates matrix metalloproteinase-9 in toxic liver injury.
    Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:5

    Topics: Animals; Carbon Tetrachloride; Cytokines; Disease Models, Animal; Etanercept; Immunoglobulin G; Inte

2006
Induction of Gas6 protein in CCl4-induced rat liver injury and anti-apoptotic effect on hepatic stellate cells.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:1

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Survival; Cells, Cultured; Chemical and Drug Induced

2006
[Expression of Fas antigen and Fas ligand in acute liver injury induced by carbon tetrachloride in rat].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2006, Volume: 18, Issue:7

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, An

2006
Up-regulation of Metabotropic glutamate receptor 3 (mGluR3) in rat fibrosis and cirrhosis model of persistent hypoxic condition.
    Molecular and cellular biochemistry, 2007, Volume: 294, Issue:1-2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Fibrosis; Hypoxia; Immunohistochemistry; Live

2007
Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity.
    Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:2

    Topics: Acetaminophen; Animals; Animals, Newborn; Calcium-Binding Proteins; Calpain; Carbon Tetrachloride; C

2006
Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury.
    International journal of experimental pathology, 2006, Volume: 87, Issue:5

    Topics: alpha-Fetoproteins; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Proliferation; Disease

2006
Therapeutic effect of Chinese medicine formula DSQRL on experimental pulmonary fibrosis.
    Journal of ethnopharmacology, 2007, Feb-12, Volume: 109, Issue:3

    Topics: Animals; Bronchoalveolar Lavage Fluid; Carbon Tetrachloride; Collagen; Disease Models, Animal; Drugs

2007
Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis.
    Proteomics, 2006, Volume: 6, Issue:24

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4;

2006
Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats.
    Transplantation proceedings, 2006, Volume: 38, Issue:9

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Cell Differentiation; Disease Models,

2006
Functional abnormalities of the motor tract in the rat after portocaval anastomosis and after carbon tetrachloride induction of cirrhosis.
    Metabolic brain disease, 2006, Volume: 21, Issue:4

    Topics: Anastomosis, Surgical; Anesthetics, Intravenous; Animals; Carbon Tetrachloride; Disease Models, Anim

2006
Preliminary studies on antihepatotoxic effect of Physalis peruviana Linn. (Solanaceae) against carbon tetrachloride induced acute liver injury in rats.
    Journal of ethnopharmacology, 2007, Apr-20, Volume: 111, Issue:1

    Topics: Animals; Antioxidants; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dis

2007
Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure.
    Gut, 2007, Volume: 56, Issue:7

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anthracenes; Biopsy; Carbon Tetrachloride; Cell De

2007
Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats.
    Pharmacological research, 2007, Volume: 55, Issue:4

    Topics: Actins; Alanine Transaminase; Animals; Carbon Tetrachloride; Collagen; Dietary Fats; Disease Models,

2007
Rheumatoid factor induction in murine models of liver injury.
    Clinical and experimental immunology, 2007, Volume: 147, Issue:2

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Autoimmunity; Carbon Tetrachloride; Chem

2007
The effect of oculo-acupuncture on acute hepatic injury induced by carbon tetrachloride in dogs.
    The American journal of Chinese medicine, 2007, Volume: 35, Issue:1

    Topics: Acupuncture Points; Acupuncture Therapy; Alanine Transaminase; Animals; Aspartate Aminotransferases;

2007
Involvement of transforming growth factor-beta in the expression of gicerin, a cell adhesion molecule, in the regeneration of hepatocytes.
    International journal of molecular medicine, 2007, Volume: 19, Issue:3

    Topics: Animals; Carbon Tetrachloride; CD146 Antigen; Cells, Cultured; Chemical and Drug Induced Liver Injur

2007
[Cystic degeneration in liver injury induced by CCl4 in SD rats].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2006, Volume: 31, Issue:22

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cysts; Disease Models, Animal

2006
Hepatoprotective potential of Aloe barbadensis Mill. against carbon tetrachloride induced hepatotoxicity.
    Journal of ethnopharmacology, 2007, May-22, Volume: 111, Issue:3

    Topics: Administration, Oral; Aloe; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dos

2007
Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts.
    European journal of pharmacology, 2007, Mar-22, Volume: 559, Issue:2-3

    Topics: Actins; Animals; Apoptosis; bcl-2-Associated X Protein; Carbon Tetrachloride; Caspase 3; Cells, Cult

2007
Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites.
    Journal of hepatology, 2007, Volume: 46, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Ascitic Fluid; Bacterial Translocation; Carbon Tetrachloride; Disea

2007
FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2.
    Laboratory investigation; a journal of technical methods and pathology, 2007, Volume: 87, Issue:6

    Topics: Animals; Carbon Tetrachloride; Core Binding Factor Alpha 1 Subunit; Disease Models, Animal; Dose-Res

2007
The pharmacodynamics of mivacurium in the rabbit with carbon tetrachloride-induced liver disease.
    European journal of anaesthesiology, 2007, Volume: 24, Issue:9

    Topics: Animals; Biomarkers; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cholinesterases;

2007
Contribution of mononuclear bone marrow cells to carbon tetrachloride-induced liver fibrosis in rats.
    World journal of gastroenterology, 2007, Mar-28, Volume: 13, Issue:12

    Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Collagen; Disease Mod

2007
Hepatic stellate cells: the only cells involved in liver fibrogenesis? A dogma challenged.
    Gastroenterology, 2007, Volume: 132, Issue:5

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Gene Expression Profiling; Gene Expression Re

2007
Increased Smad1 expression and transcriptional activity enhances trans-differentiation of hepatic stellate cells.
    Journal of cellular physiology, 2007, Volume: 212, Issue:3

    Topics: Actins; Adenoviridae; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Line; Cell Prolifera

2007
Development of an experimental model of induced bacterial peritonitis in cirrhotic rats with or without ascites.
    The American journal of gastroenterology, 2007, Volume: 102, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Ascites; Bacterial Infections; Carbon Tetrachloride; Ceftriaxone; Di

2007
Liver nuclear and microsomal CYP2E1-mediated metabolism of xenobiotics in rats chronically drinking an alcohol-containing liquid diet.
    Toxicology and industrial health, 2006, Volume: 22, Issue:9

    Topics: Alcoholism; Aniline Compounds; Animals; Carbon Tetrachloride; Cell Nucleus; Central Nervous System D

2006
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats.
    American journal of physiology. Heart and circulatory physiology, 2007, Volume: 293, Issue:3

    Topics: Amidohydrolases; Animals; Blood Pressure; Cannabinoid Receptor Modulators; Carbon Tetrachloride; Dis

2007
Acute liver toxicity by carbon tetrachloride in HSP70 knock out mice.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2007, Volume: 59, Issue:1

    Topics: Acute Disease; Alanine Transaminase; Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning;

2007
Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:6

    Topics: Alanine Transaminase; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver I

2007
Quantitative ultrasonic tissue characterization as a new tool for continuous monitoring of chronic liver remodelling in mice.
    Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:6

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Collagen; Disease Models, Animal; Disease Progression; Fe

2007
Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model.
    Gastroenterology, 2007, Volume: 133, Issue:1

    Topics: Animals; Bone Marrow Cells; Carbon Tetrachloride; Cell Division; Cells, Cultured; Disease Models, An

2007
Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
    American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 293, Issue:3

    Topics: Actins; Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Apoptosis; Carbon Tetrach

2007
Role of STAT3 in liver regeneration: survival, DNA synthesis, inflammatory reaction and liver mass recovery.
    Laboratory investigation; a journal of technical methods and pathology, 2007, Volume: 87, Issue:10

    Topics: Animals; Carbon Tetrachloride; Digestive System; Disease Models, Animal; DNA; Gene Deletion; Hepatec

2007
Characterization of cytokeratin 19-positive hepatocyte foci in the regenerating rat liver after 2-AAF/CCl4 injury.
    Histochemistry and cell biology, 2007, Volume: 128, Issue:3

    Topics: 2-Acetylaminofluorene; Administration, Oral; alpha-Fetoproteins; Animals; Carbon Tetrachloride; Cell

2007
[The tracking of allogenic grafted rat bone marrow stem cells in rat liver and their role on repairing injured liver].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2007, May-01, Volume: 45, Issue:9

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Bone Marrow Transplantation; Carbon Tetr

2007
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:10

    Topics: Animals; Carbon Tetrachloride; Colony-Stimulating Factors; Disease Models, Animal; Image Cytometry;

2007
Treatment of chronic liver injuries in mice by oral administration of ethanolic extract of the fruit of Hovenia dulcis.
    The American journal of Chinese medicine, 2007, Volume: 35, Issue:4

    Topics: Administration, Oral; Animals; Aspartate Aminotransferase, Cytoplasmic; Carbon Tetrachloride; Chemic

2007
Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in wistar rats.
    Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2007, Volume: 10, Issue:3

    Topics: Acute Disease; Administration, Oral; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, An

2007
Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats.
    Pharmacology, 2008, Volume: 81, Issue:1

    Topics: Animals; Carbon Tetrachloride; Collagen Type I; Disease Models, Animal; Genistein; Immunohistochemis

2008
Heme oxygenase-1 induction by hemin protects liver cells from ischemia/reperfusion injury in cirrhotic rats.
    World journal of gastroenterology, 2007, Oct-28, Volume: 13, Issue:40

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Caspase 3; Disease Models, Animal; Enzyme Induction; Heme

2007
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
    Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxid

2008
Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis.
    Journal of gastroenterology and hepatology, 2008, Volume: 23, Issue:7 Pt 2

    Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Liver; Liver Cirrhosis; Mal

2008
Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis.
    American journal of physiology. Gastrointestinal and liver physiology, 2008, Volume: 294, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cell Hypoxia; Chemokine CCL2; Chemotaxis, Leukocyte; Collagen Type I;

2008
[Efficacy and safety of heptral, vitamin B6 and folic acid during toxic hepatitis induced by CCL4].
    Georgian medical news, 2007, Issue:150

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Syste

2007
Hepatoprotective effects of Solanum nigrum Linn extract against CCl(4)-induced oxidative damage in rats.
    Chemico-biological interactions, 2008, Feb-15, Volume: 171, Issue:3

    Topics: Administration, Oral; Animals; Antioxidants; Biomarkers; Body Weight; Carbon Tetrachloride; Disease

2008
Continuous high expression of XBP1 and GRP78 is important for the survival of bone marrow cells in CCl4-treated cirrhotic liver.
    Biochemical and biophysical research communications, 2008, Mar-14, Volume: 367, Issue:3

    Topics: Animals; Blotting, Western; Bone Marrow Cells; Bone Marrow Transplantation; Carbon Tetrachloride; Ce

2008
Protective effects of Ginkgo biloba, Panax ginseng, and Schizandra chinensis extract on liver injury in rats.
    The American journal of Chinese medicine, 2007, Volume: 35, Issue:6

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chin

2007
Protective effect of baicalin against carbon tetrachloride-induced acute hepatic injury in mice.
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:1

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclooxygenase

2008
Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis.
    World journal of gastroenterology, 2008, Feb-07, Volume: 14, Issue:5

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Endothelin-1; Kupffer Cells; Liver Cirrhosis;

2008
Ecto-5'-nucleotidase (CD73) -mediated extracellular adenosine production plays a critical role in hepatic fibrosis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2008, Volume: 22, Issue:7

    Topics: 5'-Nucleotidase; Adenosine; Animals; Carbon Tetrachloride; Disease Models, Animal; Extracellular Spa

2008
Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice.
    Journal of cellular and molecular medicine, 2008, Volume: 12, Issue:5B

    Topics: Actins; Animals; Apoptosis; Carbon Tetrachloride; Collagen; Disease Models, Animal; Fibrosis; Genes,

2008
Posttranslational activation of endothelial nitric oxide synthase attenuates carbon tetrachloride-induced hepatotoxicity in newborn rats.
    Pediatric research, 2008, Volume: 63, Issue:6

    Topics: Age Factors; Androstadienes; Animals; Animals, Newborn; Carbon Tetrachloride; Cytoprotection; Diseas

2008
Large-conductance calcium-activated potassium channels modulate vascular tone in experimental cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:4

    Topics: Animals; Blotting, Western; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Hepatocyt

2008
[Inducing rat liver cirrhosis by adjusting the dosage of CCl4 according to body weight changes].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2008, Volume: 16, Issue:3

    Topics: Animals; Body Weight; Carbon Tetrachloride; Disease Models, Animal; Liver Cirrhosis, Experimental; M

2008
Keratin mutation predisposes to mouse liver fibrosis and unmasks differential effects of the carbon tetrachloride and thioacetamide models.
    Gastroenterology, 2008, Volume: 134, Issue:4

    Topics: Animals; Arsenamide; Carbon Tetrachloride; Disease Models, Animal; Female; Genetic Predisposition to

2008
[Study of hepatoprotective activity of ethylmethylhydroxypyridine fumarate and lipoate in the experimental toxic hepatitis].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:6

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Femal

2007
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Gastroenterology, 2008, Volume: 134, Issue:7

    Topics: Animals; Antioxidants; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Differentiation; Cell

2008
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Gastroenterology, 2008, Volume: 134, Issue:7

    Topics: Animals; Antioxidants; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Differentiation; Cell

2008
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Gastroenterology, 2008, Volume: 134, Issue:7

    Topics: Animals; Antioxidants; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Differentiation; Cell

2008
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.
    Gastroenterology, 2008, Volume: 134, Issue:7

    Topics: Animals; Antioxidants; Bone Marrow Transplantation; Carbon Tetrachloride; Cell Differentiation; Cell

2008
Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Journal of hepatology, 2008, Volume: 49, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Dopamine beta-Hydroxylase; Down-Regulation; G

2008
Laparoscopy-assisted creation of a liver failure model in pigs.
    Cell transplantation, 2008, Volume: 17, Issue:1-2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatic Artery; Hepatocytes; Laparoscopy; Liv

2008
Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats.
    Neuroscience letters, 2008, Jun-13, Volume: 438, Issue:1

    Topics: Acetylcholine; Acetylcholinesterase; Actins; Animals; Atropine; Bone Morphogenetic Protein 6; Bone M

2008
Elucidation of the role of COX-2 in liver fibrogenesis using transgenic mice.
    Biochemical and biophysical research communications, 2008, Aug-08, Volume: 372, Issue:4

    Topics: Alanine Transaminase; Animals; Bilirubin; Body Weight; Carbon Tetrachloride; Collagen; Cyclooxygenas

2008
EVP-ABD-enhanced MRI to evaluate diffuse liver disease in a rat model.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 27, Issue:6

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Contrast Media; Disease Model

2008
Medroxyprogesterone acetate improvement of the hepatic drug-metabolizing enzyme system in rats after chemical liver injury.
    Biochemical pharmacology, 1983, Mar-15, Volume: 32, Issue:6

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dimethylnitrosamine; Disease

1983
A sensitive experimental model for the assessment of hepatotoxicity by halogenocompounds: prolactin binding to the specific receptors.
    Developments in toxicology and environmental science, 1980, Volume: 8

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models, Animal; Female; Hydro

1980
Carbon tetrachloride-induced hepatic fibrosis and cirrhosis in the developing rat: an experimental model of cirrhosis in childhood.
    British journal of experimental pathology, 1983, Volume: 64, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Carbon Tetrachlori

1983
Standardized micronodular cirrhosis in the rat.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1984, Volume: 16, Issue:3

    Topics: Animals; Body Weight; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug

1984
Sensitivity of serum glutamic oxaloacetic transaminase and bile acid levels for the detection of experimental liver injury in rats.
    Journal of medicine, 1981, Volume: 12, Issue:4

    Topics: Animals; Aspartate Aminotransferases; Bile Acids and Salts; Carbon Tetrachloride; Chemical and Drug

1981
Changes in expression of the albumin, fibronectin and type I procollagen genes in CCl4-induced liver fibrosis: effect of pyridoxol L,2-pyrrolidon-5 carboxylate.
    Pharmacology & toxicology, 1993, Volume: 73, Issue:6

    Topics: Albumins; Animals; Blotting, Northern; Carbon Tetrachloride; Disease Models, Animal; Drug Combinatio

1993
Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease.
    Annals of nutrition & metabolism, 1994, Volume: 38, Issue:4

    Topics: Amino Acids; Animals; Carbon Tetrachloride; Cholesterol; Disease Models, Animal; Fatty Acids, Nonest

1994
Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin.
    Life sciences, 1993, Volume: 53, Issue:18

    Topics: Amino Acid Sequence; Animals; Bile Ducts; Carbon Tetrachloride; Chemical and Drug Induced Liver Inju

1993
Effect of ursodeoxycholic acid on in vivo and in vitro toxic liver injury in rats.
    Alimentary pharmacology & therapeutics, 1994, Volume: 8, Issue:3

    Topics: Acetaminophen; Administration, Oral; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Car

1994
The effect of Chinese hepatoprotective medicines on experimental liver injury in mice.
    Journal of ethnopharmacology, 1994, Volume: 42, Issue:3

    Topics: 1-Propanol; Acetaminophen; Animals; Cadmium; Carbon Tetrachloride; Chemical and Drug Induced Liver I

1994
CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels.
    Hepato-gastroenterology, 1994, Volume: 41, Issue:4

    Topics: Animals; Carbon Tetrachloride; Carcinoma, Hepatocellular; Copper; Disease Models, Animal; Estradiol;

1994
Hepatoprotective effects of Taiwan folk medicine: wedelia chinensis on three hepatotoxin-induced hepatotoxicity.
    The American journal of Chinese medicine, 1994, Volume: 22, Issue:2

    Topics: Acetaminophen; Acute Disease; Alanine Transaminase; Analysis of Variance; Animals; Aspartate Aminotr

1994
Effects of zinc on hepatic ornithine transcarbamylase (OTC) activity.
    Journal of trace elements and electrolytes in health and disease, 1993, Volume: 7, Issue:4

    Topics: Ammonia; Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis, Experimental

1993
Effect of hepatotoxic doses of paracetamol and carbon tetrachloride on the serum and hepatic carboxylesterase activity in mice.
    The Journal of pharmacy and pharmacology, 1993, Volume: 45, Issue:5

    Topics: Acetaminophen; Animals; Aspartate Aminotransferases; Biomarkers; Carbon Tetrachloride; Carboxylic Es

1993
[Acidified aspirin-induced gastric lesion in rats with hepatic cirrhosis produced by N-nitrosodiethylamine or carbon tetrachloride. Effect of aldioxa on gastric lesions].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1994, Volume: 103, Issue:3

    Topics: Allantoin; Aluminum Hydroxide; Animals; Antacids; Aspirin; Carbon Tetrachloride; Diethylnitrosamine;

1994
[Establishment of a model of human gastric cancer with liver metastasis in nude mice].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1993, Volume: 15, Issue:3

    Topics: Adenocarcinoma, Mucinous; Animals; Carbon Tetrachloride; Disease Models, Animal; Female; Liver Neopl

1993
Liver distribution of 99mTc-DL-homocysteine in experimental hepatitis rats.
    Nuclear medicine and biology, 1993, Volume: 20, Issue:8

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Interactions; Hepatitis, Viral, Animal;

1993
Antihepatotoxic activity of phenolic flavan-3-ols and their derivatives.
    The American journal of Chinese medicine, 1993, Volume: 21, Issue:1

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug

1993
Pharmacological and pathological studies on Taiwan folk medicine (IX): The hepatoprotective effect of the methanolic extract from echinops grijisii.
    The American journal of Chinese medicine, 1993, Volume: 21, Issue:1

    Topics: 1-Butanol; Acetates; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biopsy; Butanols; C

1993
Evaluation of the anti-inflammatory and liver-protective effects of anoectochilus formosanus, ganoderma lucidum and gynostemma pentaphyllum in rats.
    The American journal of Chinese medicine, 1993, Volume: 21, Issue:1

    Topics: Alanine Transaminase; Alkaloids; Animals; Aspartate Aminotransferases; Biopsy; Carbon Tetrachloride;

1993
Plasma membrane form of phosphatidate phosphohydrolase: a possible role in signal transduction during liver fibrogenesis.
    Clinical science (London, England : 1979), 1993, Volume: 85, Issue:3

    Topics: Animals; Carbon Tetrachloride; Cell Membrane; Disease Models, Animal; Fatty Liver, Alcoholic; Fibros

1993
Hepatocarcinogenic potency of mixed and pure enantiomers of trans-7,8-dihydrobenzo[a]pyrene-7,8-diol in trout.
    Cancer letters, 1993, Volume: 68, Issue:2-3

    Topics: Animals; Benzoflavones; beta-Naphthoflavone; Carbon Tetrachloride; Dihydroxydihydrobenzopyrenes; Dis

1993
Modulation of perisinusoidal cell cytoskeletal features during experimental hepatic fibrosis.
    Virchows Archiv. A, Pathological anatomy and histopathology, 1993, Volume: 422, Issue:2

    Topics: Actin Cytoskeleton; Actins; Animals; Carbon Tetrachloride; Cytoskeleton; Desmin; Disease Models, Ani

1993
Acute-phase response in rat to carbon tetrachloride-azathioprine induced cirrhosis and partial hepatectomy of cirrhotic liver.
    Journal of toxicology and environmental health, 1996, Apr-19, Volume: 47, Issue:6

    Topics: Acute-Phase Reaction; alpha 1-Antitrypsin; Animals; Antimetabolites; Azathioprine; Carbon Tetrachlor

1996
A potential experimental model for the study of osteopenia in CCl4 liver cirrhotic rats.
    Revista espanola de fisiologia, 1996, Volume: 52, Issue:2

    Topics: Animals; Body Weight; Bone Diseases, Metabolic; Carbon Tetrachloride; Densitometry; Disease Models,

1996
Improvement in cholestasis-associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment.
    Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:2

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cholestasis; Dise

1997
Potent antihepatotoxic activity of dicaffeoyl quinic acids from propolis.
    Biological & pharmaceutical bulletin, 1996, Volume: 19, Issue:4

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cells, Cultured; C

1996
The cytoprotective effect of iloprost against carbon tetrachloride induced necrosis in rat liver.
    Research communications in molecular pathology and pharmacology, 1997, Volume: 95, Issue:3

    Topics: Animals; Carbon Tetrachloride; Dinoprostone; Disease Models, Animal; Female; Histamine; Hypertension

1997
Protective effect of Rhinax, a herbal formulation, against CCl4-induced liver injury and survival in rats.
    Journal of ethnopharmacology, 1997, Volume: 56, Issue:2

    Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cytochrome P-450 E

1997
Cytoprotective activity in the gastric mucosa of rats exposed to carbon tetrachloride-induced liver injury.
    Inflammation, 1997, Volume: 21, Issue:5

    Topics: Animals; Carbon Tetrachloride; Dinoprostone; Disease Models, Animal; Drug Resistance; Ethanol; Gastr

1997
A microcholangiographic study of liver disease models in rats.
    Academic radiology, 1995, Volume: 2, Issue:6

    Topics: 1-Naphthylisothiocyanate; Animals; Bile Duct Diseases; Bile Ducts; Carbon Tetrachloride; Cell Divisi

1995
Effect of narcotic agents and of bleeding on systemic and renal haemodynamics in healthy and CCl4-treated cirrhotic rats.
    Clinical science (London, England : 1979), 1997, Volume: 93, Issue:6

    Topics: Animals; Blood Pressure; Butyrophenones; Carbon Tetrachloride; Diazepam; Disease Models, Animal; Dru

1997
Spirulina maxima prevents induction of fatty liver by carbon tetrachloride in the rat.
    Biochemistry and molecular biology international, 1998, Volume: 44, Issue:4

    Topics: Acute Disease; Animals; Carbon Tetrachloride; Cyanobacteria; Disease Models, Animal; Fatty Liver; Li

1998
Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.
    The American journal of pathology, 1998, Volume: 153, Issue:3

    Topics: Animals; Apoptosis; Carbon Tetrachloride; Cell Division; Dimethylnitrosamine; Disease Models, Animal

1998
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver.
    Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:2

    Topics: Animals; Apoptosis; Bicarbonates; Bile; Bile Ducts, Intrahepatic; Carbon Tetrachloride; Cell Divisio

1999
[Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1999, Volume: 113, Issue:1

    Topics: Animals; Bone Density; Calcitriol; Calcium; Carbon Tetrachloride; Disease Models, Animal; Female; Hu

1999
Effects of Corylus avellana in acetaminophen and CCl4 induced toxicosis.
    Phytotherapy research : PTR, 1999, Volume: 13, Issue:2

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Carbon Tetrachloride; Chemical and Drug Induced Li

1999
Effects of ammonia solution on the gastric mucosa in cirrhotic rats and therapeutic effects of geranylgeranylacetone.
    Journal of gastroenterology and hepatology, 1999, Volume: 14, Issue:6

    Topics: Ammonia; Animals; Anti-Ulcer Agents; Carbon Tetrachloride; Disease Models, Animal; Diterpenes; Gastr

1999
Functional capacity of the cirrhotic liver after partial hepatectomy in the rat.
    Surgery, 1999, Volume: 126, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Hepatectomy; Liver Cirrhosis, Experimental; L

1999
31P and 1H NMR spectroscopic studies of liver extracts of carbon tetrachloride-treated rats.
    NMR in biomedicine, 1999, Volume: 12, Issue:6

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Carbon Tetrachloride; Carbon Tetrachloride P

1999
Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats.
    Journal of hepatology, 2000, Volume: 32, Issue:3

    Topics: Animals; Carbon Tetrachloride; Collateral Circulation; Dimethylnitrosamine; Disease Models, Animal;

2000
Protective effects of seaweeds against liver injury caused by carbon tetrachloride in rats.
    Chemosphere, 2000, Volume: 41, Issue:1-2

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models,

2000
Progression of hepatic stellate cell activation is associated with the level of oxidative stress rather than cytokines during CCl4-induced fibrogenesis.
    Molecules and cells, 2000, Jun-30, Volume: 10, Issue:3

    Topics: Actins; Animals; Arginase; Biological Assay; Carbon Tetrachloride; Cells, Cultured; Cytokines; Disea

2000
The ethanol-soluble part of a hot-water extract from Artemisia iwayomogi inhibits liver fibrosis induced by carbon tetrachloride in rats.
    The Journal of pharmacy and pharmacology, 2000, Volume: 52, Issue:7

    Topics: Animals; Artemisia; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Hot Temperature; Hydroxyp

2000
FTIR spectroscopic and HPLC chromatographic studies of carbon tetrachloride induced acute hepatitis in rats: damage in liver phospholipid membrane.
    Biopolymers, 2000, Volume: 57, Issue:5

    Topics: Acute Disease; Animals; Carbon Tetrachloride; Cell Membrane; Chemical and Drug Induced Liver Injury;

2000
Improvement of phase I drug metabolism with Schisandra chinensis against CCl4 hepatotoxicity in a rat model.
    Planta medica, 2000, Volume: 66, Issue:6

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Male;

2000
Yang-Gan-Wan protects mice against experimental liver damage.
    The American journal of Chinese medicine, 2000, Volume: 28, Issue:2

    Topics: Acetaminophen; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models

2000
Hepatoprotective effects of Arctium lappa on carbon tetrachloride- and acetaminophen-induced liver damage.
    The American journal of Chinese medicine, 2000, Volume: 28, Issue:2

    Topics: Acetaminophen; Animals; Antioxidants; Asteraceae; Carbon Tetrachloride; Chemical and Drug Induced Li

2000
Therapeutic effect of gypenoside on chronic liver injury and fibrosis induced by CCl4 in rats.
    The American journal of Chinese medicine, 2000, Volume: 28, Issue:2

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury, Chronic; Disease Models, Anim

2000
Three-dimensional observations of spatial arrangement of hepatic zonation and vein system in mice and house musk shrews.
    The Anatomical record, 2000, 11-01, Volume: 260, Issue:3

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Di

2000
Antioxidant properties of colchicine in acute carbon tetrachloride induced rat liver injury and its role in the resolution of established cirrhosis.
    Biochimica et biophysica acta, 2000, Nov-15, Volume: 1502, Issue:3

    Topics: Animals; Antioxidants; Carbon Tetrachloride; Colchicine; Disease Models, Animal; Dose-Response Relat

2000
Aloe-Emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride.
    Pharmacology & toxicology, 2000, Volume: 87, Issue:5

    Topics: Albumins; Animals; Anthraquinones; Antineoplastic Agents; Aspartate Aminotransferases; Blotting, Nor

2000
Ampelopsis brevipedunculata (Vitaceae) extract inhibits a progression of carbon tetrachloride-induced hepatic injury in the mice.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2000, Volume: 7, Issue:6

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drugs

2000
Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide.
    Journal of gastroenterology, 2001, Volume: 36, Issue:1

    Topics: Animals; Carbon Tetrachloride; Cell Cycle Proteins; Disease Models, Animal; Liver Cirrhosis; Male; R

2001
Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.
    Infection and immunity, 2001, Volume: 69, Issue:6

    Topics: Animals; Bacteremia; Bacterial Proteins; Carbon Tetrachloride; Complement Activation; Complement C3;

2001
Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats.
    Biochimica et biophysica acta, 2001, May-31, Volume: 1536, Issue:2-3

    Topics: Actins; Animals; Carbon Tetrachloride; Collagen; Disease Models, Animal; Dose-Response Relationship,

2001
Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration.
    Journal of immunology (Baltimore, Md. : 1950), 2001, Jul-01, Volume: 167, Issue:1

    Topics: Animals; Bile Ducts; Carbon Tetrachloride; Cell Fractionation; Cell Line; Cells, Cultured; Chemokine

2001
A rat model of liver cirrhosis and esophageal varices.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 2001, Volume: 200, Issue:3

    Topics: Animals; Carbon Tetrachloride; Collateral Circulation; Disease Models, Animal; Esophageal and Gastri

2001
Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure.
    The Journal of pharmacy and pharmacology, 2001, Volume: 53, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; C

2001
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats.
    Gastroenterology, 2001, Volume: 121, Issue:3

    Topics: Animals; Anti-Allergic Agents; Apoptosis; Calcium; Carbon Tetrachloride; Chlorpromazine; Collagen; C

2001
Induction of hepatic tissue-type plasminogen activator and type 1 plasminogen activator-inhibitor gene expressions and appearance of their translation products in the bile following acute liver injury in rats.
    Thrombosis research, 2001, Nov-15, Volume: 104, Issue:4

    Topics: Animals; Bile; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal;

2001
Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection.
    Biomedical chromatography : BMC, 2001, Volume: 15, Issue:8

    Topics: Adrenergic beta-Antagonists; Animals; Carbon Tetrachloride; Chromatography, High Pressure Liquid; Di

2001
[The coordinated expression of laminin and its integrin receptor in hepatic sinusoidal capillarization].
    Zhonghua nei ke za zhi, 2001, Volume: 40, Issue:9

    Topics: Animals; Antigens, CD; Carbon Tetrachloride; Disease Models, Animal; Integrin alpha6; Laminin; Liver

2001
Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats.
    World journal of gastroenterology, 2001, Volume: 7, Issue:1

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Cell Division; Col

2001
[The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 1998, Volume: 36, Issue:3

    Topics: Animals; Arginine; Carbon Tetrachloride; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Hy

1998
[Dynamic expression of tenascin in rat liver during liver fibrogenesis induced by CCl(4)].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Extracellular Matrix Proteins; Image Processi

2002
[Effects of glycyrrhetinic acid and IFN-alpha on HSCs collagen metabolism in rat fibrotic liver of varying stages].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1

    Topics: Alcohols; Animals; Carbon Tetrachloride; Collagen Type I; Collagen Type III; Disease Models, Animal;

2002
[Experimental study of the therapeutic effect of interferon-alpha on liver fibrosis].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1

    Topics: Animals; Carbon Tetrachloride; Collagen Type IV; Disease Models, Animal; Hyaluronic Acid; Inflammati

2002
Role of plant metabolites in toxic liver injury.
    Asia Pacific journal of clinical nutrition, 2002, Volume: 11, Issue:1

    Topics: Acid Phosphatase; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases;

2002
Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats.
    Toxicology, 2002, Jul-01, Volume: 176, Issue:1-2

    Topics: Acetaminophen; Administration, Oral; Animals; Aryl Hydrocarbon Hydroxylases; Carbon Tetrachloride; C

2002
Tropoelastin expression is up-regulated during activation of hepatic stellate cells and in the livers of CCl(4)-cirrhotic rats.
    Liver, 2002, Volume: 22, Issue:3

    Topics: Actins; Animals; Carbon Tetrachloride; Cells, Cultured; Disease Models, Animal; Electrophoresis, Aga

2002
Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b--an antiendotoxin.
    Gastroenterology, 1978, Volume: 75, Issue:3

    Topics: Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models, Animal; Female; Genta

1978
[Experiments to reproduce Yersinia enterocolitica type 9 infection in guinea pigs].
    Veterinarno-meditsinski nauki, 1976, Volume: 13, Issue:9

    Topics: Administration, Oral; Administration, Topical; Animals; Carbon Tetrachloride; Disease Models, Animal

1976
Manganese induced hepatic lesions in carbon tetrachloride pretreated rats.
    Experimentelle Pathologie, 1975, Volume: 10, Issue:5-6

    Topics: Administration, Oral; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease

1975
Pharmacokinetics of diazepam in the rat: influence of a carbon tetrachloride-induced hepatic injury.
    Journal of pharmaceutical sciences, 1992, Volume: 81, Issue:8

    Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Proteins; Ca

1992
Gastric mucosal blood flow distribution in the CCl4-induced cirrhotic rat--a model of portal hypertensive gastropathy?
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1992, Volume: 192, Issue:5

    Topics: Animals; Blood Flow Velocity; Carbon Tetrachloride; Disease Models, Animal; Gastric Mucosa; Hyperten

1992
Pharmacological and pathological studies on hepatic protective crude drugs from Taiwan (V): The effects of Bombax malabarica and Scutellaria rivularis.
    The American journal of Chinese medicine, 1992, Volume: 20, Issue:3-4

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug

1992
Liver cirrhosis induced by carbon tetrachloride and the effect of superoxide dismutase and xanthine oxidase inhibitor treatment.
    Journal of the Royal College of Surgeons of Edinburgh, 1992, Volume: 37, Issue:1

    Topics: Allopurinol; Animals; Body Weight; Carbon Tetrachloride; Disease Models, Animal; Liver Cirrhosis, Ex

1992
Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture.
    Journal of submicroscopic cytology and pathology, 1992, Volume: 24, Issue:2

    Topics: Actins; Adipose Tissue; Animals; Carbon Tetrachloride; Cell Division; Cell Separation; Common Bile D

1992
Hepatoprotective effects of 1-[(2-thiazolin-2-yl)-amino]acetyl-4-(1,3-dithiol-2-ylidene)-2,3,4,5- tetrahydro-1H-1-benzazepin-3,5-dione hydrochloride (KF-14363) in various experimental liver injuries.
    Japanese journal of pharmacology, 1991, Volume: 57, Issue:2

    Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Benzazepines; Carbon Tetrachloride; Chem

1991
Mucosal lesions of the stomach in liver cirrhosis with a special reference to phospholipid metabolism.
    Gastroenterologia Japonica, 1991, Volume: 26, Issue:3

    Topics: Animals; Bile Reflux; Carbon Tetrachloride; Disease Models, Animal; Gastric Mucosa; Liver Cirrhosis,

1991
The hepatic microcirculation in experimental cirrhosis. A scanning electron microscopy study of microcorrosion casts.
    Scanning microscopy, 1991, Volume: 5, Issue:2

    Topics: Animals; Carbon Tetrachloride; Corrosion Casting; Disease Models, Animal; Liver; Liver Cirrhosis, Ex

1991
Pneumococcal pneumonia in a rat model of cirrhosis: effects of cirrhosis on pulmonary defense mechanisms against Streptococcus pneumoniae.
    The Journal of infectious diseases, 1991, Volume: 163, Issue:1

    Topics: Animals; Antigens, Bacterial; Carbon Tetrachloride; Complement System Proteins; Disease Models, Anim

1991
A rodent model of cirrhosis, ascites, and bacterial peritonitis.
    Gastroenterology, 1991, Volume: 100, Issue:2

    Topics: Animals; Ascites; Bacterial Infections; Carbon Tetrachloride; Disease Models, Animal; Liver Cirrhosi

1991
Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat.
    Hepatology (Baltimore, Md.), 1991, Volume: 13, Issue:5

    Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis,

1991
Biokinetics of 99mTc-labelled liver-imaging agents in an animal model of liver cirrhosis.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1991, Volume: 10, Issue:2

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Liver; Liver Cirrhosis, Experimental; Male; O

1991
Impaired hepatic handling and processing of lysophosphatidylcholine in rats with liver cirrhosis.
    Gastroenterology, 1991, Volume: 101, Issue:1

    Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Carbon Radioisotopes; Carbon Tetrachloride;

1991
Two rat models of hepatic fibrosis. A morphologic and molecular comparison.
    Laboratory investigation; a journal of technical methods and pathology, 1990, Volume: 63, Issue:4

    Topics: Animals; Antigen-Antibody Complex; Carbon Tetrachloride; Collagen; Disease Models, Animal; Gene Expr

1990
Availability of exchange blood transfusion and plasma exchange in treatment of acute liver failure.
    Progress in clinical and biological research, 1990, Volume: 337

    Topics: Acute Disease; Animals; Blood Transfusion; Carbon Tetrachloride; Chemical and Drug Induced Liver Inj

1990
Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in acute liver injury.
    Growth factors (Chur, Switzerland), 1989, Volume: 1, Issue:3

    Topics: Acute Disease; Animals; Blotting, Northern; Carbon Tetrachloride; Chemical and Drug Induced Liver In

1989
Problems with animal models of chronic liver disease: suggestions for improvement in standardization.
    Hepatology (Baltimore, Md.), 1989, Volume: 9, Issue:3

    Topics: Animals; Behavior, Animal; Carbon Tetrachloride; Chronic Disease; Disease Models, Animal; Hepatic En

1989
Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin-aldosterone system.
    Clinical science (London, England : 1979), 1988, Volume: 75, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Animals; Carbon Tetrachloride; Disease Models, Animal; Ki

1988
Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis.
    The Journal of pathology, 1988, Volume: 156, Issue:1

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Drug Synergism; Ethanol; Liver; Liver Cirrhos

1988
The effect of prostaglandins, branched-chain amino acids and other drugs on the outcome of experimental acute porcine hepatic failure.
    Journal of hepatology, 1987, Volume: 4, Issue:1

    Topics: Acetylcysteine; Amino Acids, Branched-Chain; Amino Acids, Essential; Animals; Carbon Tetrachloride;

1987
A predictable pathophysiological model of porcine hepatic failure.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1986, Volume: 18, Issue:5

    Topics: Amino Acids; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Disease Models, Animal; Hep

1986
[Substance-induced liver injury as a model for evaluating hepatoprotective drugs].
    Casopis lekaru ceskych, 1985, Feb-08, Volume: 124, Issue:6

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug

1985
[Changes in the bile secretion and bile ductules in the course of development of experimental hepatitis and liver cirrhosis].
    Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie, 1971, Volume: 114, Issue:2

    Topics: Acute Disease; Adenosine Triphosphatases; Animals; Bile; Bile Ducts; Carbon Tetrachloride; Chemical

1971
[Experimental carbon tetrachloride poisoning and fat embolism in rabbits].
    Acta morphologica Academiae Scientiarum Hungaricae, 1974, Volume: 22, Issue:2

    Topics: Administration, Oral; Animals; Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Disease Models,

1974
Experimental siderosis and liver injury in the rhesus monkey.
    The Journal of pathology, 1972, Volume: 106, Issue:2

    Topics: Animals; Blood Proteins; Carbon Tetrachloride; Disease Models, Animal; Ethanol; Female; Haplorhini;

1972
The effects of azathioprine on CCl4 induced cirrhosis in the rat.
    Beitrage zur Pathologie, 1974, Volume: 152, Issue:1

    Topics: Adenosine Triphosphate; Animals; Azathioprine; Carbon Tetrachloride; Carbon Tetrachloride Poisoning;

1974
[Behavior of serum protein fractions--especially of glycoproteins--in an inflammation model under varied response conditions].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1971, Dec-15, Volume: 26, Issue:24

    Topics: Animals; Blood Proteins; Carbon Tetrachloride; Ceruloplasmin; Disease Models, Animal; Electrophoresi

1971
[Comparative studies on the induction of chronic hepatitis in the rat].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1971, Dec-15, Volume: 26, Issue:24

    Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Chronic Disease; Diabetes Mel

1971
Effect of sirepar on experimental cirrhosis in rats.
    Therapia Hungarica (English edition), 1970, Volume: 18, Issue:3

    Topics: Animals; Carbon Tetrachloride; Disease Models, Animal; Fatty Liver; Liver; Liver Cirrhosis; Liver Ex

1970
Studies on the effect of various anthelmintics upon Fasciola hepatica in albino rats.
    Research in veterinary science, 1970, Volume: 11, Issue:1

    Topics: Age Factors; Animals; Anthelmintics; Carbon Tetrachloride; Disease Models, Animal; Fasciola hepatica

1970